CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: tert-butyl hydroperoxide
Accession: CHEBI:64090
browse the term
Definition: An alkyl hydroperoxide in which the alkyl group is tert-butyl. It is widely used in a variety of oxidation processes.
Synonyms: related_synonym: 1,1-Dimethylethyl hydroperoxide; 2-Hydroperoxy-2-methylpropane; Dimethylethyl hydroperoxide; Formula=C4H10O2; Hydroperoxyde de butyle tertiaire; InChI=1S/C4H10O2/c1-4(2,3)6-5/h5H,1-3H3; InChIKey=CIHOLLKRGTVIJN-UHFFFAOYSA-N; SMILES=CC(C)(C)OO; TBHP; Tertiary-butyl hydroperoxide; t-Butylhydroperoxide; t-butyl hydroperoxide; tert-Butylhydroperoxide
xref: CAS:75-91-2
xref_mesh: MESH:D020122
xref: PMID:21418283; PMID:22037478; PMID:22039964; PMID:22326806; PMID:22337620; PMID:22369679; Reaxys:1098280; Wikipedia:Tert-Butyl_hydroperoxide
Symbol
Object Name
Qualifiers
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
Abca1
ATP binding cassette subfamily A member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ABCA1 mRNA
CTD
PMID:15336504
NCBI chr 5:72,473,676...72,596,563
Ensembl chr 5:67,681,297...67,801,170
G
Abcb11
ATP binding cassette subfamily B member 11
multiple interactions affects localization decreases expression
EXP ISO
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ABCB11 protein]; Bilirubin analog inhibits the reaction [tert-Butylhydroperoxide affects the localization of and results in decreased activity of ABCB11 protein]; Bucladesine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ABCB11 protein]; tert-Butylhydroperoxide affects the localization of and results in decreased activity of ABCB11 protein tert-Butylhydroperoxide results in decreased expression of ABCB11 mRNA
CTD
PMID:16452108 PMID:24306262 PMID:34767876
NCBI chr 3:74,424,620...74,520,646
Ensembl chr 3:54,017,127...54,112,730
G
Abcb1a
ATP binding cassette subfamily B member 1A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ABCB1A mRNA
CTD
PMID:14729362
NCBI chr 4:26,312,403...26,488,456
Ensembl chr 4:25,158,362...25,442,709
G
Abcc2
ATP binding cassette subfamily C member 2
decreases expression multiple interactions affects localization
ISO EXP
tert-Butylhydroperoxide results in decreased expression of ABCC2 mRNA Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ABCC2 protein]; Bilirubin analog inhibits the reaction [tert-Butylhydroperoxide affects the localization of and results in decreased activity of ABCC2 protein]; Go 6976 inhibits the reaction [tert-Butylhydroperoxide affects the localization of ABCC2 protein]; tert-Butylhydroperoxide affects the localization of and results in decreased activity of ABCC2 protein
CTD
PMID:22956110 PMID:24306262 PMID:34303734
NCBI chr 1:252,613,875...252,672,459
Ensembl chr 1:242,664,657...242,723,238
G
Abcd1
ATP binding cassette subfamily D member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ABCD1 mRNA
CTD
PMID:15003993
NCBI chr X:156,579,669...156,601,448
Ensembl chr X:151,428,578...151,450,115
G
Abhd17a
abhydrolase domain containing 17A, depalmitoylase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ABHD17A mRNA
CTD
PMID:15336504
NCBI chr 7:9,775,016...9,781,447
Ensembl chr 7:9,124,332...9,130,762
G
Ablim1
actin-binding LIM protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ABLIM1 mRNA
CTD
PMID:15336504
NCBI chr 1:266,088,868...266,377,169
Ensembl chr 1:256,084,297...256,371,969
G
Abr
ABR activator of RhoGEF and GTPase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ABR mRNA
CTD
PMID:15003993
NCBI chr10:61,760,743...61,959,526
Ensembl chr10:61,262,516...61,461,505
G
Acads
acyl-CoA dehydrogenase short chain
increases expression decreases expression multiple interactions
ISO EXP
tert-Butylhydroperoxide results in increased expression of ACADS mRNA tert-Butylhydroperoxide results in decreased expression of ACADS mRNA acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of ACADS mRNA]; acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of and results in decreased activity of ACADS protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of ACADS mRNA]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of and results in decreased activity of ACADS protein]; tert-Butylhydroperoxide results in decreased expression of and results in decreased activity of ACADS protein
CTD
PMID:15003993 PMID:26989860
NCBI chr12:47,154,259...47,163,580
Ensembl chr12:41,493,626...41,502,898
G
Ache
acetylcholinesterase
multiple interactions increases expression increases secretion
EXP
Benzenaminium, 4,4'-(3-oxo-1,5-pentanediyl)bis(N,N-dimethyl-N-2-propenyl-), Dibromide inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of ACHE protein] tert-Butylhydroperoxide results in increased expression of ACHE mRNA alternative form
CTD
PMID:16903848
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
G
Ackr3
atypical chemokine receptor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ACKR3 mRNA
CTD
PMID:15336504
NCBI chr 9:98,247,300...98,258,877
Ensembl chr 9:90,799,686...90,811,237
G
Aco1
aconitase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACO1 mRNA
CTD
PMID:15336504
NCBI chr 5:60,055,895...60,111,920
Ensembl chr 5:55,259,827...55,316,391
G
Acot1
acyl-CoA thioesterase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACOT1 mRNA
CTD
PMID:14729362
NCBI chr 6:109,367,274...109,375,268
Ensembl chr 6:103,636,041...103,644,163
G
Acot7
acyl-CoA thioesterase 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACOT7 mRNA
CTD
PMID:15003993
NCBI chr 5:167,969,284...168,062,033
Ensembl chr 5:162,684,645...162,779,309
G
Acsl3
acyl-CoA synthetase long-chain family member 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ACSL3 mRNA
CTD
PMID:15336504
NCBI chr 9:87,563,601...87,613,078
Ensembl chr 9:80,115,112...80,164,627
G
Actb
actin, beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ACTB mRNA
CTD
PMID:12419474
NCBI chr12:16,776,664...16,779,634
Ensembl chr12:11,663,109...11,672,877
G
Actg2
actin gamma 2, smooth muscle
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACTG2 mRNA
CTD
PMID:15336504
NCBI chr 4:117,579,513...117,604,379
Ensembl chr 4:116,021,832...116,046,465
G
Actn1
actinin, alpha 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACTN1 mRNA
CTD
PMID:15336504
NCBI chr 6:104,731,485...104,826,312
Ensembl chr 6:98,998,556...99,093,251
G
Actr3
actin related protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACTR3 mRNA
CTD
PMID:15336504
NCBI chr13:39,353,413...39,396,509
Ensembl chr13:36,800,093...36,844,124
G
Actr3b
actin related protein 3B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ACTR3B mRNA
CTD
PMID:15336504
NCBI chr 4:9,995,553...10,089,422
Ensembl chr 4:9,262,233...9,355,441
G
Acy3
aminoacylase 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ACY3 mRNA
CTD
PMID:15003993
NCBI chr 1:210,709,238...210,715,258
Ensembl chr 1:201,279,851...201,283,175
G
Acyp1
acylphosphatase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ACYP1 mRNA
CTD
PMID:15336504
NCBI chr 6:110,650,213...110,663,404
Ensembl chr 6:104,919,162...104,932,387
G
Adam19
ADAM metallopeptidase domain 19
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ADAM19 mRNA
CTD
PMID:15336504
NCBI chr10:30,992,713...31,084,455
Ensembl chr10:30,491,405...30,583,105
G
Adam8
ADAM metallopeptidase domain 8
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ADAM8 mRNA
CTD
PMID:15003993
NCBI chr 1:204,206,206...204,218,988
Ensembl chr 1:194,770,060...194,788,801
G
Adam9
ADAM metallopeptidase domain 9
multiple interactions increases expression affects expression
ISO
[rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ADAM9 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADAM9 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADAM9 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADAM9 mRNA] tert-Butylhydroperoxide affects the expression of ADAM9 mRNA
CTD
PMID:20847119 PMID:23410634
NCBI chr16:73,725,186...73,804,284
Ensembl chr16:67,022,655...67,100,917
G
Adar
adenosine deaminase, RNA-specific
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ADAR mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 2:177,436,076...177,475,969
Ensembl chr 2:175,138,403...175,178,282
G
Adat1
adenosine deaminase, tRNA-specific 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ADAT1 mRNA
CTD
PMID:15963989
NCBI chr19:39,918,083...39,956,886
Ensembl chr19:39,918,227...39,956,883
G
Adcy3
adenylate cyclase 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ADCY3 mRNA
CTD
PMID:12414654
NCBI chr 6:32,819,602...32,923,174
Ensembl chr 6:27,124,828...27,203,686
G
Adcy9
adenylate cyclase 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ADCY9 mRNA
CTD
PMID:15336504
NCBI chr10:11,645,373...11,768,462
Ensembl chr10:11,139,446...11,262,066
G
Add2
adducin 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ADD2 mRNA
CTD
PMID:15336504
NCBI chr 4:120,001,977...120,101,090
Ensembl chr 4:118,497,416...118,538,505
G
Add3
adducin 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ADD3 mRNA
CTD
PMID:15336504
NCBI chr 1:262,152,722...262,260,504
Ensembl chr 1:252,147,386...252,255,124
G
Adgrg6
adhesion G protein-coupled receptor G6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ADGRG6 mRNA
CTD
PMID:15336504
NCBI chr 1:10,633,004...10,774,685
Ensembl chr 1:8,812,904...8,954,123
G
Adh7
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ADH7 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 2:229,422,125...229,436,584
Ensembl chr 2:226,741,788...226,763,182
G
Adipor2
adiponectin receptor 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ADIPOR2 mRNA
CTD
PMID:15336504
NCBI chr 4:154,195,440...154,261,141
Ensembl chr 4:152,524,623...152,559,355
G
Adm
adrenomedullin
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ADM mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ADM mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ADM mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADM mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ADM mRNA]
CTD
PMID:14729362 PMID:15003993 PMID:15336504 PMID:20847119 PMID:29432895
NCBI chr 1:174,164,178...174,182,372
Ensembl chr 1:164,745,466...164,747,654
G
Adora1
adenosine A1 receptor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ADORA1 mRNA
CTD
PMID:12419474
NCBI chr13:48,210,922...48,247,826
Ensembl chr13:45,658,872...45,695,801
G
Adora2b
adenosine A2B receptor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ADORA2B mRNA
CTD
PMID:15336504
NCBI chr10:47,439,712...47,456,092
Ensembl chr10:46,940,384...46,956,772
G
Agk
acylglycerol kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AGK mRNA
CTD
PMID:15336504
NCBI chr 4:70,081,550...70,160,642
Ensembl chr 4:69,114,269...69,193,934
G
Ago2
argonaute RISC catalytic component 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AGO2 mRNA
CTD
PMID:15336504
NCBI chr 7:106,907,209...106,994,124
Ensembl chr 7:105,029,120...105,104,974
G
Agpat1
1-acylglycerol-3-phosphate O-acyltransferase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AGPAT1 mRNA
CTD
PMID:15003993
NCBI chr20:4,140,565...4,149,531
Ensembl chr20:4,135,957...4,145,278
G
Ahsa1
activator of Hsp90 ATPase activity 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AHSA1 mRNA
CTD
PMID:15336504
NCBI chr 6:112,644,287...112,652,290
Ensembl chr 6:106,913,530...106,921,345
G
Aifm1
apoptosis inducing factor, mitochondria associated 1
multiple interactions increases expression
ISO
resveratrol inhibits the reaction [tert-Butylhydroperoxide results in increased expression of AIFM1 protein]
CTD
PMID:25522270
NCBI chr X:132,528,107...132,567,237
Ensembl chr X:127,650,226...127,689,256
G
Aip
aryl-hydrocarbon receptor-interacting protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AIP mRNA
CTD
PMID:15336504
NCBI chr 1:210,837,473...210,848,691
Ensembl chr 1:201,407,288...201,419,122
G
Ajuba
ajuba LIM protein
multiple interactions decreases expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AJUBA mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AJUBA mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AJUBA mRNA; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of AJUBA mRNA]
CTD
PMID:20847119
NCBI chr15:31,989,796...32,000,042
Ensembl chr15:28,019,778...28,030,021
G
Ak2
adenylate kinase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AK2 mRNA
CTD
PMID:15336504
NCBI chr 5:146,609,469...146,649,008
Ensembl chr 5:141,346,063...141,364,632
G
Ak4
adenylate kinase 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AK4 mRNA
CTD
PMID:15003993
NCBI chr 5:121,154,565...121,214,403
Ensembl chr 5:116,039,616...116,098,618
G
Akap12
A-kinase anchoring protein 12
affects expression
ISO
tert-Butylhydroperoxide affects the expression of AKAP12 mRNA
CTD
PMID:23410634
NCBI chr 1:43,135,515...43,225,245
Ensembl chr 1:40,730,123...40,819,886
G
Akap9
A-kinase anchoring protein 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AKAP9 mRNA
CTD
PMID:15336504
NCBI chr 4:31,011,475...31,147,338
Ensembl chr 4:30,056,738...30,192,606
G
Akr1b10
aldo-keto reductase family 1 member B10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AKR1B10 mRNA
CTD
PMID:23410634 PMID:34767876
NCBI chr 4:64,005,632...64,027,860
Ensembl chr 4:63,040,169...63,053,852
G
Akr1c1
aldo-keto reductase family 1, member C1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AKR1C1 mRNA
CTD
PMID:15336504
NCBI chr17:70,720,397...70,747,285
Ensembl chr17:65,810,475...65,837,326
G
Akr1c2
aldo-keto reductase family 1, member C2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AKR1C2 mRNA
CTD
PMID:12414654 PMID:15336504 PMID:23410634
NCBI chr17:70,669,684...70,717,935
Ensembl chr17:65,759,788...65,775,764
G
Akt1
AKT serine/threonine kinase 1
decreases phosphorylation multiple interactions
ISO
tert-Butylhydroperoxide results in decreased phosphorylation of AKT1 protein 3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased phosphorylation of AKT1 protein]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of AKT1 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of AKT1 mRNA]
CTD
PMID:29128606 PMID:35690295
NCBI chr 6:137,534,810...137,555,131
Ensembl chr 6:131,713,720...131,733,921
G
Akt2
AKT serine/threonine kinase 2
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of AKT2 mRNA tert-Butylhydroperoxide results in increased methylation of AKT2 gene
CTD
PMID:27509014
NCBI chr 1:92,004,705...92,061,420
Ensembl chr 1:82,883,547...82,933,817
G
Alad
aminolevulinate dehydratase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALAD mRNA
CTD
PMID:15336504
NCBI chr 5:80,977,562...80,987,901
Ensembl chr 5:75,961,993...75,972,474
G
Alas1
5'-aminolevulinate synthase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALAS1 protein
CTD
PMID:21659532
NCBI chr 8:115,755,238...115,768,642
Ensembl chr 8:106,876,514...106,889,917
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALDH1A1 mRNA tert-Butylhydroperoxide affects the expression of ALDH1A1 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 1:227,426,939...227,579,497
Ensembl chr 1:218,042,127...218,152,961
G
Aldh1a3
aldehyde dehydrogenase 1 family, member A3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ALDH1A3 mRNA
CTD
PMID:15336504
NCBI chr 1:129,392,516...129,436,552
Ensembl chr 1:119,982,277...120,017,436
G
Aldh2
aldehyde dehydrogenase 2 family member
increases expression decreases response to substance
ISO
tert-Butylhydroperoxide results in increased expression of ALDH2 mRNA ALDH2 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr12:40,610,244...40,643,220
Ensembl chr12:34,901,219...34,982,521
G
Aldh3a2
aldehyde dehydrogenase 3 family, member A2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALDH3A2 mRNA
CTD
PMID:15336504
NCBI chr10:46,427,789...46,448,449
Ensembl chr10:45,908,524...45,949,281
G
Aldh4a1
aldehyde dehydrogenase 4 family, member A1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALDH4A1 mRNA
CTD
PMID:15336504
NCBI chr 5:157,163,189...157,188,673
Ensembl chr 5:151,830,701...151,925,345
G
Aldh6a1
aldehyde dehydrogenase 6 family, member A1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALDH6A1 mRNA
CTD
PMID:15336504
NCBI chr 6:109,809,092...109,829,725
Ensembl chr 6:104,077,979...104,098,656
G
Aldh7a1
aldehyde dehydrogenase 7 family, member A1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALDH7A1 mRNA
CTD
PMID:15336504
NCBI chr18:52,208,035...52,240,293
Ensembl chr18:50,009,934...50,042,193
G
Aldoc
aldolase, fructose-bisphosphate C
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ALDOA mRNA
CTD
PMID:15003993
NCBI chr10:63,715,544...63,719,133
Ensembl chr10:63,217,451...63,221,066
G
Alox5
arachidonate 5-lipoxygenase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ALOX5 mRNA
CTD
PMID:15336504
NCBI chr 4:151,203,948...151,251,126
Ensembl chr 4:149,531,515...149,578,743
G
Amd1
adenosylmethionine decarboxylase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AMD1 mRNA
CTD
PMID:27509014
NCBI chr20:43,695,783...43,711,476
Ensembl chr20:43,697,237...43,711,476
G
Amigo2
adhesion molecule with Ig like domain 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AMIGO2 mRNA
CTD
PMID:15336504
NCBI chr 7:130,270,639...130,273,735
Ensembl chr 7:128,390,412...128,394,695
G
Amotl2
angiomotin like 2
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AMOTL2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AMOTL2 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of AMOTL2 mRNA; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of AMOTL2 mRNA]
CTD
PMID:20847119
NCBI chr 8:112,182,060...112,198,032
Ensembl chr 8:103,302,992...103,318,910
G
Ampd3
adenosine monophosphate deaminase 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AMPD3 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 1:174,319,526...174,364,605
Ensembl chr 1:164,885,320...164,929,887
G
Amph
amphiphysin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AMPH mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr17:50,435,018...50,678,583
Ensembl chr17:45,739,395...45,983,315
G
Anapc5
anaphase-promoting complex subunit 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ANAPC5 mRNA
CTD
PMID:15336504
NCBI chr12:39,409,519...39,442,518
Ensembl chr12:33,748,735...33,781,781
G
Angptl2
angiopoietin-like 2
multiple interactions increases expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANGPTL2 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANGPTL2 mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANGPTL2 mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANGPTL2 mRNA]
CTD
PMID:15003993 PMID:20847119
NCBI chr 3:36,914,876...36,944,715
Ensembl chr 3:16,517,420...16,548,178
G
Angptl7
angiopoietin like 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ANGPTL7 mRNA
CTD
PMID:15336504
NCBI chr 5:158,932,096...158,937,281
Ensembl chr 5:158,932,794...158,937,324
G
Ankmy2
ankyrin repeat and MYND domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ANKMY2 mRNA
CTD
PMID:15336504
NCBI chr 6:58,616,251...58,657,634
Ensembl chr 6:52,888,963...52,930,394
G
Ankra2
ankyrin repeat family A member 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of ANKRA2 mRNA
CTD
PMID:23410634
NCBI chr 2:31,347,158...31,358,002
Ensembl chr 2:29,612,925...29,623,730
G
Ankrd10
ankyrin repeat domain 10
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ANKRD10 mRNA
CTD
PMID:15336504
NCBI chr16:84,566,021...84,591,849
Ensembl chr16:77,864,261...77,889,745
G
Ankrd2
ankyrin repeat domain 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ANKRD2 mRNA
CTD
PMID:15336504
NCBI chr 1:250,796,419...250,805,867
Ensembl chr 1:240,847,072...240,856,566
G
Ankrd37
ankyrin repeat domain 37
multiple interactions increases expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANKRD37 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANKRD37 mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ANKRD37 mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANKRD37 mRNA]; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANKRD37 mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ANKRD37 mRNA]
CTD
PMID:20847119
NCBI chr16:53,001,487...53,004,545
Ensembl chr16:46,268,443...46,271,963
G
Ankrd6
ankyrin repeat domain 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ANKRD6 mRNA
CTD
PMID:15336504
NCBI chr 5:51,999,225...52,139,623
Ensembl chr 5:47,202,873...47,343,090
G
Anp32a
acidic nuclear phosphoprotein 32 family member A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ANP32A mRNA
CTD
PMID:15336504
NCBI chr 8:71,724,578...71,760,922
Ensembl chr 8:62,827,456...62,865,443
G
Anpep
alanyl aminopeptidase, membrane
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ANPEP mRNA
CTD
PMID:15336504
NCBI chr 1:143,176,645...143,219,447
Ensembl chr 1:133,767,332...133,785,789
G
Anxa4
annexin A4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ANXA4 mRNA
CTD
PMID:15336504
NCBI chr 4:120,741,750...120,798,534
Ensembl chr 4:119,184,374...119,241,161
G
Anxa8
annexin A8
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ANXA8 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr16:9,403,267...9,418,317
Ensembl chr16:9,397,113...9,412,043
G
Aox1
aldehyde oxidase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AOX1 mRNA
CTD
PMID:15336504
NCBI chr 9:67,073,831...67,152,980
Ensembl chr 9:59,579,649...59,658,770
G
Ap3b1
adaptor related protein complex 3 subunit beta 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AP3B1 mRNA
CTD
PMID:15336504
NCBI chr 2:27,331,241...27,535,683
Ensembl chr 2:25,600,040...25,800,935
G
Ap3d1
adaptor related protein complex 3 subunit delta 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AP3D1 mRNA
CTD
PMID:15336504
NCBI chr 7:9,620,909...9,656,350
Ensembl chr 7:8,970,291...9,005,643
G
Apaf1
apoptotic peptidase activating factor 1
increases expression multiple interactions
ISO EXP
tert-Butylhydroperoxide results in increased expression of APAF1 protein Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of APAF1 protein] [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of APAF1 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of APAF1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of APAF1 mRNA]
CTD
PMID:15877105 PMID:17419000 PMID:35690295
NCBI chr 7:27,381,392...27,466,772
Ensembl chr 7:25,494,609...25,579,540
G
Aplp2
amyloid beta precursor like protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of APLP2 mRNA
CTD
PMID:15336504
NCBI chr 8:37,857,407...37,920,487
Ensembl chr 8:29,599,230...29,661,855
G
Apoa5
apolipoprotein A5
affects expression
ISO
tert-Butylhydroperoxide affects the expression of APOA5 mRNA
CTD
PMID:23410634
NCBI chr 8:55,446,329...55,460,509
Ensembl chr 8:46,561,229...46,563,816
G
Apoe
apolipoprotein E
increases expression affects localization
ISO EXP
tert-Butylhydroperoxide results in increased expression of APOE mRNA tert-Butylhydroperoxide affects the localization of APOE protein
CTD
PMID:15336504 PMID:19720132
NCBI chr 1:88,481,889...88,485,816
Ensembl chr 1:79,353,916...79,357,932
G
Apold1
apolipoprotein L domain containing 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of APOLD1 mRNA
CTD
PMID:15336504
NCBI chr 4:169,499,728...169,557,075
Ensembl chr 4:167,818,271...167,825,706
G
App
amyloid beta precursor protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of APP mRNA
CTD
PMID:12419474
NCBI chr11:37,506,207...37,724,351
Ensembl chr11:24,019,778...24,236,561
G
Appl1
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of APPL1 mRNA
CTD
PMID:15336504
NCBI chr16:2,125,234...2,173,457
Ensembl chr16:2,121,255...2,166,692
G
Appl2
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of APPL2 mRNA
CTD
PMID:15336504
NCBI chr 7:22,019,480...22,072,386
Ensembl chr 7:20,135,375...20,184,754
G
Aqp1
aquaporin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AQP1 mRNA
CTD
PMID:15336504
NCBI chr 4:85,812,784...85,824,964
Ensembl chr 4:84,482,512...84,494,690
G
Aqp4
aquaporin 4
multiple interactions
EXP
tert-Butylhydroperoxide results in increased expression of and affects the localization of AQP4 protein
CTD
PMID:20648640
NCBI chr18:6,782,389...6,799,034
Ensembl chr18:6,507,903...6,524,856
G
Aqr
aquarius intron-binding spliceosomal factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AQR mRNA
CTD
PMID:15336504
NCBI chr 3:121,329,287...121,399,375
Ensembl chr 3:100,874,987...100,945,044
G
Areg
amphiregulin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AREG mRNA
CTD
PMID:12414654
NCBI chr14:17,256,384...17,265,641
Ensembl chr14:16,972,187...16,981,535
G
Arf6
ARF GTPase 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ARF6 mRNA
CTD
PMID:15336504
NCBI chr 6:93,589,777...93,590,925
Ensembl chr 6:87,840,142...87,874,114
G
Arg2
arginase 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of ARG2 mRNA
CTD
PMID:23410634
NCBI chr 6:103,669,001...103,694,375
Ensembl chr 6:97,936,002...97,961,378
G
Arhgdia
Rho GDP dissociation inhibitor alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ARHGDIA mRNA
CTD
PMID:12419474
NCBI chr10:106,352,858...106,356,347
Ensembl chr10:105,854,533...105,858,023
G
Arhgef10
Rho guanine nucleotide exchange factor 10
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ARHGEF10 mRNA
CTD
PMID:15336504
NCBI chr16:81,349,429...81,440,439
Ensembl chr16:74,647,153...74,738,173
G
Arhgef7
Rho guanine nucleotide exchange factor 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ARHGEF7 mRNA
CTD
PMID:15336504
NCBI chr16:84,373,123...84,484,759
Ensembl chr16:77,671,023...77,782,697
G
Arid3a
AT-rich interaction domain 3A
affects expression
ISO
tert-Butylhydroperoxide affects the expression of ARID3A mRNA
CTD
PMID:23410634
NCBI chr 7:10,403,161...10,431,551
Ensembl chr 7:9,755,294...9,780,599
G
Arl6ip1
ARL6 interacting reticulophagy regulator 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ARL6IP1 mRNA
CTD
PMID:15336504
NCBI chr 1:181,864,717...181,874,232
Ensembl chr 1:172,430,489...172,439,994
G
Arl6ip5
ARF like GTPase 6 interacting protein 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ARL6IP5 mRNA
CTD
PMID:15336504
NCBI chr 4:131,365,320...131,395,311
Ensembl chr 4:129,810,645...129,838,608
G
Arnt
aryl hydrocarbon receptor nuclear translocator
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of ARNT mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of ARNT mRNA]
CTD
PMID:35690295
NCBI chr 2:185,686,703...185,745,546
Ensembl chr 2:182,997,736...183,056,580
G
Arpc1a
actin related protein 2/3 complex, subunit 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ARPC1A mRNA
CTD
PMID:15336504
NCBI chr12:9,502,496...9,525,304
Ensembl chr12:9,502,501...9,525,330
G
Asf1a
anti-silencing function 1A histone chaperone
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ASF1A mRNA
CTD
PMID:23410634
NCBI chr20:33,436,632...33,451,478
Ensembl chr20:32,893,573...32,908,808
G
Asf1b
anti-silencing function 1B histone chaperone
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ASF1B mRNA
CTD
PMID:15336504
NCBI chr19:41,085,786...41,100,352
Ensembl chr19:24,181,028...24,195,549
G
Asph
aspartate-beta-hydroxylase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ASPH mRNA
CTD
PMID:15336504
NCBI chr 5:27,398,933...27,611,519
Ensembl chr 5:22,603,486...22,813,876
G
Aspscr1
ASPSCR1 tether for SLC2A4, UBX domain containing
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ASPSCR1 mRNA
CTD
PMID:15336504
NCBI chr10:106,450,600...106,488,231
Ensembl chr10:105,952,227...105,989,904
G
Ass1
argininosuccinate synthase 1
decreases expression
ISO EXP
tert-Butylhydroperoxide results in decreased expression of ASS1 mRNA; tert-Butylhydroperoxide results in decreased expression of ASS1 protein
CTD
PMID:15336504 PMID:24394546
NCBI chr 3:35,144,765...35,194,632
Ensembl chr 3:14,747,368...14,796,903
G
Asxl1
ASXL transcriptional regulator 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ASXL1 mRNA
CTD
PMID:15336504
NCBI chr 3:162,273,828...162,341,742
Ensembl chr 3:141,813,433...141,881,538
G
Atad2
ATPase family, AAA domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ATAD2 mRNA
CTD
PMID:15336504
NCBI chr 7:91,523,626...91,566,238
Ensembl chr 7:89,634,123...89,676,738
G
Atf3
activating transcription factor 3
multiple interactions increases expression decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ATF3 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ATF3 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ATF3 mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ATF3 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ATF3 mRNA] tert-Butylhydroperoxide results in decreased expression of ATF3 mRNA
CTD
PMID:12414654 PMID:20196124 PMID:20847119
NCBI chr13:105,274,103...105,331,653
Ensembl chr13:102,751,321...102,764,631
G
Atg4b
autophagy related 4B, cysteine peptidase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ATG4B mRNA
CTD
PMID:15336504
NCBI chr 9:101,729,772...101,761,456
Ensembl chr 9:94,282,509...94,314,103
G
Atg5
autophagy related 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ATG5 mRNA
CTD
PMID:15336504
NCBI chr20:49,380,835...49,471,826
Ensembl chr20:47,798,290...47,889,209
G
Atp13a3
ATPase 13A3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ATP13A3 mRNA
CTD
PMID:15336504
NCBI chr11:83,860,725...83,946,899
Ensembl chr11:70,365,322...70,441,235
G
Atp2a2
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ATP2A2 mRNA
CTD
PMID:15336504
NCBI chr12:39,733,519...39,782,942
Ensembl chr12:34,072,683...34,122,101
G
Atp2b1
ATPase plasma membrane Ca2+ transporting 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ATP2B1 mRNA
CTD
PMID:15336504
NCBI chr 7:35,622,267...35,731,904
Ensembl chr 7:33,735,871...33,843,295
G
Atp6v1a
ATPase H+ transporting V1 subunit A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ATP6V1A mRNA
CTD
PMID:15336504
NCBI chr11:70,066,800...70,120,603
Ensembl chr11:56,560,974...56,614,694
G
Atp6v1c1
ATPase H+ transporting V1 subunit C1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ATP6V1C1 mRNA
CTD
PMID:15336504
NCBI chr 7:71,719,326...71,757,191
Ensembl chr 7:69,834,463...69,872,278
G
Atr
ATR serine/threonine kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ATR mRNA
CTD
PMID:12419474
NCBI chr 8:105,306,299...105,403,742
Ensembl chr 8:96,426,724...96,524,136
G
Atxn1
ataxin 1
affects localization multiple interactions decreases expression
ISO
tert-Butylhydroperoxide affects the localization of ATXN1 protein mutant form Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide affects the localization of ATXN1 protein mutant form]; Buthionine Sulfoximine promotes the reaction [tert-Butylhydroperoxide affects the localization of ATXN1 protein mutant form] tert-Butylhydroperoxide results in decreased expression of ATXN1 mRNA
CTD
PMID:12893416 PMID:15336504
NCBI chr17:18,943,397...19,354,751
Ensembl chr17:18,737,533...19,142,360
G
Atxn3
ataxin 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ATXN3 mRNA
CTD
PMID:15336504
NCBI chr 6:126,837,107...126,872,919
Ensembl chr 6:121,074,448...121,107,902
G
Aurka
aurora kinase A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of AURKA mRNA
CTD
PMID:15003993
NCBI chr 3:181,546,742...181,562,890
Ensembl chr 3:161,128,313...161,144,390
G
Aurkb
aurora kinase B
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AURKB mRNA tert-Butylhydroperoxide results in increased expression of AURKB mRNA
CTD
PMID:12414654 PMID:29432895
NCBI chr10:54,243,116...54,249,675
Ensembl chr10:53,745,142...53,750,837
G
Auts2
activator of transcription and developmental regulator AUTS2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AUTS2 mRNA
CTD
PMID:15336504
NCBI chr12:29,739,138...30,830,386
Ensembl chr12:24,104,192...25,194,416
G
Azin1
antizyme inhibitor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of AZIN1 mRNA
CTD
PMID:15336504
NCBI chr 7:71,539,711...71,566,515
Ensembl chr 7:69,654,663...69,681,578
G
Babam1
BRISC and BRCA1 A complex member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BABAM1 mRNA
CTD
PMID:15336504
NCBI chr16:18,102,885...18,108,916
Ensembl chr16:18,068,884...18,074,923
G
Babam2
BRISC and BRCA1 A complex member 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BABAM2 mRNA
CTD
PMID:15003993
NCBI chr 6:30,089,065...30,467,508
Ensembl chr 6:24,369,022...24,833,951
G
Bace2
beta-secretase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BACE2 mRNA
CTD
PMID:15336504
NCBI chr11:50,176,852...50,258,948
Ensembl chr11:36,707,458...36,789,546
G
Bad
BCL2-associated agonist of cell death
decreases expression increases expression multiple interactions
ISO EXP
tert-Butylhydroperoxide results in decreased expression of BAD mRNA tert-Butylhydroperoxide results in increased expression of BAD protein Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAD protein]
CTD
PMID:12419474 PMID:15569404 PMID:17419000
NCBI chr 1:213,562,719...213,572,034
Ensembl chr 1:204,131,501...204,142,823
G
Bak1
BCL2-antagonist/killer 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BAK1 mRNA
CTD
PMID:12419474
NCBI chr20:5,102,334...5,111,615
Ensembl chr20:5,100,480...5,109,264
G
Bambi
BMP and activin membrane-bound inhibitor
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of BAMBI mRNA tert-Butylhydroperoxide affects the expression of BAMBI mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr17:58,816,438...58,821,003
Ensembl chr17:54,121,255...54,126,060
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions decreases expression increases expression affects localization
ISO EXP
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of BAX mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of BAX mRNA]; hyperoside inhibits the reaction [tert-Butylhydroperoxide affects the localization of BAX protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of BAX mRNA]; Peptides inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein] tert-Butylhydroperoxide results in decreased expression of BAX mRNA acadesine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]
CTD
PMID:12419474 PMID:15569404 PMID:17419000 PMID:18552516 PMID:20510348 PMID:23994092 PMID:25522270 PMID:26989860 PMID:28063877 PMID:29111459 PMID:35690295 More...
NCBI chr 1:105,076,472...105,081,906
Ensembl chr 1:95,938,808...95,945,368
G
Baz1b
bromodomain adjacent to zinc finger domain, 1B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BAZ1B mRNA
CTD
PMID:15336504
NCBI chr12:27,068,541...27,126,511
Ensembl chr12:21,431,985...21,490,426
G
Bbln
bublin coiled coil protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BBLN mRNA
CTD
PMID:15336504
NCBI chr 3:36,072,325...36,075,070
Ensembl chr 3:15,674,580...15,677,374
G
Bcl2
BCL2, apoptosis regulator
multiple interactions decreases expression affects localization
EXP ISO
acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide affects the localization of BCL2 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Silymarin inhibits the reaction [tert-Butylhydroperoxide affects the localization of BCL2 protein]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein] tert-Butylhydroperoxide results in decreased expression of BCL2 mRNA; tert-Butylhydroperoxide results in decreased expression of BCL2 protein 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; 3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in decreased expression of BCL2 mRNA; Genistein inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in decreased expression of BCL2 mRNA]; Peptides inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]
CTD
PMID:12782109 PMID:15288519 PMID:15569404 PMID:17419000 PMID:19772912 PMID:20510348 PMID:22659508 PMID:23994092 PMID:25522270 PMID:26989860 PMID:27050144 PMID:29111459 PMID:29128606 PMID:35690295 More...
NCBI chr13:23,204,464...23,366,900
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bcl2l1
Bcl2-like 1
multiple interactions decreases expression
EXP ISO
Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein] Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein]; puag-haad inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein] tert-Butylhydroperoxide results in decreased expression of BCL2L1 mRNA; tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein
CTD
PMID:12419474 PMID:15569404 PMID:26102008 PMID:27050144
NCBI chr 3:161,713,777...161,764,844
Ensembl chr 3:141,253,523...141,303,479 Ensembl chr 1:141,253,523...141,303,479
G
Bcl2l13
Bcl2-like 13
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BCL2L13 mRNA
CTD
PMID:15336504
NCBI chr 4:155,728,284...155,785,058
Ensembl chr 4:154,056,127...154,108,985
G
Bdh1
3-hydroxybutyrate dehydrogenase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BDH1 mRNA
CTD
PMID:29432895
NCBI chr11:82,806,125...82,848,133
Ensembl chr11:69,302,534...69,337,671
G
Bdnf
brain-derived neurotrophic factor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BDNF mRNA
CTD
PMID:15336504
NCBI chr 3:116,619,633...116,670,212
Ensembl chr 3:96,165,042...96,215,615
G
Bex2
brain expressed X-linked 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BEX1 mRNA
CTD
PMID:15336504
NCBI chr X:103,811,458...103,812,986
Ensembl chr X:99,019,000...99,021,503
G
Bex4
brain expressed, X-linked 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BEX4 mRNA
CTD
PMID:15336504
NCBI chr X:103,923,609...103,925,041
Ensembl chr X:99,131,942...99,133,531
G
Bhmt
betaine-homocysteine S-methyltransferase
increases methylation decreases expression
ISO
tert-Butylhydroperoxide results in increased methylation of BHMT gene tert-Butylhydroperoxide results in decreased expression of BHMT mRNA
CTD
PMID:27509014
NCBI chr 2:26,594,852...26,614,429
Ensembl chr 2:24,859,873...24,879,742
G
Bicd1
BICD cargo adaptor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BICD1 mRNA
CTD
PMID:15336504
NCBI chr 4:184,208,891...184,362,840
Ensembl chr 4:182,479,071...182,627,434
G
Bik
BCL2-interacting killer
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BIK mRNA
CTD
PMID:23410634
NCBI chr 7:116,552,303...116,571,317
Ensembl chr 7:114,672,277...114,691,296
G
Birc5
baculoviral IAP repeat-containing 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BIRC5 mRNA
CTD
PMID:15003993
NCBI chr10:103,567,369...103,580,069
Ensembl chr10:103,073,408...103,081,380
G
Bles03
basophilic leukemia expressed protein BLES03
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of C11ORF68 mRNA
CTD
PMID:15336504
NCBI chr 1:212,163,892...212,166,146
Ensembl chr 1:202,734,555...202,736,804
G
Blnk
B-cell linker
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BLNK mRNA
CTD
PMID:14729362
NCBI chr 1:249,703,064...249,770,533
Ensembl chr 1:239,753,648...239,821,113
G
Bmal2
basic helix-loop-helix ARNT like 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BMAL2 mRNA
CTD
PMID:15336504
NCBI chr 4:181,429,097...181,478,384
Ensembl chr 4:179,699,502...179,746,949
G
Bmerb1
bMERB domain containing 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BMERB1 mRNA
CTD
PMID:15336504
NCBI chr10:2,286,999...2,453,890
Ensembl chr10:1,779,835...1,946,575
G
Bmp1
bone morphogenetic protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BMP1 mRNA
CTD
PMID:12419474
NCBI chr15:51,961,310...52,005,597
Ensembl chr15:45,551,603...45,595,776
G
Bmp4
bone morphogenetic protein 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BMP4 mRNA
CTD
PMID:12419474
NCBI chr15:22,098,191...22,113,145
Ensembl chr15:19,618,542...19,623,306
G
Bnip3
BCL2 interacting protein 3
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BNIP3 mRNA tert-Butylhydroperoxide results in increased expression of BNIP3 mRNA
CTD
PMID:12419474 PMID:15003993
NCBI chr 1:203,137,778...203,154,962
Ensembl chr 1:193,708,167...193,725,359
G
Bora
bora, aurora kinase A activator
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BORA mRNA
CTD
PMID:15336504
NCBI chr15:82,205,467...82,243,499
Ensembl chr15:75,797,891...75,821,322
G
Braf
B-Raf proto-oncogene, serine/threonine kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BRAF mRNA
CTD
PMID:12419474
NCBI chr 4:69,329,772...69,476,931
Ensembl chr 4:68,384,649...68,510,463
G
Brd3
bromodomain containing 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BRD3 mRNA
CTD
PMID:15336504
NCBI chr 3:31,173,332...31,227,749
Ensembl chr 3:10,775,272...10,829,577
G
Brd3os
BRD3 opposite strand
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BRD3OS mRNA
CTD
PMID:15336504
NCBI chr 3:10,770,229...10,771,860
G
Bscl2
BSCL2 lipid droplet biogenesis associated, seipin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BSCL2 mRNA
CTD
PMID:22003191
NCBI chr 1:215,160,764...215,172,540
Ensembl chr 1:205,733,872...205,743,421
G
Bst1
bone marrow stromal cell antigen 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BST1 mRNA
CTD
PMID:15336504
NCBI chr14:71,466,179...71,482,671
Ensembl chr14:67,252,998...67,270,180
G
Bst2
bone marrow stromal cell antigen 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BST2 mRNA
CTD
PMID:15336504
NCBI chr16:18,250,593...18,254,967
Ensembl chr16:18,217,407...18,220,979
G
Btbd2
BTB domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BTBD2 mRNA
CTD
PMID:15336504
NCBI chr 7:9,710,392...9,726,032
Ensembl chr 7:9,060,788...9,075,344
G
Btd
biotinidase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BTD mRNA
CTD
PMID:15336504
NCBI chr16:6,869,448...6,900,711
Ensembl chr16:6,862,407...6,940,945
G
Btf3
basic transcription factor 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BTF3 mRNA
CTD
PMID:15336504
NCBI chr 2:31,394,010...31,401,138
Ensembl chr 2:29,659,231...29,666,879 Ensembl chr13:29,659,231...29,666,879
G
Btg1
BTG anti-proliferation factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BTG1 mRNA
CTD
PMID:15003993
NCBI chr 7:33,228,149...33,230,406
Ensembl chr 7:31,341,027...31,343,649
G
Btg2
BTG anti-proliferation factor 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of BTG2 mRNA
CTD
PMID:12414654 PMID:21382384
NCBI chr13:48,083,931...48,087,690
Ensembl chr13:45,531,925...45,535,628
G
Bub1
BUB1 mitotic checkpoint serine/threonine kinase
affects expression
ISO
tert-Butylhydroperoxide affects the expression of BUB1 mRNA
CTD
PMID:23410634
NCBI chr 3:135,473,525...135,504,921
Ensembl chr 3:115,020,254...115,051,650
G
Bud23
BUD23, rRNA methyltransferase and ribosome maturation factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of BUD23 mRNA
CTD
PMID:15336504
NCBI chr12:21,629,551...21,640,758
Ensembl chr12:21,629,536...21,640,751
G
Bzw1
basic leucine zipper and W2 domains 1
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of BZW1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of BZW1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BZW1 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BZW1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of BZW1 mRNA]
CTD
PMID:20847119
NCBI chr 9:67,424,860...67,438,656
Ensembl chr 9:59,930,744...59,944,430
G
C10h17orf100
similar to human chromosome 17 open reading frame 100
affects expression
ISO
tert-Butylhydroperoxide affects the expression of C17ORF100 mRNA
CTD
PMID:23410634
NCBI chr10:56,840,451...56,843,674
Ensembl chr10:56,832,412...56,843,871
G
C13h1orf115
similar to human chromosome 1 open reading frame 115
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of C1ORF115 mRNA
CTD
PMID:15336504
NCBI chr13:98,953,841...98,963,577
Ensembl chr13:96,422,302...96,432,068
G
C17h6orf62
similar to human chromosome 6 open reading frame 62
affects expression
ISO
tert-Butylhydroperoxide affects the expression of C6ORF62 mRNA
CTD
PMID:23410634
NCBI chr17:40,684,236...40,695,874
Ensembl chr17:40,256,211...40,276,020
G
C1r
complement C1r
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of C1R mRNA
CTD
PMID:15336504
NCBI chr 4:159,099,013...159,109,770
Ensembl chr 4:157,412,692...157,423,484
G
C2cd2
C2 calcium-dependent domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of C2CD2 mRNA
CTD
PMID:15336504
NCBI chr11:50,694,680...50,759,096
Ensembl chr11:37,227,415...37,289,739
G
C5
complement C5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of C5 mRNA
CTD
PMID:15336504
NCBI chr 3:38,668,174...38,759,468
Ensembl chr 3:18,270,696...18,361,994
G
C7h8orf76
similar to human chromosome 8 open reading frame 76
affects expression
ISO
tert-Butylhydroperoxide affects the expression of C8ORF76 mRNA
CTD
PMID:23410634
NCBI chr 7:89,558,890...89,569,810
Ensembl chr 7:89,558,909...89,569,810
G
Cadm1
cell adhesion molecule 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CADM1 mRNA
CTD
PMID:15336504
NCBI chr 8:56,744,374...57,075,264
Ensembl chr 8:47,847,325...48,182,833
G
Cadm4
cell adhesion molecule 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CADM4 mRNA
CTD
PMID:15336504
NCBI chr 1:89,203,089...89,225,345
Ensembl chr 1:80,075,202...80,097,423
G
Calhm2
calcium homeostasis modulator family member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CALHM2 mRNA
CTD
PMID:15336504
NCBI chr 1:255,963,661...255,969,387
Ensembl chr 1:246,022,324...246,028,218
G
Calm1
calmodulin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CALM1 mRNA
CTD
PMID:15336504
NCBI chr 6:125,217,191...125,227,855
Ensembl chr 6:119,487,621...119,498,227
G
Calm3
calmodulin 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CALM3 mRNA
CTD
PMID:15003993
NCBI chr 1:86,718,761...86,725,869
Ensembl chr 1:77,589,230...77,592,207
G
Calml4
calmodulin-like 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CALML4 mRNA
CTD
PMID:15003993
NCBI chr 8:72,218,870...72,230,650
Ensembl chr 8:63,323,351...63,335,234
G
Calr
calreticulin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CALR mRNA
CTD
PMID:15336504
NCBI chr19:40,213,367...40,218,262
Ensembl chr19:23,308,351...23,313,414
G
Calu
calumenin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CALU mRNA
CTD
PMID:15336504
NCBI chr 4:58,914,456...58,941,957
Ensembl chr 4:57,948,997...57,976,593
G
Camk2n1
calcium/calmodulin-dependent protein kinase II inhibitor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CAMK2N1 mRNA
CTD
PMID:15336504
NCBI chr 5:155,958,116...155,959,897
Ensembl chr 5:150,673,507...150,676,600
G
Camlg
calcium modulating ligand
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAML mRNA
CTD
PMID:14729362
NCBI chr17:8,997,868...9,009,140
Ensembl chr17:8,992,696...9,003,552
G
Camp
cathelicidin antimicrobial peptide
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of CAMP mRNA
CTD
PMID:22659508
NCBI chr 8:118,720,184...118,721,998
Ensembl chr 8:109,841,729...109,843,543
G
Cand1
cullin-associated and neddylation-dissociated 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAND1 mRNA
CTD
PMID:15336504
NCBI chr 7:56,566,765...56,604,653
Ensembl chr 7:54,680,900...54,718,993
G
Capn1
calpain 1
increases response to substance increases expression
ISO
CAPN1 protein results in increased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of CAPN1 mRNA
CTD
PMID:12842444 PMID:15003993
NCBI chr 1:212,705,219...212,736,134
Ensembl chr 1:203,277,344...203,300,177
G
Capn2
calpain 2
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAPN2 mRNA tert-Butylhydroperoxide affects the expression of CAPN2 mRNA
CTD
PMID:12419474 PMID:23410634
NCBI chr13:96,681,902...96,732,625
Ensembl chr13:94,150,240...94,200,969
G
Capn5
calpain 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CAPN5 mRNA
CTD
PMID:15003993
NCBI chr 1:161,827,474...161,884,142
Ensembl chr 1:152,416,252...152,472,923
G
Capn7
calpain 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAPN7 mRNA
CTD
PMID:15336504
NCBI chr16:6,552,048...6,588,317
Ensembl chr16:6,545,731...6,581,905
G
Capns1
calpain, small subunit 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAPNS1 mRNA
CTD
PMID:12419474
NCBI chr 1:94,572,083...94,582,332
Ensembl chr 1:85,444,608...85,454,795
G
Caprin2
caprin family member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAPRIN2 mRNA
CTD
PMID:15336504
NCBI chr 4:183,537,935...183,592,162
Ensembl chr 4:181,806,575...181,860,830
G
Car8
carbonic anhydrase 8
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CA8 mRNA
CTD
PMID:15336504
NCBI chr 5:26,102,767...26,199,819
Ensembl chr 5:21,305,383...21,402,374
G
Cars2
cysteinyl-tRNA synthetase 2, mitochondrial
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CARS2 mRNA
CTD
PMID:15336504
NCBI chr16:84,649,617...84,689,254
Ensembl chr16:77,950,008...77,987,772
G
Cask
calcium/calmodulin dependent serine protein kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CASK mRNA
CTD
PMID:12419474
NCBI chr X:11,572,328...11,915,831
Ensembl chr X:8,899,833...9,238,694
G
Casp3
caspase 3
multiple interactions increases activity increases expression increases cleavage decreases expression decreases activity
ISO EXP
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CASP3 protein modified form]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP3 mRNA; acetyl-aspartyl-glutamyl-valyl-aspartal inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP3 mRNA]; Drugs, Chinese Herbal inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CASP3 protein]; GPX4 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; KN 93 inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CASP3 protein modified form]; MCL1 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP3 mRNA]; N-(3-methoxyphenyl)-4-chlorocinnamanilide inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]]; nectandrin-B inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; PAFAH2 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; puag-haad inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CASP3 protein]; rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; zinc protoporphyrin inhibits the reaction [rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]] tert-Butylhydroperoxide results in increased expression of CASP3 protein; tert-Butylhydroperoxide results in increased expression of CASP3 protein modified form 6,7-dihydroxyflavone inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; caffeoylquinic acid analog inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; Drugs, Chinese Herbal inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; tert-Butylhydroperoxide results in increased expression of and results in increased cleavage of CASP3 protein acadesine inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP3 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein] tert-butylhydroperoxide decreases activity of Casp3 protein in hepatocyte cytosol
CTD RGD
PMID:12406338 PMID:15496407 PMID:15569404 PMID:15611089 PMID:15877105 PMID:16753784 PMID:17419000 PMID:19647727 PMID:19772912 PMID:20510348 PMID:20847119 PMID:26102008 PMID:26989860 PMID:27511913 PMID:28025122 PMID:28063877 PMID:28733231 PMID:35690295 PMID:38053484 PMID:18316105 More...
RGD:2311460
NCBI chr16:52,395,539...52,413,794
Ensembl chr16:45,662,910...45,684,648
G
Casp6
caspase 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CASP6 mRNA
CTD
PMID:15003993
NCBI chr 2:221,140,287...221,152,727
Ensembl chr 2:218,466,076...218,478,502
G
Casp7
caspase 7
multiple interactions increases cleavage decreases activity
ISO EXP
Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP7 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP7 protein] tert-butylhydroperoxide decreases activity of Casp7 protein in hepatocyte cytosol
CTD RGD
PMID:27050144 PMID:18316105
RGD:2311460
NCBI chr 1:265,442,647...265,481,938
Ensembl chr 1:255,437,172...255,476,729
G
Casp8
caspase 8
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP8 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP8 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP8 mRNA]
CTD
PMID:35690295
NCBI chr 9:67,747,109...67,806,699
Ensembl chr 9:60,264,075...60,312,542
G
Casp9
caspase 9
increases cleavage increases expression multiple interactions decreases activity
EXP ISO
tert-Butylhydroperoxide results in increased cleavage of CASP9 protein tert-Butylhydroperoxide results in increased expression of CASP9 protein Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP9 protein]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP9 protein] Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP9 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of CASP9 protein] Tert-butylhydroperoxide decreases activity of Casp9 protein in hepatocyte cytosol
CTD RGD
PMID:15877105 PMID:17003459 PMID:19772912 PMID:20510348 PMID:27050144 PMID:18316105 More...
RGD:2311460
Ensembl chr 5:154,109,046...154,126,626
G
Cast
calpastatin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAST mRNA
CTD
PMID:15336504
NCBI chr 2:5,707,633...5,817,213
Ensembl chr 2:3,973,112...4,082,659
G
Cat
catalase
affects response to substance decreases response to substance multiple interactions decreases activity decreases expression increases expression increases activity
ISO EXP
CAT protein affects the susceptibility to tert-Butylhydroperoxide CAT protein results in decreased susceptibility to tert-Butylhydroperoxide [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CAT mRNA; Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CAT protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CAT protein] tert-Butylhydroperoxide results in decreased activity of CAT protein tert-Butylhydroperoxide results in decreased expression of CAT mRNA; tert-Butylhydroperoxide results in decreased expression of CAT protein CAT protein inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FOS mRNA]; CAT protein inhibits the reaction [tert-Butylhydroperoxide results in increased expression of JUN mRNA]; Catechin inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of CAT protein] tert-Butylhydroperoxide results in increased expression of CAT mRNA CAT protein results in increased susceptibility to [tert-Butylhydroperoxide co-treated with Desoxycorticosterone co-treated with tempol]
CTD
PMID:10754530 PMID:11178967 PMID:12423650 PMID:12628296 PMID:12646410 PMID:14729362 PMID:15003993 PMID:15105052 PMID:15207383 PMID:15336504 PMID:15849717 PMID:16126241 PMID:16753784 PMID:16928893 PMID:17003459 PMID:20100471 PMID:34303734 PMID:35690295 More...
NCBI chr 3:110,297,340...110,329,526
Ensembl chr 3:89,842,399...89,874,478
G
Cav1
caveolin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CAV1 mRNA
CTD
PMID:15963989
NCBI chr 4:46,606,538...46,639,616
Ensembl chr 4:45,634,918...45,673,705
G
Cav2
caveolin 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CAV2 mRNA
CTD
PMID:15336504
NCBI chr 4:46,582,681...46,590,058
Ensembl chr 4:45,616,712...45,624,244
G
Cavin2
caveolae associated protein 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of CAVIN2 mRNA
CTD
PMID:23410634
NCBI chr 9:57,794,007...57,806,024
Ensembl chr 9:50,301,206...50,314,147
G
Cbfb
core-binding factor subunit beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CBFB mRNA
CTD
PMID:15336504
NCBI chr19:49,955,133...50,002,661
Ensembl chr19:33,049,172...33,092,751
G
Cbr3
carbonyl reductase 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CBR3 mRNA
CTD
PMID:21382384
NCBI chr11:46,478,295...46,486,555
Ensembl chr11:33,008,615...33,016,875
G
Cbs
cystathionine beta synthase
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of CBS mRNA tert-Butylhydroperoxide results in increased methylation of CBS gene
CTD
PMID:15336504 PMID:27509014
NCBI chr20:9,709,394...9,733,925
Ensembl chr20:9,708,090...9,732,764
G
Ccdc25
coiled-coil domain containing 25
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CCDC25 mRNA
CTD
PMID:15336504
NCBI chr15:44,230,927...44,263,317
Ensembl chr15:40,055,368...40,087,758
G
Ccdc86
coiled-coil domain containing 86
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCDC86 mRNA
CTD
PMID:15336504
NCBI chr 1:217,015,059...217,021,439
Ensembl chr 1:207,590,168...207,596,544
G
Ccdc93
coiled-coil domain containing 93
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCDC93 mRNA
CTD
PMID:15336504
NCBI chr13:35,160,354...35,233,877
Ensembl chr13:32,607,587...32,676,023
G
Ccl2
C-C motif chemokine ligand 2
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCL2 mRNA; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CCL2 mRNA]
CTD
PMID:20847119
NCBI chr10:67,503,077...67,504,875
Ensembl chr10:67,005,424...67,007,226
G
Ccl5
C-C motif chemokine ligand 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCL5 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr10:68,820,330...68,824,906
Ensembl chr10:68,322,829...68,327,377
G
Ccn1
cellular communication network factor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCN1 mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr 2:237,222,730...237,225,689
Ensembl chr 2:234,562,408...234,565,484
G
Ccn2
cellular communication network factor 2
multiple interactions decreases expression affects expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCN2 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCN2 mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of CCN2 mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CCN2 mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of CCN2 mRNA] tert-Butylhydroperoxide affects the expression of CCN2 mRNA
CTD
PMID:20847119 PMID:23410634
NCBI chr 1:22,621,498...22,624,614
Ensembl chr 1:20,802,199...20,805,734
G
Ccn3
cellular communication network factor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CCN3 mRNA
CTD
PMID:15336504
NCBI chr 7:87,983,788...87,990,810
Ensembl chr 7:86,094,000...86,101,019
G
Ccna2
cyclin A2
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of CCNA2 mRNA tert-Butylhydroperoxide affects the expression of CCNA2 mRNA
CTD
PMID:12414654 PMID:12419474 PMID:15336504 PMID:23410634
NCBI chr 2:121,355,363...121,361,762
Ensembl chr 2:119,426,089...119,433,577
G
Ccnb2
cyclin B2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCNB2 mRNA
CTD
PMID:15003993
NCBI chr 8:79,968,459...79,981,717
Ensembl chr 8:71,087,595...71,100,874
G
Ccne1
cyclin E1
multiple interactions
ISO
ginsenoside Rg1 affects the reaction [tert-Butylhydroperoxide affects the expression of CCNE1 protein]
CTD
PMID:15606011
NCBI chr 1:99,918,672...99,927,986
Ensembl chr 1:90,781,949...90,791,101
G
Ccne2
cyclin E2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CCNE2 mRNA
CTD
PMID:15336504
NCBI chr 5:29,082,169...29,094,879
Ensembl chr 5:24,284,922...24,297,632
G
Ccnf
cyclin F
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCNF mRNA
CTD
PMID:15003993
NCBI chr10:13,757,884...13,783,669
Ensembl chr10:13,253,380...13,279,101
G
Ccng2
cyclin G2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CCNG2 mRNA
CTD
PMID:15336504
NCBI chr14:15,088,694...15,097,190
Ensembl chr14:14,804,322...14,812,830
G
Ccnj
cyclin J
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCNJ mRNA
CTD
PMID:15336504
NCBI chr 1:239,659,588...239,677,367
G
Ccnk
cyclin K
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CCNK mRNA
CTD
PMID:12419474
NCBI chr 6:132,854,428...132,877,604
Ensembl chr 6:127,090,569...127,113,191
G
Ccs
copper chaperone for superoxide dismutase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CCS mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 1:211,543,192...211,564,354
Ensembl chr 1:202,113,804...202,134,915
G
Cd24
CD24 molecule
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CD24 mRNA
CTD
PMID:15336504
NCBI chr20:48,655,549...48,661,786
Ensembl chr20:47,073,512...47,079,662
G
Cd320
CD320 molecule
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CD320 mRNA
CTD
PMID:15336504
NCBI chr 7:15,328,320...15,334,138
Ensembl chr 7:14,609,146...14,631,976
G
Cd46
CD46 molecule
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CD46 mRNA
CTD
PMID:15336504
NCBI chr13:109,104,122...109,134,903
Ensembl chr13:106,574,858...106,660,445
G
Cd47
Cd47 molecule
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CD47 mRNA
CTD
PMID:12419474
NCBI chr11:64,374,816...64,438,763
Ensembl chr11:50,906,177...50,969,425
G
Cd55
CD55 molecule (Cromer blood group)
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CD55 mRNA
CTD
PMID:15336504
NCBI chr13:44,409,574...44,438,913
Ensembl chr13:41,857,395...41,885,831
G
Cd68
Cd68 molecule
increases expression decreases response to substance
ISO
tert-Butylhydroperoxide results in increased expression of CD68 mRNA CD68 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr10:54,880,562...54,882,441
Ensembl chr10:54,381,815...54,383,697
G
Cd82
Cd82 molecule
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CD82 mRNA
CTD
PMID:15336504
NCBI chr 3:99,842,748...99,887,298
Ensembl chr 3:79,385,887...79,431,809
G
Cd9
CD9 molecule
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of CD9 mRNA tert-Butylhydroperoxide affects the expression of CD9 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 4:159,942,553...159,975,463
Ensembl chr 4:158,256,328...158,289,222
G
Cd99
CD99 molecule (Xg blood group)
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CD99 mRNA
CTD
PMID:15336504
NCBI chr20:56,000,494...56,005,140
G
Cdc16
cell division cycle 16
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDC16 mRNA
CTD
PMID:15336504
NCBI chr16:82,475,234...82,498,797
Ensembl chr16:75,773,028...75,796,550
G
Cdc25b
cell division cycle 25B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDC25B mRNA
CTD
PMID:15336504
NCBI chr 3:138,860,148...138,870,287
Ensembl chr 3:118,407,128...118,417,272
G
Cdc25c
cell division cycle 25C
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDC25C mRNA tert-Butylhydroperoxide results in increased expression of CDC25C mRNA
CTD
PMID:12419474 PMID:14729362 PMID:15003993
NCBI chr18:26,608,483...26,630,292
Ensembl chr18:26,335,834...26,356,185
G
Cdc27
cell division cycle 27
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDC27 mRNA
CTD
PMID:15336504
NCBI chr10:89,900,676...89,949,770
Ensembl chr10:89,400,940...89,449,736
G
Cdc37l1
cell division cycle 37-like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDC37L1 mRNA
CTD
PMID:15963989
NCBI chr 1:226,705,019...226,733,994
Ensembl chr 1:226,705,003...226,761,175
G
Cdc42
cell division cycle 42
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDC42 mRNA
CTD
PMID:15336504
NCBI chr 5:154,838,478...154,876,629
Ensembl chr 5:149,553,724...149,593,111
G
Cdc42ep2
CDC42 effector protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDC42EP2 mRNA
CTD
PMID:15336504
NCBI chr 1:212,631,317...212,640,231
Ensembl chr 1:203,201,873...203,210,897
G
Cdc42ep3
CDC42 effector protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDC42EP3 mRNA
CTD
PMID:15336504
NCBI chr 6:21,463,081...21,483,553
Ensembl chr 6:15,708,730...15,732,721
G
Cdc42ep4
CDC42 effector protein 4
affects expression
ISO
tert-Butylhydroperoxide affects the expression of CDC42EP4 mRNA
CTD
PMID:23410634
NCBI chr10:99,271,750...99,298,551
Ensembl chr10:98,772,495...98,797,695
G
Cdc42se1
CDC42 small effector 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDC42SE1 mRNA
CTD
PMID:15336504
NCBI chr 2:185,494,692...185,502,519
Ensembl chr 2:182,804,925...182,814,028
G
Cdc5l
cell division cycle 5-like
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDC5L mRNA
CTD
PMID:15336504
NCBI chr 9:23,062,397...23,100,901
Ensembl chr 9:15,564,767...15,603,450
G
Cdca3
cell division cycle associated 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDCA3 mRNA
CTD
PMID:15336504
NCBI chr 4:159,321,203...159,325,072
Ensembl chr 4:157,634,928...157,638,799
G
Cdcp1
CUB domain containing protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDCP1 mRNA
CTD
PMID:15336504
NCBI chr 8:131,706,140...131,742,799
Ensembl chr 8:122,828,685...122,865,388
G
Cdh11
cadherin 11
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDH11 mRNA
CTD
PMID:12419474
NCBI chr19:2,152,961...2,312,140
Ensembl chr19:2,148,458...2,304,272
G
Cdh3
cadherin 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDH3 mRNA
CTD
PMID:12419474
NCBI chr19:51,303,414...51,353,900
Ensembl chr19:34,393,727...34,444,084
G
Cdh5
cadherin 5
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of CDH5 mRNA
CTD
PMID:22659508
NCBI chr19:821,875...860,931
Ensembl chr19:815,411...854,368
G
Cdk1
cyclin-dependent kinase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDK1 mRNA
CTD
PMID:15003993
NCBI chr20:19,265,252...19,280,456
Ensembl chr20:19,266,248...19,281,408
G
Cdk10
cyclin-dependent kinase 10
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDK10 mRNA
CTD
PMID:12419474
NCBI chr19:68,168,040...68,184,923
Ensembl chr19:51,261,356...51,269,078
G
Cdk2
cyclin dependent kinase 2
decreases activity multiple interactions decreases expression
ISO
tert-Butylhydroperoxide results in decreased activity of CDK2 protein ginsenoside Rg1 affects the reaction [tert-Butylhydroperoxide affects the expression of CDK2 protein] tert-Butylhydroperoxide results in decreased expression of CDK2 mRNA
CTD
PMID:12766906 PMID:15336504 PMID:15606011
NCBI chr 7:1,714,392...1,721,964
Ensembl chr 7:1,129,811...1,137,403
G
Cdkn1a
cyclin-dependent kinase inhibitor 1A
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of CDKN1A mRNA; tert-Butylhydroperoxide results in increased expression of CDKN1A protein [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1A mRNA; ginsenoside Rg1 affects the reaction [tert-Butylhydroperoxide affects the expression of CDKN1A protein]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1A mRNA]; Niacinamide inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CDKN1A protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CDKN1A protein]
CTD
PMID:12414654 PMID:12766906 PMID:12782109 PMID:15336504 PMID:15606011 PMID:18619952 PMID:22563892 PMID:35690295 More...
NCBI chr20:7,150,820...7,161,373
Ensembl chr20:7,149,217...7,159,585
G
Cdkn1b
cyclin-dependent kinase inhibitor 1B
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1B mRNA
CTD
PMID:35690295
NCBI chr 4:169,491,273...169,496,500
Ensembl chr 4:167,760,181...167,764,982
G
Cdkn1c
cyclin-dependent kinase inhibitor 1C
multiple interactions decreases expression increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1C mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1C mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1C mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CDKN1C mRNA]; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CDKN1C mRNA] tert-Butylhydroperoxide results in decreased expression of CDKN1C mRNA
CTD
PMID:12419474 PMID:20847119
NCBI chr 1:208,084,801...208,087,680
Ensembl chr 1:198,655,407...198,658,048
G
Cdkn2b
cyclin-dependent kinase inhibitor 2B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDKN2B mRNA
CTD
PMID:12419474 PMID:14729362
NCBI chr 5:109,123,308...109,134,906
Ensembl chr 5:104,010,680...104,019,050
G
Cdkn2c
cyclin-dependent kinase inhibitor 2C
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CDKN2C mRNA
CTD
PMID:15336504
NCBI chr 5:129,639,736...129,645,564
Ensembl chr 5:124,411,124...124,416,278
G
Cdkn3
cyclin-dependent kinase inhibitor 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CDKN3 mRNA
CTD
PMID:15003993 PMID:27509014
NCBI chr15:22,502,299...22,513,725
Ensembl chr15:20,022,664...20,033,945
G
Cebpa
CCAAT/enhancer binding protein alpha
affects expression
ISO
tert-Butylhydroperoxide affects the expression of CEBPA mRNA
CTD
PMID:23410634
NCBI chr 1:96,896,584...96,899,256
Ensembl chr 1:87,759,433...87,762,412
G
Cebpb
CCAAT/enhancer binding protein beta
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CEBPB mRNA
CTD
PMID:15336504
NCBI chr 3:176,817,005...176,818,436
Ensembl chr 3:156,397,052...156,399,473
G
Celf2
CUGBP, Elav-like family member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CELF2 mRNA
CTD
PMID:15336504
NCBI chr17:75,813,928...76,639,300
Ensembl chr17:71,210,853...71,728,333
G
Celsr2
cadherin, EGF LAG seven-pass G-type receptor 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CELSR2 mRNA
CTD
PMID:15336504
NCBI chr 2:198,717,333...198,741,689
Ensembl chr 2:196,029,434...196,053,845
G
Cenpa
centromere protein A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CENPA mRNA
CTD
PMID:12414654
NCBI chr 6:31,420,062...31,431,703
Ensembl chr 6:25,700,142...25,711,675
G
Cenpm
centromere protein M
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CENPM mRNA
CTD
PMID:15336504
NCBI chr 7:115,628,117...115,639,401
Ensembl chr 7:113,747,516...113,764,258
G
Cep170
centrosomal protein 170
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CEP170 mRNA
CTD
PMID:15336504
NCBI chr13:91,201,808...91,285,990
Ensembl chr13:88,670,358...88,732,226
G
Cep170b
centrosomal protein 170B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CEP170B mRNA
CTD
PMID:15336504
NCBI chr 6:131,780,935...131,806,658
Ensembl chr 6:131,778,957...131,806,658
G
Cep192
centrosomal protein 192
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CEP192 mRNA
CTD
PMID:15336504
NCBI chr18:63,643,816...63,728,264
Ensembl chr18:61,332,158...61,458,379
G
Cep43
centrosomal protein 43
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CEP43 mRNA
CTD
PMID:15336504
NCBI chr 1:55,080,983...55,111,509
Ensembl chr 1:52,533,428...52,563,923
G
Cep57
centrosomal protein 57
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CEP57 mRNA
CTD
PMID:15336504
NCBI chr 8:18,951,179...18,971,205
Ensembl chr 8:10,669,590...10,689,249
G
Cep89
centrosomal protein 89
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CEP89 mRNA
CTD
PMID:15003993
NCBI chr 1:97,195,116...97,237,015
Ensembl chr 1:88,058,227...88,100,112
G
Cfb
complement factor B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CFB mRNA
CTD
PMID:15336504
NCBI chr20:3,975,271...3,981,138
Ensembl chr20:3,951,474...3,976,505
G
Cfi
complement factor I
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CFI mRNA
CTD
PMID:15336504
NCBI chr 2:221,062,206...221,104,790
Ensembl chr 2:218,387,990...218,430,561
G
Chaf1a
chromatin assembly factor 1 subunit A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CHAF1A mRNA
CTD
PMID:15336504
NCBI chr 9:961,225...987,825
Ensembl chr 9:874,051...900,654
G
Chdh
choline dehydrogenase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CHDH mRNA
CTD
PMID:27509014
NCBI chr16:5,194,269...5,225,541
Ensembl chr16:5,194,269...5,225,537
G
Chek1
checkpoint kinase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CHEK1 mRNA
CTD
PMID:12414654
NCBI chr 8:44,609,417...44,629,867
Ensembl chr 8:36,420,569...36,441,009
G
Chka
choline kinase alpha
affects expression
ISO
tert-Butylhydroperoxide affects the expression of CHKA mRNA
CTD
PMID:23410634
NCBI chr 1:210,506,069...210,554,753
Ensembl chr 1:201,076,860...201,125,516
G
Chmp2a
charged multivesicular body protein 2A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CHMP2A mRNA
CTD
PMID:15336504
NCBI chr 1:82,731,212...82,735,088
Ensembl chr 1:73,660,046...73,662,452
G
Chordc1
cysteine and histidine rich domain containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CHORDC1 mRNA
CTD
PMID:15336504
NCBI chr 8:23,650,721...23,674,786
Ensembl chr 8:15,374,471...15,399,162
G
Chrdl1
chordin-like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CHRDL1 mRNA
CTD
PMID:15336504
NCBI chr X:111,685,864...111,789,684
Ensembl chr X:106,889,125...106,992,921
G
Chst15
carbohydrate sulfotransferase 15
affects expression
ISO
tert-Butylhydroperoxide affects the expression of CHST15 mRNA
CTD
PMID:23410634
NCBI chr 1:196,458,978...196,540,088
Ensembl chr 1:187,028,970...187,107,707
G
Chst2
carbohydrate sulfotransferase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CHST2 mRNA
CTD
PMID:15336504
NCBI chr 8:104,839,716...104,845,961
Ensembl chr 8:95,959,826...95,966,955
G
Clasp1
cytoplasmic linker associated protein 1
decreases methylation decreases expression
ISO
tert-Butylhydroperoxide results in decreased methylation of CLASP1 intron tert-Butylhydroperoxide results in decreased expression of CLASP1 mRNA
CTD
PMID:29432895
NCBI chr13:32,046,362...32,267,954
Ensembl chr13:29,493,596...29,715,146
G
Clcn3
chloride voltage-gated channel 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CLCN3 mRNA
CTD
PMID:15003993
NCBI chr16:34,138,004...34,210,984
Ensembl chr16:29,127,419...29,200,119
G
Clic3
chloride intracellular channel 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CLIC3 mRNA
CTD
PMID:15336504
NCBI chr 3:28,670,176...28,672,166
Ensembl chr 3:8,272,097...8,274,018
G
Cln3
CLN3 lysosomal/endosomal transmembrane protein, battenin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CLN3 mRNA
CTD
PMID:15336504
NCBI chr 1:190,586,649...190,600,034
Ensembl chr 1:181,156,073...181,167,434
G
Cln6
CLN6, transmembrane ER protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CLN6 mRNA
CTD
PMID:15003993
NCBI chr 8:72,198,773...72,213,777
Ensembl chr 8:63,303,029...63,318,360
G
Clstn1
calsyntenin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CLSTN1 mRNA
CTD
PMID:15336504
NCBI chr 5:165,314,128...165,377,627
Ensembl chr 5:160,031,308...160,094,583
G
Clu
clusterin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CLU mRNA
CTD
PMID:15963989
NCBI chr15:44,336,619...44,375,861
Ensembl chr15:40,174,617...40,200,315
G
Cmtm1
CKLF-like MARVEL transmembrane domain containing 1
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of CMTM1 gene
CTD
PMID:29432895
NCBI chr19:651,641...661,184
Ensembl chr19:651,644...661,184
G
Cndp2
carnosine dipeptidase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CNDP2 mRNA
CTD
PMID:15003993
NCBI chr18:80,314,799...80,331,900
Ensembl chr18:78,039,932...78,056,922
G
Cnnm3
cyclin and CBS domain divalent metal cation transport mediator 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CNNM3 mRNA
CTD
PMID:15336504
NCBI chr 9:46,251,252...46,266,613
Ensembl chr 9:38,755,390...38,770,740
G
Cnot8
CCR4-NOT transcription complex, subunit 8
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CNOT8 mRNA
CTD
PMID:15336504
NCBI chr10:42,281,614...42,294,740
Ensembl chr10:42,281,722...42,294,730
G
Cog5
component of oligomeric golgi complex 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COG5 mRNA
CTD
PMID:15336504
NCBI chr 6:53,969,967...54,267,869
Ensembl chr 6:48,242,482...48,529,009
G
Cog8
component of oligomeric golgi complex 8
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of COG8 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of COG8 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of COG8 mRNA]
CTD
PMID:20847119
NCBI chr19:34,951,625...34,962,377
Ensembl chr19:34,951,627...34,962,397
G
Col13a1
collagen type XIII alpha 1 chain
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of COL13A1 mRNA
CTD
PMID:15336504
NCBI chr20:30,326,744...30,466,800
Ensembl chr20:29,783,965...29,924,032
G
Col1a2
collagen type I alpha 2 chain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COL1A2 mRNA
CTD
PMID:15336504
NCBI chr 4:33,518,557...33,553,484
Ensembl chr 4:32,563,381...32,598,867
G
Col3a1
collagen type III alpha 1 chain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COL3A1 mRNA
CTD
PMID:15336504
NCBI chr 9:54,866,646...54,902,578
Ensembl chr 9:47,374,593...47,410,547
G
Col4a1
collagen type IV alpha 1 chain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COL4A1 mRNA
CTD
PMID:15336504
NCBI chr16:84,885,597...84,996,482
Ensembl chr16:78,183,533...78,294,412
G
Col4a2
collagen type IV alpha 2 chain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COL4A2 mRNA
CTD
PMID:15336504
NCBI chr16:84,749,672...84,885,520
Ensembl chr16:78,047,602...78,183,839
G
Col5a1
collagen type V alpha 1 chain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COL5A1 mRNA
CTD
PMID:15336504
NCBI chr 3:31,606,475...31,755,097
Ensembl chr 3:11,208,512...11,354,588
G
Col5a2
collagen type V alpha 2 chain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COL5A2 mRNA
CTD
PMID:15336504
NCBI chr 9:54,940,768...55,090,151
Ensembl chr 9:47,448,736...47,598,154
G
Col6a1
collagen type VI alpha 1 chain
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of COL6A1 mRNA
CTD
PMID:15336504
NCBI chr20:11,905,690...11,924,111
Ensembl chr20:11,905,957...11,924,597
G
Col6a2
collagen type VI alpha 2 chain
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of COL6A2 mRNA
CTD
PMID:15336504
NCBI chr20:12,021,182...12,048,932
Ensembl chr20:12,021,767...12,057,564
G
Col7a1
collagen type VII alpha 1 chain
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of COL7A1 mRNA
CTD
PMID:15336504
NCBI chr 8:118,483,364...118,515,736
Ensembl chr 8:109,604,861...109,637,252
G
Col8a2
collagen type VIII alpha 2 chain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COL8A2 mRNA
CTD
PMID:15336504
NCBI chr 5:143,870,754...143,897,372
Ensembl chr 5:138,585,999...138,612,850
G
Comt
catechol-O-methyltransferase
decreases expression
ISO EXP
tert-Butylhydroperoxide results in decreased expression of COMT mRNA tert-Butylhydroperoxide results in decreased expression of COMT protein
CTD
PMID:12419474 PMID:24394546
NCBI chr11:96,072,371...96,091,956
Ensembl chr11:82,568,025...82,587,642
G
Copa
COPI coat complex subunit alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COPA mRNA
CTD
PMID:15336504
NCBI chr13:87,078,853...87,119,256
Ensembl chr13:84,545,943...84,586,874
G
Copb1
COPI coat complex subunit beta 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of COPB1 mRNA
CTD
PMID:15336504
NCBI chr 1:177,838,751...177,876,688
Ensembl chr 1:168,404,335...168,438,416
G
Cope
COPI coat complex subunit epsilon
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COPE mRNA
CTD
PMID:15336504
NCBI chr16:19,148,832...19,159,052
Ensembl chr16:19,114,871...19,128,907
G
Cops6
COP9 signalosome subunit 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COPS6 mRNA
CTD
PMID:15336504
NCBI chr12:17,038,979...17,041,818
Ensembl chr12:17,038,979...17,046,371
G
Cops8
COP9 signalosome subunit 8
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of COPS8 mRNA
CTD
PMID:15336504
NCBI chr 9:98,655,031...98,664,861
Ensembl chr 9:91,207,395...91,217,258
G
Cox7a1
cytochrome c oxidase subunit 7A1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of COX7A1 mRNA
CTD
PMID:15003993
NCBI chr 1:94,549,663...94,572,330
Ensembl chr 1:85,441,871...85,445,151
G
Cp
ceruloplasmin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CP mRNA
CTD
PMID:14729362
NCBI chr 2:104,368,336...104,427,119
Ensembl chr 2:102,439,624...102,498,075
G
Cpe
carboxypeptidase E
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CPE mRNA tert-Butylhydroperoxide results in increased expression of CPE mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr16:29,796,707...29,908,647
Ensembl chr16:25,030,276...25,142,233
G
Cpm
carboxypeptidase M
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CPM mRNA
CTD
PMID:15336504
NCBI chr 7:55,111,599...55,172,114
Ensembl chr 7:53,225,696...53,286,220
G
Cpne1
copine 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CPNE1 mRNA
CTD
PMID:15336504
NCBI chr 3:165,047,615...165,089,994
Ensembl chr 3:144,588,995...144,598,636
G
Cpq
carboxypeptidase Q
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CPQ mRNA
CTD
PMID:15336504
NCBI chr 7:66,148,973...66,719,189
Ensembl chr 7:64,264,081...64,724,546
G
Crat
carnitine O-acetyltransferase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CRAT mRNA
CTD
PMID:15336504
NCBI chr 3:34,073,504...34,087,099
Ensembl chr 3:13,675,684...13,689,255
G
Creb1
cAMP responsive element binding protein 1
decreases expression multiple interactions increases phosphorylation
ISO
tert-Butylhydroperoxide results in decreased expression of CREB1 mRNA U 0126 inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of CREB1 protein]
CTD
PMID:12419474 PMID:17003459
NCBI chr 9:73,397,333...73,466,339
Ensembl chr 9:65,903,547...65,970,816
G
Crip1
cysteine rich protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CRIP1 mRNA
CTD
PMID:15003993
NCBI chr 6:138,047,801...138,055,672
Ensembl chr 6:132,226,746...132,234,620
G
Crispld2
cysteine-rich secretory protein LCCL domain containing 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CRISPLD2 mRNA
CTD
PMID:15336504
NCBI chr19:64,961,764...65,020,099
Ensembl chr19:48,053,287...48,110,465
G
Cryab
crystallin, alpha B
multiple interactions increases expression decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CRYAB mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CRYAB mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CRYAB mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CRYAB mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CRYAB mRNA] tert-Butylhydroperoxide results in decreased expression of CRYAB mRNA
CTD
PMID:15336504 PMID:20847119
NCBI chr 8:59,989,885...59,995,532
Ensembl chr 8:51,093,441...51,099,157
G
Cryz
crystallin zeta
decreases response to substance increases expression
ISO
CRYZ protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of CRYZ mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 2:246,211,707...246,239,472
Ensembl chr 2:243,552,119...243,579,758
G
Csf1
colony stimulating factor 1
decreases response to substance
ISO
CSF1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:16446085
NCBI chr 2:198,065,400...198,084,774
Ensembl chr 2:195,377,215...195,411,704
G
Csnk1d
casein kinase 1, delta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CSNK1D mRNA
CTD
PMID:15336504
NCBI chr10:106,713,497...106,754,953
Ensembl chr10:106,221,992...106,256,614
G
Cspg4
chondroitin sulfate proteoglycan 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CSPG4 mRNA
CTD
PMID:15336504
NCBI chr 8:66,160,942...66,195,987
Ensembl chr 8:57,264,962...57,300,010
G
Ctdspl
CTD small phosphatase like
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CTDSPL mRNA
CTD
PMID:15336504
NCBI chr 8:127,520,478...127,644,999
Ensembl chr 8:118,642,672...118,767,117
G
Cth
cystathionine gamma-lyase
increases activity
EXP
tert-Butylhydroperoxide results in increased activity of CTH protein
CTD
PMID:18184479
NCBI chr 2:249,634,731...249,661,066
Ensembl chr 2:246,975,894...247,002,234
G
Ctnna1
catenin alpha 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CTNNA1 mRNA
CTD
PMID:12419474
NCBI chr18:27,002,330...27,135,009
Ensembl chr18:26,728,485...26,860,910
G
Ctnnb1
catenin beta 1
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CTNNB1 mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CTNNB1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CTNNB1 mRNA]
CTD
PMID:20847119
NCBI chr 8:129,517,576...129,544,661
Ensembl chr 8:120,639,995...120,667,111
G
Ctsb
cathepsin B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CTSB mRNA
CTD
PMID:15336504
NCBI chr15:41,565,607...41,586,479
Ensembl chr15:37,389,629...37,410,500
G
Ctsl
cathepsin L
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of CTSL mRNA tert-Butylhydroperoxide results in decreased expression of CTSL mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr17:770,104...776,266
Ensembl chr17:764,309...770,548
G
Cttn
cortactin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CTTN mRNA
CTD
PMID:12419474
NCBI chr 1:209,029,048...209,064,577
Ensembl chr 1:199,599,710...199,635,164
G
Cul3
cullin 3
multiple interactions increases expression
ISO
Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CUL3 mRNA]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CUL3 mRNA]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CUL3 protein] tert-Butylhydroperoxide results in increased expression of CUL3 mRNA; tert-Butylhydroperoxide results in increased expression of CUL3 protein
CTD
PMID:38272317
NCBI chr 9:89,040,987...89,118,775
Ensembl chr 9:81,592,641...81,670,462
G
Cul4a
cullin 4A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CUL4A mRNA
CTD
PMID:15336504
NCBI chr16:83,086,688...83,124,503
Ensembl chr16:76,384,546...76,422,330
G
Cux1
cut-like homeobox 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CUX1 mRNA
CTD
PMID:12419474
NCBI chr12:25,728,393...26,062,497
Ensembl chr12:20,107,311...20,425,866 Ensembl chr 4:20,107,311...20,425,866
G
Cxadr
CXADR, Ig-like cell adhesion molecule
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CXADR mRNA
CTD
PMID:15336504
NCBI chr11:30,469,778...30,516,990
Ensembl chr11:16,982,860...17,030,046
G
Cxcl1
C-X-C motif chemokine ligand 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CXCL1 mRNA
CTD
PMID:15336504
NCBI chr14:17,477,542...17,479,321
Ensembl chr14:17,193,365...17,195,215
G
Cxcl10
C-X-C motif chemokine ligand 10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CXCL10 mRNA
CTD
PMID:15003993
NCBI chr14:15,989,066...15,991,263
Ensembl chr14:15,704,758...15,706,975
G
Cxcl2
C-X-C motif chemokine ligand 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CXCL2 mRNA
CTD
PMID:15336504
NCBI chr14:17,465,210...17,467,255
Ensembl chr14:17,181,062...17,183,075
G
Cxcl3
C-X-C motif chemokine ligand 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CXCL1 mRNA
CTD
PMID:15336504
NCBI chr14:17,571,900...17,573,624
Ensembl chr14:17,270,146...17,289,511
G
Cxcr4
C-X-C motif chemokine receptor 4
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CXCR4 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CXCR4 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of CXCR4 mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CXCR4 mRNA]; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]; troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of CXCR4 mRNA]
CTD
PMID:20847119
NCBI chr13:42,630,383...42,634,288
Ensembl chr13:40,077,976...40,081,883
G
Cxxc5
CXXC finger protein 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CXXC5 mRNA
CTD
PMID:29432895
NCBI chr18:27,701,650...27,732,633
Ensembl chr18:27,427,230...27,458,673
G
Cyb561
cytochrome b-561
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CYB561 mRNA
CTD
PMID:15336504
NCBI chr10:91,377,866...91,388,548
Ensembl chr10:90,878,054...90,884,787
G
Cyb5d2
cytochrome b5 domain containing 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of CYB5D2 mRNA
CTD
PMID:23410634
NCBI chr10:57,394,268...57,413,336
Ensembl chr10:57,396,765...57,413,715
G
Cyb5r2
cytochrome b5 reductase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CYB5R2 mRNA
CTD
PMID:15336504
NCBI chr 1:171,062,083...171,076,183
Ensembl chr 1:161,655,864...161,664,097
G
Cybc1
cytochrome b-245 chaperone 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of CYBC1 mRNA
CTD
PMID:15336504
NCBI chr10:106,997,018...107,003,895
Ensembl chr10:106,498,725...106,505,596
G
Cycs
cytochrome c, somatic
affects localization multiple interactions
ISO
tert-Butylhydroperoxide affects the localization of CYCS protein hyperoside inhibits the reaction [tert-Butylhydroperoxide affects the localization of CYCS protein]
CTD
PMID:18552516
NCBI chr 4:80,982,667...80,984,767
Ensembl chr 4:79,651,378...79,654,054 Ensembl chr18:79,651,378...79,654,054
G
Cygb
cytoglobin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CYGB mRNA
CTD
PMID:27509014
NCBI chr10:102,376,506...102,386,272
Ensembl chr10:101,877,676...101,887,442
G
Cyp1b1
cytochrome P450, family 1, subfamily b, polypeptide 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CYP1B1 mRNA
CTD
PMID:12414654
NCBI chr 6:21,093,927...21,103,091
Ensembl chr 6:15,342,344...15,350,917
G
Cyp24a1
cytochrome P450, family 24, subfamily a, polypeptide 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of CYP24A1 mRNA
CTD
PMID:23410634
NCBI chr 3:179,694,647...179,709,083
Ensembl chr 3:159,275,947...159,290,383
G
Cyria
CYFIP related Rac1 interactor A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of CYRIA mRNA
CTD
PMID:15336504
NCBI chr 6:40,774,165...40,883,005
Ensembl chr 6:35,045,208...35,150,668
G
Dap3
death associated protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DAP3 mRNA
CTD
PMID:14729362
NCBI chr 2:176,617,151...176,645,293
Ensembl chr 2:174,318,983...174,346,461
G
Dapk1
death associated protein kinase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DAPK1 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr17:3,935,826...4,096,858
Ensembl chr17:3,930,213...4,090,991
G
Dars1
aspartyl-tRNA synthetase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DARS1 mRNA
CTD
PMID:15336504
NCBI chr13:42,410,351...42,465,467
Ensembl chr13:39,857,936...39,913,116
G
Dazap2
DAZ associated protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DAZAP2 mRNA
CTD
PMID:15336504
NCBI chr 7:133,593,503...133,599,044
Ensembl chr 7:131,714,745...131,720,265
G
Dbi
diazepam binding inhibitor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DBI mRNA
CTD
PMID:15336504
NCBI chr13:33,794,231...33,802,632
Ensembl chr13:31,206,988...31,268,693
G
Dcaf7
DDB1 and CUL4 associated factor 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DCAF7 mRNA
CTD
PMID:15336504
NCBI chr10:91,473,900...91,496,080
Ensembl chr10:90,974,095...90,996,275
G
Dctn5
dynactin subunit 5
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of DCTN5 gene
CTD
PMID:29432895
NCBI chr 1:186,120,415...186,137,146
Ensembl chr 1:176,689,156...176,705,906
G
Ddb2
damage specific DNA binding protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DDB2 mRNA
CTD
PMID:15336504
NCBI chr 3:97,640,923...97,667,617
Ensembl chr 3:77,185,109...77,207,631
G
Ddit3
DNA-damage inducible transcript 3
increases expression multiple interactions
ISO EXP
tert-Butylhydroperoxide results in increased expression of DDIT3 mRNA; tert-Butylhydroperoxide results in increased expression of DDIT3 protein Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DDIT3 protein]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DDIT3 protein]
CTD
PMID:12414654 PMID:22659508 PMID:24394546
NCBI chr 7:65,001,695...65,006,517
Ensembl chr 7:63,116,380...63,121,201
G
Ddit4
DNA-damage-inducible transcript 4
affects expression
ISO
tert-Butylhydroperoxide affects the expression of DDIT4 mRNA
CTD
PMID:23410634
NCBI chr20:28,434,938...28,437,037
Ensembl chr20:27,891,998...27,894,105
G
Ddr1
discoidin domain receptor tyrosine kinase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DDR1 mRNA
CTD
PMID:15336504
NCBI chr20:3,047,269...3,069,277
Ensembl chr20:3,044,320...3,064,468
G
Ddx11
DEAD/H-box helicase 11
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DDX11 mRNA
CTD
PMID:15336504
NCBI chr 9:113,204,886...113,309,692
Ensembl chr 9:105,833,504...105,862,550
G
Ddx21
DExD-box helicase 21
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DDX21 mRNA
CTD
PMID:15336504
NCBI chr20:31,077,044...31,097,238
Ensembl chr20:30,534,319...30,554,543
G
Ddx42
DEAD-box helicase 42
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DDX42 mRNA
CTD
PMID:12414654
NCBI chr10:91,648,719...91,680,730
Ensembl chr10:91,148,254...91,180,939
G
Ddx43
DEAD-box helicase 43
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DDX43 mRNA
CTD
PMID:15336504
NCBI chr 8:88,135,255...88,172,872
Ensembl chr 8:79,255,655...79,284,453
G
Ddx50
DExD-box helicase 50
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DDX50 mRNA
CTD
PMID:15003993
NCBI chr20:31,104,354...31,133,652
Ensembl chr20:30,560,544...30,591,152
G
Ddx52
DExD-box helicase 52
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DDX52 mRNA
CTD
PMID:15336504
NCBI chr10:69,322,062...69,344,856
Ensembl chr10:68,824,645...68,848,266
G
Ddx56
DEAD-box helicase 56
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DDX56 mRNA
CTD
PMID:15336504
NCBI chr14:85,325,942...85,336,262
Ensembl chr14:81,112,012...81,122,333
G
Ddx6
DEAD-box helicase 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DDX6 mRNA
CTD
PMID:15003993
NCBI chr 8:53,827,661...53,864,538
Ensembl chr 8:44,931,974...44,964,405 Ensembl chr 8:44,931,974...44,964,405
G
Dennd3
DENN domain containing 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DENND3 mRNA
CTD
PMID:15336504
NCBI chr 7:107,304,860...107,362,573
Ensembl chr 7:105,415,677...105,473,592
G
Depp1
DEPP autophagy regulator 1
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DEPP1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DEPP1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DEPP1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DEPP1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DEPP1 mRNA]
CTD
PMID:20847119
NCBI chr 4:151,583,105...151,585,455
Ensembl chr 4:149,910,779...149,914,542
G
Derl1
derlin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DERL1 mRNA
CTD
PMID:15003993
NCBI chr 7:91,293,963...91,316,639
Ensembl chr 7:89,404,417...89,427,145
G
Dffb
DNA fragmentation factor subunit beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DFFB mRNA
CTD
PMID:12419474
NCBI chr 5:169,804,873...169,817,157
Ensembl chr 5:164,522,463...164,534,628
G
Dgat2
diacylglycerol O-acyltransferase 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of DGAT2 mRNA
CTD
PMID:23410634
NCBI chr 1:162,866,237...162,896,655
Ensembl chr 1:153,454,080...153,484,428
G
Dhps
deoxyhypusine synthase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DHPS mRNA
CTD
PMID:15336504
NCBI chr19:39,987,328...39,991,418
Ensembl chr19:23,082,448...23,086,881
G
Dhx9
DExH-box helicase 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DHX9 mRNA
CTD
PMID:15336504
NCBI chr13:68,152,813...68,189,580
Ensembl chr13:65,602,323...65,639,069
G
Dimt1
DIM1 rRNA methyltransferase and ribosome maturation factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DIMT1 mRNA
CTD
PMID:15336504
NCBI chr 2:38,343,086...38,368,242
Ensembl chr 2:38,354,854...38,368,227
G
Dip2c
disco-interacting protein 2 homolog C
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DIP2C mRNA
CTD
PMID:15336504
NCBI chr17:60,647,346...61,032,467
Ensembl chr17:60,649,065...61,032,305
G
Dkk1
dickkopf WNT signaling pathway inhibitor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DKK1 mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr 1:237,794,969...237,798,650
Ensembl chr 1:228,381,521...228,385,202
G
Dlg1
discs large MAGUK scaffold protein 1
multiple interactions increases expression
ISO
[rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DLG1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of DLG1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DLG1 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DLG1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DLG1 mRNA]
CTD
PMID:20847119
NCBI chr11:82,416,853...82,607,797
Ensembl chr11:68,911,883...69,102,689
G
Dlg3
discs large MAGUK scaffold protein 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DLG3 mRNA
CTD
PMID:15336504
NCBI chr X:69,899,694...69,951,928
Ensembl chr X:65,860,172...65,910,322
G
Dlgap4
DLG associated protein 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DLGAP4 mRNA
CTD
PMID:15336504
NCBI chr 3:165,584,271...165,731,868
Ensembl chr 3:145,175,479...145,270,490
G
Dlgap5
DLG associated protein 5
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of DLGAP5 mRNA tert-Butylhydroperoxide affects the expression of DLGAP5 mRNA
CTD
PMID:15003993 PMID:23410634
NCBI chr15:23,113,678...23,144,281
Ensembl chr15:20,633,966...20,664,518
G
Dlx2
distal-less homeobox 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DLX2 mRNA
CTD
PMID:14729362 PMID:29432895
NCBI chr 3:76,777,912...76,781,255
Ensembl chr 3:56,370,483...56,373,597
G
Dmpk
DM1 protein kinase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DMPK mRNA
CTD
PMID:15003993
NCBI chr 1:87,858,294...87,868,624
Ensembl chr 1:78,730,275...78,740,593
G
Dnaaf2
dynein, axonemal, assembly factor 2
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of DNAAF2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of DNAAF2 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of DNAAF2 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of DNAAF2 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of DNAAF2 mRNA]
CTD
PMID:20847119
NCBI chr 6:93,397,157...93,406,323
Ensembl chr 6:87,660,821...87,670,199
G
Dnajb1
DnaJ heat shock protein family (Hsp40) member B1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DNAJB1 mRNA
CTD
PMID:15336504
NCBI chr19:41,427,453...41,431,141
Ensembl chr19:24,522,717...24,526,458
G
Dnajb11
DnaJ heat shock protein family (Hsp40) member B11
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DNAJB11 mRNA
CTD
PMID:15003993
NCBI chr11:91,656,334...91,672,800
Ensembl chr11:78,150,429...78,180,407
G
Dnajb4
DnaJ heat shock protein family (Hsp40) member B4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DNAJB4 mRNA
CTD
PMID:15336504
NCBI chr 2:243,790,296...243,819,042
Ensembl chr 2:241,130,340...241,159,089
G
Dnajb7
DnaJ heat shock protein family (Hsp40) member B7
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of DNAJB7 intron
CTD
PMID:29432895
NCBI chr 7:114,812,886...114,814,200
Ensembl chr 7:112,932,616...112,945,537
G
Dnase2
deoxyribonuclease 2, lysosomal
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DNASE2 mRNA
CTD
PMID:15336504
NCBI chr19:40,149,505...40,152,225
Ensembl chr19:23,244,664...23,247,376
G
Dnm2
dynamin 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DNM2 mRNA
CTD
PMID:15336504
NCBI chr 8:28,254,344...28,336,297
Ensembl chr 8:19,978,400...20,060,157
G
Dnmbp
dynamin binding protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DNMBP mRNA
CTD
PMID:15336504
NCBI chr 1:252,685,406...252,778,642
Ensembl chr 1:242,736,189...242,802,604
G
Dnph1
2'-deoxynucleoside 5'-phosphate N-hydrolase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DNPH1 mRNA
CTD
PMID:12419474
NCBI chr 9:21,978,894...21,981,631
Ensembl chr 9:14,481,066...14,484,022
G
Dock2
dedicator of cytokinesis 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DOCK2 mRNA
CTD
PMID:15336504
NCBI chr10:19,331,412...19,748,987
Ensembl chr10:18,827,239...19,244,808
G
Dock4
dedicator of cytokinesis 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DOCK4 mRNA
CTD
PMID:15336504
NCBI chr 6:63,240,050...63,629,772
Ensembl chr 6:57,512,908...57,901,855
G
Dpp4
dipeptidylpeptidase 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DPP4 mRNA
CTD
PMID:15336504
NCBI chr 3:67,370,794...67,452,422
Ensembl chr 3:46,962,243...47,043,901
G
Dpy19l1
dpy-19 like C-mannosyltransferase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DPY19L1 mRNA
CTD
PMID:15336504
NCBI chr 8:31,209,025...31,297,485
Ensembl chr 8:22,933,163...23,021,751
G
Dpysl3
dihydropyrimidinase-like 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DPYSL3 mRNA
CTD
PMID:15336504
NCBI chr18:35,625,357...35,731,152
Ensembl chr18:35,377,181...35,480,157
G
Drap1
Dr1 associated protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DRAP1 mRNA
CTD
PMID:15003993
NCBI chr 1:212,161,107...212,163,833
Ensembl chr 1:202,731,788...202,734,425
G
Dsc3
desmocollin 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DSC3 mRNA
CTD
PMID:15336504
NCBI chr18:11,654,833...11,688,871
Ensembl chr18:11,377,347...11,413,797
G
Dst
dystonin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DST mRNA
CTD
PMID:12419474
NCBI chr 9:43,631,716...44,025,535
Ensembl chr 9:36,135,284...36,529,615
G
Dusp1
dual specificity phosphatase 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of DUSP1 mRNA
CTD
PMID:23410634
NCBI chr10:17,184,853...17,187,646
G
Dusp10
dual specificity phosphatase 10
multiple interactions increases expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DUSP10 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DUSP10 mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of DUSP10 mRNA; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DUSP10 mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DUSP10 mRNA]
CTD
PMID:15336504 PMID:20847119
NCBI chr13:98,145,317...98,183,304
Ensembl chr13:95,614,292...95,651,716
G
Dusp5
dual specificity phosphatase 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of DUSP5 mRNA
CTD
PMID:15336504
NCBI chr 1:262,543,774...262,557,201
Ensembl chr 1:252,538,449...252,551,818
G
Dusp6
dual specificity phosphatase 6
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DUSP6 mRNA tert-Butylhydroperoxide results in increased expression of DUSP6 mRNA
CTD
PMID:15336504 PMID:17003459
NCBI chr 7:35,979,502...35,983,834
Ensembl chr 7:34,092,943...34,097,185
G
Dusp9
dual specificity phosphatase 9
affects expression
ISO
tert-Butylhydroperoxide affects the expression of DUSP9 mRNA
CTD
PMID:23410634
NCBI chr X:156,503,237...156,507,162
Ensembl chr X:151,351,897...151,355,821
G
Dut
deoxyuridine triphosphatase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DUT mRNA
CTD
PMID:15336504
NCBI chr 3:132,952,258...132,963,433
Ensembl chr 3:112,498,982...112,510,771
G
Dvl3
dishevelled segment polarity protein 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DVL3 mRNA
CTD
PMID:29432895
NCBI chr11:93,869,834...93,887,013
Ensembl chr11:80,366,117...80,382,462
G
Dynll1
dynein light chain LC8-type 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DYNLL1 mRNA
CTD
PMID:12419474
NCBI chr12:46,945,291...46,976,867
Ensembl chr12:41,312,367...41,314,741
G
Dynlrb1
dynein light chain roadblock-type 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of DYNLRB1 mRNA
CTD
PMID:15336504
NCBI chr 3:164,197,892...164,224,409
Ensembl chr 3:143,742,586...143,764,227
G
E2f1
E2F transcription factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of E2F1 mRNA
CTD
PMID:12419474
NCBI chr 3:163,524,739...163,535,563
Ensembl chr 3:143,049,478...143,075,361
G
Ech1
enoyl-CoA hydratase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ECH1 mRNA
CTD
PMID:15003993
NCBI chr 1:93,241,076...93,248,314
Ensembl chr 1:84,112,751...84,120,795
G
Echdc2
enoyl CoA hydratase domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ECHDC2 mRNA
CTD
PMID:15336504
NCBI chr 5:128,144,241...128,163,611
Ensembl chr 5:122,916,134...122,934,859
G
Echs1
enoyl-CoA hydratase, short chain 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ECHS1 protein
CTD
PMID:24394546
NCBI chr 1:204,324,679...204,333,506
Ensembl chr 1:194,895,036...194,903,884
G
Eci1
enoyl-CoA delta isomerase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ECI1 mRNA
CTD
PMID:15336504
NCBI chr10:13,961,250...13,974,595
Ensembl chr10:13,456,563...13,470,061
G
Ecsit
ECSIT signaling integrator
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ECSIT mRNA
CTD
PMID:15336504
NCBI chr 8:28,881,594...28,894,443
Ensembl chr 8:20,605,583...20,618,390
G
Edil3
EGF like repeats and discoidin domains 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EDIL3 mRNA
CTD
PMID:15336504
NCBI chr 2:21,625,604...22,140,380
Ensembl chr 2:19,890,373...20,405,008
G
Edn1
endothelin 1
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of EDN1 mRNA tert-Butylhydroperoxide affects the expression of EDN1 mRNA
CTD
PMID:12414654 PMID:23410634
NCBI chr17:22,660,799...22,666,687
Ensembl chr17:22,454,420...22,460,885
G
Eef2
eukaryotic translation elongation factor 2
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of EEF2 protein
CTD
PMID:16469450
NCBI chr 7:9,183,836...9,196,255
Ensembl chr 7:8,533,116...8,559,183
G
Efemp1
EGF containing fibulin extracellular matrix protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EFEMP1 mRNA
CTD
PMID:15336504
NCBI chr14:106,811,769...106,890,961
Ensembl chr14:102,610,908...102,690,018
G
Efhd1
EF-hand domain family, member D1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EFHD1 mRNA
CTD
PMID:15336504
NCBI chr 9:95,386,155...95,432,800
Ensembl chr 9:87,938,284...87,984,917
G
Efna4
ephrin A4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EFNA4 mRNA
CTD
PMID:12419474
NCBI chr 2:177,046,463...177,050,713
Ensembl chr 2:174,748,724...174,752,979
G
Efs
embryonal Fyn-associated substrate
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EFS mRNA
CTD
PMID:15336504
NCBI chr15:32,362,401...32,374,490
Ensembl chr15:28,392,187...28,401,902
G
Egfr
epidermal growth factor receptor
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EGFR mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EGFR mRNA]
CTD
PMID:35690295
NCBI chr14:95,378,626...95,551,358
Ensembl chr14:91,177,067...91,344,382
G
Egr1
early growth response 1
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of EGR1 mRNA tert-Butylhydroperoxide affects the expression of EGR1 mRNA
CTD
PMID:12414654 PMID:23410634
NCBI chr18:26,737,078...26,740,877
Ensembl chr18:26,462,981...26,466,766
G
Eif2ak2
eukaryotic translation initiation factor 2-alpha kinase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EIF2AK2 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 6:21,941,147...21,977,115
Ensembl chr 6:16,188,979...16,224,971
G
Eif2b4
eukaryotic translation initiation factor 2B subunit delta
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EIF2B4 mRNA
CTD
PMID:15336504
NCBI chr 6:30,903,148...30,908,803
Ensembl chr 6:25,183,186...25,188,829
G
Eif3m
eukaryotic translation initiation factor 3, subunit M
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EIF3M mRNA
CTD
PMID:15336504
NCBI chr 3:111,879,589...111,897,193
Ensembl chr 3:91,416,325...91,442,392
G
Eif5
eukaryotic translation initiation factor 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EIF5 mRNA
CTD
PMID:15336504
NCBI chr 6:136,410,333...136,418,827
Ensembl chr 6:130,589,143...130,597,656
G
Eif5b
eukaryotic translation initiation factor 5B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EIF5B mRNA
CTD
PMID:15336504
NCBI chr 9:47,718,706...47,773,289
Ensembl chr 9:40,222,898...40,277,482
G
Elavl1
ELAV like RNA binding protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ELAVL1 mRNA
CTD
PMID:15336504
NCBI chr12:7,441,699...7,482,625
Ensembl chr12:2,645,061...2,684,784
G
Elf1
E74 like ETS transcription factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ELF1 mRNA
CTD
PMID:15336504
NCBI chr15:61,354,026...61,395,762
Ensembl chr15:54,865,616...54,986,699
G
Elf5
E74 like ETS transcription factor 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ELF5 mRNA
CTD
PMID:15003993
NCBI chr 3:110,264,460...110,291,926
Ensembl chr 3:89,797,880...89,836,973
G
Elob
elongin B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ELOB mRNA
CTD
PMID:15336504
NCBI chr10:13,353,413...13,358,484
Ensembl chr10:12,848,827...12,853,635
G
Eme1
essential meiotic structure-specific endonuclease 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EME1 mRNA
CTD
PMID:27509014
NCBI chr10:80,083,585...80,092,450
Ensembl chr10:79,586,729...79,595,435
G
Emilin1
elastin microfibril interfacer 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of EMILIN1 mRNA
CTD
PMID:23410634
NCBI chr 6:31,175,919...31,183,657
Ensembl chr 6:25,445,298...25,463,698
G
Eml1
EMAP like 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EML1 mRNA
CTD
PMID:15336504
NCBI chr 6:133,048,271...133,221,642
Ensembl chr 6:127,284,029...127,457,246
G
Eml4
EMAP like 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EML4 mRNA
CTD
PMID:15336504
NCBI chr 6:16,972,054...17,087,365
Ensembl chr 6:11,219,566...11,334,879
G
Emp3
epithelial membrane protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EMP3 mRNA
CTD
PMID:15003993
NCBI chr 1:105,525,086...105,528,370
Ensembl chr 1:96,388,652...96,391,988
G
Eng
endoglin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ENG mRNA
CTD
PMID:15336504
NCBI chr 3:36,332,190...36,370,324
Ensembl chr 3:15,934,518...15,973,230
G
Epb41l2
erythrocyte membrane protein band 4.1-like 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EPB41L2 mRNA
CTD
PMID:15336504
NCBI chr 1:21,682,336...21,857,106
Ensembl chr 1:19,863,009...20,037,721
G
Epb42
erythrocyte membrane protein band 4.2
increases degradation
ISO
tert-Butylhydroperoxide results in increased degradation of EPB42 protein
CTD
PMID:15040847
NCBI chr 3:128,433,460...128,451,683
Ensembl chr 3:107,979,713...107,997,932
G
Ephb2
Eph receptor B2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EPHB2 mRNA
CTD
PMID:15336504
NCBI chr 5:154,179,065...154,360,459
Ensembl chr 5:148,897,246...149,077,059
G
Ephb4
EPH receptor B4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EPHB4 mRNA
CTD
PMID:15336504
NCBI chr12:24,963,174...24,988,473
Ensembl chr12:19,326,427...19,351,314
G
Ephx1
epoxide hydrolase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EPHX1 mRNA
CTD
PMID:21382384
NCBI chr13:95,246,079...95,275,852
Ensembl chr13:92,714,315...92,790,235
G
Ephx2
epoxide hydrolase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of EPHX2 mRNA
CTD
PMID:14729362
NCBI chr15:44,465,447...44,503,157
Ensembl chr15:40,289,902...40,327,615
G
Erbb2
erb-b2 receptor tyrosine kinase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ERBB2 mRNA
CTD
PMID:15336504
NCBI chr10:83,907,491...83,931,365
Ensembl chr10:83,411,313...83,435,078
G
Erbb4
erb-b2 receptor tyrosine kinase 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ERBB4 mRNA
CTD
PMID:12419474
NCBI chr 9:76,973,386...78,045,633
Ensembl chr 9:69,531,481...70,596,595
G
Erbin
erbb2 interacting protein
multiple interactions increases expression
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of ERBIN mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ERBIN mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ERBIN mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ERBIN mRNA]
CTD
PMID:20847119
NCBI chr 2:36,660,399...36,762,584
Ensembl chr 2:34,928,863...35,027,852
G
Ercc5
ERCC excision repair 5, endonuclease
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ERCC5 mRNA
CTD
PMID:12419474
NCBI chr 9:53,801,471...53,846,611
Ensembl chr 9:46,309,389...46,354,472
G
Ern1
endoplasmic reticulum to nucleus signaling 1
multiple interactions
ISO
Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]; tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]
CTD
PMID:24394546
NCBI chr10:91,826,663...91,920,976
Ensembl chr10:91,330,654...91,421,029
G
Erp29
endoplasmic reticulum protein 29
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ERP29 mRNA
CTD
PMID:15336504
NCBI chr12:40,750,177...40,756,607
Ensembl chr12:35,089,707...35,096,376
G
Esm1
endothelial cell-specific molecule 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ESM1 mRNA
CTD
PMID:15336504
NCBI chr 2:46,609,253...46,617,991
Ensembl chr 2:44,876,067...44,884,804
G
Ess2
ess-2 splicing factor homolog
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ESS2 mRNA
CTD
PMID:15336504
NCBI chr11:96,580,185...96,596,673
Ensembl chr11:83,075,925...83,084,846
G
Etf1
eukaryotic translation termination factor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ETF1 mRNA
CTD
PMID:15336504
NCBI chr18:26,776,518...26,804,857
Ensembl chr18:26,504,080...26,530,810
G
Etfa
electron transfer flavoprotein subunit alpha
multiple interactions increases expression decreases expression
ISO EXP
ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide results in increased expression of DDIT3 protein]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NFKB1 protein]; pyrazolanthrone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ETFA protein] tert-Butylhydroperoxide results in decreased expression of ETFA protein
CTD
PMID:24394546
NCBI chr 8:64,731,192...64,787,965
Ensembl chr 8:55,835,134...55,891,969
G
Etfb
electron transfer flavoprotein subunit beta
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of ETFB mRNA tert-Butylhydroperoxide results in increased methylation of ETFB gene
CTD
PMID:15336504 PMID:29432895
NCBI chr 1:102,988,499...103,002,663
Ensembl chr 1:93,851,858...93,866,068
G
Ets1
ETS proto-oncogene 1, transcription factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ETS1 mRNA
CTD
PMID:12419474
NCBI chr 8:39,303,936...39,426,022
Ensembl chr 8:31,045,945...31,168,010
G
Ets2
ETS proto-oncogene 2, transcription factor
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ETS2 mRNA tert-Butylhydroperoxide results in increased expression of ETS2 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr11:48,491,057...48,507,843
Ensembl chr11:35,021,596...35,038,319
G
Etv3
ETS variant transcription factor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ETV3 mRNA
CTD
PMID:12419474
NCBI chr 2:175,263,389...175,278,217
Ensembl chr 2:172,965,588...172,980,314
G
Etv4
ETS variant transcription factor 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ETV4 mRNA
CTD
PMID:15003993
NCBI chr10:87,206,977...87,222,202
Ensembl chr10:86,706,749...86,721,974
G
Etv5
ETS variant transcription factor 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ETV5 mRNA
CTD
PMID:15336504
NCBI chr11:92,113,171...92,170,758
Ensembl chr11:78,608,710...78,666,215
G
Exo1
exonuclease 1
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EXO1 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EXO1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EXO1 mRNA]
CTD
PMID:35690295
NCBI chr13:90,341,947...90,366,861
Ensembl chr13:87,809,810...87,834,654
G
Exoc7
exocyst complex component 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EXOC7 mRNA
CTD
PMID:15336504
NCBI chr10:102,019,805...102,039,333
Ensembl chr10:101,520,927...101,540,561
G
Ezh2
enhancer of zeste 2 polycomb repressive complex 2 subunit
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EZH2 mRNA
CTD
PMID:15336504
NCBI chr 4:77,624,223...77,698,598
Ensembl chr 4:76,624,399...76,687,362
G
Ezr
ezrin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of EZR mRNA
CTD
PMID:12419474
NCBI chr 1:49,373,033...49,416,573
Ensembl chr 1:46,967,658...47,011,505
G
F2rl1
F2R like trypsin receptor 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of F2RL1 mRNA
CTD
PMID:23410634
NCBI chr 2:28,507,003...28,519,954
Ensembl chr 2:26,772,278...26,785,226
G
Fah
fumarylacetoacetate hydrolase
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of FAH protein
CTD
PMID:24394546
NCBI chr 1:147,957,931...147,980,708
Ensembl chr 1:138,548,834...138,571,505
G
Fam110b
family with sequence similarity 110, member B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FAM110B mRNA
CTD
PMID:29432895
NCBI chr 5:23,587,093...23,727,188
Ensembl chr 5:18,789,389...18,929,828
G
Fam111a
FAM111 trypsin like peptidase A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FAM111A mRNA
CTD
PMID:15336504
NCBI chr 1:219,065,542...219,081,213
Ensembl chr 1:209,640,953...209,656,547
G
Fam13b
family with sequence similarity 13, member B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FAM13B mRNA
CTD
PMID:15003993
NCBI chr18:26,314,440...26,395,260
Ensembl chr18:26,040,285...26,106,587
G
Fam171a1
family with sequence similarity 171, member A1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FAM171A1 mRNA
CTD
PMID:29432895
NCBI chr17:79,933,742...80,057,495
Ensembl chr17:75,024,575...75,150,255
G
Fam210a
family with sequence similarity 210, member A
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of FAM210A mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of FAM210A mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of FAM210A mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FAM210A mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FAM210A mRNA]
CTD
PMID:20847119
NCBI chr18:64,116,274...64,155,971
Ensembl chr18:61,852,907...61,886,171
G
Fanci
FA complementation group I
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FANCI mRNA
CTD
PMID:15336504
NCBI chr 1:142,736,636...142,792,999
Ensembl chr 1:133,327,297...133,383,640
G
Farp1
FERM, ARH/RhoGEF and pleckstrin domain protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FARP1 mRNA
CTD
PMID:15336504
NCBI chr15:104,531,196...104,770,148
Ensembl chr15:98,182,329...98,363,299
G
Fas
Fas cell surface death receptor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FAS mRNA
CTD
PMID:12414654 PMID:27509014
NCBI chr 1:241,212,155...241,245,774
Ensembl chr 1:231,798,960...231,832,591
G
Fastk
Fas-activated serine/threonine kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FASTK mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr 4:11,624,697...11,628,769
Ensembl chr 4:10,732,256...10,737,430
G
Fbln1
fibulin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FBLN1 mRNA
CTD
PMID:15336504
NCBI chr 7:118,190,347...118,269,965
Ensembl chr 7:116,310,582...116,390,075
G
Fbxo30
F-box protein 30
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FBXO30 mRNA
CTD
PMID:23410634
NCBI chr 1:7,475,636...7,491,719
Ensembl chr 1:5,655,339...5,672,441
G
Fdps
farnesyl diphosphate synthase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FDPS mRNA
CTD
PMID:15336504
NCBI chr 2:176,795,192...176,804,816
Ensembl chr 2:174,486,665...174,507,776
G
Fdx1
ferredoxin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FDX1 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 8:61,164,839...61,183,645
Ensembl chr 8:52,268,536...52,287,414
G
Fdxr
ferredoxin reductase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FDXR mRNA
CTD
PMID:12414654 PMID:27509014
NCBI chr10:101,006,845...101,015,582
Ensembl chr10:100,507,865...100,516,658
G
Fen1
flap structure-specific endonuclease 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FEN1 mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr 1:216,270,016...216,274,873
Ensembl chr 1:206,844,884...206,850,003
G
Fermt2
FERM domain containing kindlin 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FERMT2 mRNA
CTD
PMID:15336504
NCBI chr15:21,162,603...21,257,995
Ensembl chr15:18,682,927...18,751,811
G
Fgg
fibrinogen gamma chain
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FGG mRNA
CTD
PMID:12414654
NCBI chr 2:170,652,929...170,660,372
Ensembl chr 2:168,355,013...168,362,322
G
Fh
fumarate hydratase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FH mRNA
CTD
PMID:15336504
NCBI chr13:90,056,565...90,082,450
Ensembl chr13:87,524,337...87,550,266
G
Fhl1
four and a half LIM domains 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FHL1 mRNA
CTD
PMID:15336504
NCBI chr X:139,592,794...139,652,290
Ensembl chr X:134,555,479...134,614,928
G
Fhl2
four and a half LIM domains 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FHL2 mRNA
CTD
PMID:15336504
NCBI chr 9:52,881,091...52,954,540
Ensembl chr 9:45,388,981...45,431,192
G
Fhod3
formin homology 2 domain containing 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FHOD3 mRNA
CTD
PMID:15336504
NCBI chr18:16,267,830...16,700,508
Ensembl chr18:15,993,324...16,425,796
G
Fibp
FGF1 intracellular binding protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FIBP mRNA
CTD
PMID:15336504
NCBI chr 1:212,197,216...212,201,732
Ensembl chr 1:202,768,078...202,772,399
G
Fis1
fission, mitochondrial 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FIS1 mRNA
CTD
PMID:15336504
NCBI chr12:25,345,239...25,360,135
Ensembl chr12:19,708,558...19,723,377
G
Fjx1
four-jointed box kinase 1
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of FJX1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of FJX1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of FJX1 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of FJX1 mRNA]
CTD
PMID:20847119
NCBI chr 3:109,229,223...109,231,324
Ensembl chr 3:88,774,220...88,776,321
G
Fkbp1a
FKBP prolyl isomerase 1A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FKBP1A mRNA
CTD
PMID:15336504
NCBI chr 3:160,500,748...160,520,492
Ensembl chr 3:140,040,278...140,060,743
G
Fkbp8
FKBP prolyl isomerase 8
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FKBP8 mRNA
CTD
PMID:15336504
NCBI chr16:18,929,581...18,936,621
Ensembl chr16:18,893,576...18,902,612
G
Flnb
filamin B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FLNB mRNA
CTD
PMID:15336504
NCBI chr15:19,392,212...19,525,278
Ensembl chr15:16,962,003...17,095,006
G
Fmo1
flavin containing dimethylaniline monoxygenase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FMO1 mRNA
CTD
PMID:12419474
NCBI chr13:77,715,405...77,747,666
Ensembl chr13:75,182,176...75,214,647
G
Fn1
fibronectin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FN1 mRNA
CTD
PMID:15963989
NCBI chr 9:80,645,507...80,714,200
Ensembl chr 9:73,196,044...73,264,678
G
Folr1
folate receptor alpha
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of FOLR1 mRNA tert-Butylhydroperoxide results in decreased expression of FOLR1 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:22956110
NCBI chr 1:165,631,462...165,650,430
Ensembl chr 1:156,219,460...156,230,667
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
decreases expression multiple interactions increases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of FOS mRNA CAT protein inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FOS mRNA]; Glutathione inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FOS mRNA]; Thiourea inhibits the reaction [tert-Butylhydroperoxide results in increased expression of FOS mRNA] tert-Butylhydroperoxide results in increased methylation of FOS gene
CTD
PMID:12419474 PMID:15105052 PMID:27509014
NCBI chr 6:110,852,188...110,855,054
Ensembl chr 6:105,121,170...105,124,036
G
Fosl1
FOS like 1, AP-1 transcription factor subunit
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FOSL1 mRNA
CTD
PMID:15336504
NCBI chr 1:212,183,885...212,192,391
Ensembl chr 1:202,754,529...202,764,930
G
Foxd1
forkhead box D1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FOXD1 mRNA tert-Butylhydroperoxide results in increased expression of FOXD1 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 2:31,436,802...31,439,222
Ensembl chr 2:29,702,558...29,704,978
G
Foxm1
forkhead box M1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FOXM1 mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr 4:163,325,628...163,338,100
Ensembl chr 4:161,638,816...161,650,684
G
Ftl1
ferritin light chain 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FTL mRNA
CTD
PMID:12414654 PMID:15963989
NCBI chr 1:105,072,858...105,074,705
Ensembl chr 1:95,936,387...95,939,725 Ensembl chr10:95,936,387...95,939,725 Ensembl chr 2:95,936,387...95,939,725
G
Fubp1
far upstream element binding protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FUBP1 mRNA
CTD
PMID:15336504
NCBI chr 2:243,819,529...243,846,544
Ensembl chr 2:241,159,512...241,186,602
G
Fxyd5
FXYD domain-containing ion transport regulator 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of FXYD5 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 1:95,395,327...95,404,722
Ensembl chr 1:86,267,406...86,277,519
G
Fyco1
FYVE and coiled-coil domain autophagy adaptor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FYCO1 mRNA
CTD
PMID:15336504
NCBI chr 8:132,289,538...132,356,810
Ensembl chr 8:123,412,112...123,479,021
G
Fzd1
frizzled class receptor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FZD1 mRNA
CTD
PMID:29432895
NCBI chr 4:30,265,074...30,269,472
Ensembl chr 4:29,310,091...29,312,643 Ensembl chr 4:29,310,091...29,312,643
G
Fzr1
fizzy and cell division cycle 20 related 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of FZR1 mRNA
CTD
PMID:15336504
NCBI chr 7:8,982,765...8,994,689
Ensembl chr 7:8,332,029...8,343,952
G
G0s2
G0/G1switch 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of G0S2 mRNA
CTD
PMID:15336504
NCBI chr13:107,335,036...107,335,948
Ensembl chr13:104,806,156...104,807,451
G
G6pd
glucose-6-phosphate dehydrogenase
decreases activity increases activity
ISO EXP
tert-Butylhydroperoxide results in decreased activity of G6PD protein tert-Butylhydroperoxide results in increased activity of G6PD protein
CTD
PMID:12628296 PMID:15336504 PMID:16928893
NCBI chr X:157,352,364...157,372,144
Ensembl chr X:152,201,098...152,220,801
G
Gadd45b
growth arrest and DNA-damage-inducible, beta
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of GADD45B mRNA tert-Butylhydroperoxide affects the expression of GADD45B mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 7:9,428,689...9,430,991
Ensembl chr 7:8,778,007...8,780,046
G
Gak
cyclin G associated kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GAK mRNA
CTD
PMID:12419474
NCBI chr14:1,234,272...1,308,492
Ensembl chr14:1,089,866...1,216,398
G
Galm
galactose mutarotase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GALM mRNA
CTD
PMID:15003993
NCBI chr 6:20,589,775...20,641,516
Ensembl chr 6:14,837,548...14,889,310
G
Galns
galactosamine (N-acetyl)-6-sulfatase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GALNS mRNA
CTD
PMID:15336504
NCBI chr19:50,628,639...50,662,477
Ensembl chr19:50,628,552...50,662,246
G
Galnt1
polypeptide N-acetylgalactosaminyltransferase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GALNT1 mRNA
CTD
PMID:15336504
NCBI chr18:15,763,697...15,843,598
Ensembl chr18:15,489,020...15,568,245
G
Galnt3
polypeptide N-acetylgalactosaminyltransferase 3
increases methylation decreases methylation
ISO
tert-Butylhydroperoxide results in increased methylation of GALNT3 intron tert-Butylhydroperoxide results in decreased methylation of GALNT3 intron
CTD
PMID:29432895
NCBI chr 3:71,150,559...71,187,321
Ensembl chr 3:50,742,512...50,766,268
G
Galnt6
polypeptide N-acetylgalactosaminyltransferase 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GALNT6 mRNA
CTD
PMID:15336504
NCBI chr 7:133,668,612...133,715,909
Ensembl chr 7:131,789,839...131,819,661
G
Ganab
glucosidase II alpha subunit
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GANAB mRNA
CTD
PMID:15336504
NCBI chr 1:215,222,918...215,242,808
Ensembl chr 1:205,793,895...205,813,695
G
Gapdh
glyceraldehyde-3-phosphate dehydrogenase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GAPDH protein
CTD
PMID:11295360
NCBI chr 4:159,648,592...159,653,436
Ensembl chr 4:157,962,343...157,966,235
G
Gars1
glycyl-tRNA synthetase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GARS1 mRNA
CTD
PMID:15003993
NCBI chr 4:85,484,939...85,542,876
Ensembl chr 4:84,171,596...84,212,609
G
Gas2
growth arrest-specific 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GAS2 mRNA
CTD
PMID:14729362
NCBI chr 1:110,587,952...110,721,572
Ensembl chr 1:101,482,591...101,582,619
G
Gas2l1
growth arrest-specific 2 like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GAS2L1 mRNA
CTD
PMID:29432895
NCBI chr14:84,169,398...84,175,514
Ensembl chr14:79,950,555...79,961,438
G
Gata6
GATA binding protein 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GATA6 mRNA
CTD
PMID:15336504
NCBI chr18:2,460,909...2,492,322
Ensembl chr18:2,188,121...2,219,532
G
Gatd3a
glutamine amidotransferase class 1 domain containing 3A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GATD3 mRNA
CTD
PMID:15336504
NCBI chr20:10,514,459...10,522,556
Ensembl chr20:10,514,744...10,522,885
G
Gbp2
guanylate binding protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GBP2 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 2:234,005,727...234,021,812
Ensembl chr 2:231,332,284...231,348,571
G
Gbp4
guanylate binding protein 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GBP3 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 2:233,978,163...233,992,124
Ensembl chr 2:231,305,244...231,318,879
G
Gbp6
guanylate binding protein family member 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GBP6 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr14:5,034,999...5,062,023
Ensembl chr14:4,730,453...4,839,062 Ensembl chr14:4,730,453...4,839,062
G
Gchfr
GTP cyclohydrolase I feedback regulator
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GCHFR mRNA
CTD
PMID:15336504
NCBI chr 3:126,611,892...126,615,926
Ensembl chr 3:106,159,394...106,162,080
G
Gclc
glutamate-cysteine ligase, catalytic subunit
multiple interactions decreases response to substance increases expression decreases expression
ISO EXP
[Linoleic Acids, Conjugated results in increased activity of GCLC protein] which results in decreased susceptibility to tert-Butylhydroperoxide GCLC protein results in decreased susceptibility to tert-Butylhydroperoxide [Apigenin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]]; [chrysin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [Luteolin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of GCLC mRNA tert-Butylhydroperoxide results in decreased expression of GCLC mRNA
CTD
PMID:12425961 PMID:17092368 PMID:22864849 PMID:23410634 PMID:27509014 PMID:30547568 More...
NCBI chr 8:87,510,251...87,548,896
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
multiple interactions increases expression
EXP ISO
[Apigenin results in increased expression of GCLM mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]]; [chrysin results in increased expression of GCLM mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of GCLM mRNA
CTD
PMID:12414654 PMID:22864849 PMID:23410634 PMID:27509014 PMID:30547568
NCBI chr 2:213,032,135...213,052,192
Ensembl chr 2:210,347,482...210,367,535
G
Gcnt1
glucosaminyl (N-acetyl) transferase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GCNT1 mRNA
CTD
PMID:15336504
NCBI chr 1:224,145,104...224,182,496
Ensembl chr 1:214,718,293...214,758,776
G
Gcnt3
glucosaminyl (N-acetyl) transferase 3, mucin type
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GCNT3 mRNA
CTD
PMID:23410634
NCBI chr 8:79,570,081...79,577,389
Ensembl chr 8:70,686,844...70,699,562
G
Gdf15
growth differentiation factor 15
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GDF15 mRNA
CTD
PMID:12414654
NCBI chr16:18,838,436...18,842,022
Ensembl chr16:18,805,239...18,808,055
G
Gdpd5
glycerophosphodiester phosphodiesterase domain containing 5
affects expression
ISO
tert-Butylhydroperoxide affects the expression of GDPD5 mRNA
CTD
PMID:23410634
NCBI chr 1:163,091,844...163,173,559
Ensembl chr 1:153,679,718...153,761,446
G
Gem
GTP binding protein overexpressed in skeletal muscle
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of GEM mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of GEM mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of GEM mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of GEM mRNA]
CTD
PMID:20847119
NCBI chr 5:30,011,641...30,022,554
Ensembl chr 5:25,214,309...25,225,222
G
Gemin4
gem (nuclear organelle) associated protein 4
multiple interactions decreases expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of GEMIN4 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of GEMIN4 mRNA; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of GEMIN4 mRNA]
CTD
PMID:20847119
NCBI chr10:61,560,172...61,571,765
Ensembl chr10:61,066,425...61,073,431 Ensembl chr10:61,066,425...61,073,431
G
Gfap
glial fibrillary acidic protein
decreases expression increases expression
EXP
tert-Butylhydroperoxide results in decreased expression of GFAP protein tert-Butylhydroperoxide results in increased expression of GFAP protein
CTD
PMID:24394546
NCBI chr10:88,352,987...88,361,661
Ensembl chr10:87,852,890...87,861,589
G
Gfer
growth factor, augmenter of liver regeneration
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GFER mRNA
CTD
PMID:15336504
NCBI chr10:14,223,023...14,225,736
Ensembl chr10:13,718,489...13,720,869
G
Gfpt2
glutamine-fructose-6-phosphate transaminase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GFPT2 mRNA
CTD
PMID:15336504
NCBI chr10:34,616,146...34,662,420
Ensembl chr10:34,115,052...34,161,329
G
Gfra1
GDNF family receptor alpha 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GFRA1 mRNA
CTD
PMID:15336504
NCBI chr 1:267,325,297...267,557,037
Ensembl chr 1:257,321,742...257,551,473
G
Gins2
GINS complex subunit 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GINS2 mRNA
CTD
PMID:15336504
NCBI chr19:65,535,492...65,548,270
Ensembl chr19:48,626,770...48,639,339
G
Gja1
gap junction protein, alpha 1
decreases expression decreases response to substance
ISO
tert-Butylhydroperoxide results in decreased expression of GJA1 mRNA; tert-Butylhydroperoxide results in decreased expression of GJA1 protein GJA1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15336504 PMID:18235030
NCBI chr20:36,302,490...36,315,010
Ensembl chr20:35,755,991...35,768,582
G
Gjb2
gap junction protein, beta 2
decreases response to substance
ISO
GJB2 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:18235030
NCBI chr15:35,375,977...35,393,817
Ensembl chr15:31,260,357...31,278,177
G
Gla
galactosidase, alpha
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GLA mRNA
CTD
PMID:14729362
NCBI chr X:102,062,497...102,073,915
Ensembl chr X:97,768,996...97,780,664
G
Glg1
golgi glycoprotein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GLG1 mRNA
CTD
PMID:15336504
NCBI chr19:56,034,248...56,133,538
Ensembl chr19:39,124,641...39,224,178
G
Glipr1
GLI pathogenesis-related 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GLIPR1 mRNA
CTD
PMID:15336504
NCBI chr 7:49,373,579...49,399,190
Ensembl chr 7:47,487,345...47,498,429
G
Glod4
glyoxalase domain containing 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GLOD4 mRNA
CTD
PMID:15003993
NCBI chr10:61,077,535...61,095,876
Ensembl chr10:61,066,421...61,095,898
G
Glrx
glutaredoxin
multiple interactions increases expression
EXP ISO
[GLRX protein co-treated with Glutathione] inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of OGDH protein] tert-Butylhydroperoxide results in increased expression of GLRX mRNA
CTD
PMID:12414654 PMID:12680778
NCBI chr 2:7,073,737...7,083,548
Ensembl chr 2:5,341,885...5,351,680
G
Glrx3
glutaredoxin 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GLRX3 mRNA
CTD
PMID:15336504
NCBI chr 1:201,671,410...201,701,722
Ensembl chr 1:192,241,701...192,272,010
G
Glyr1
glyoxylate reductase 1 homolog
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GLYR1 mRNA
CTD
PMID:15336504
NCBI chr10:11,038,577...11,074,093
Ensembl chr10:10,532,154...10,567,637
G
Gmpr2
guanosine monophosphate reductase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GMPR2 mRNA
CTD
PMID:15336504
NCBI chr15:33,135,455...33,144,923
Ensembl chr15:29,165,783...29,174,935
G
Gna11
G protein subunit alpha 11
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of GNA11 mRNA tert-Butylhydroperoxide results in decreased expression of GNA11 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 7:8,814,285...8,828,628
Ensembl chr 7:8,162,750...8,179,812
G
Gnai1
G protein subunit alpha i1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of GNAI1 mRNA
CTD
PMID:23410634
NCBI chr 4:17,706,061...17,790,176
Ensembl chr 4:16,814,001...16,896,417
G
Gnas
GNAS complex locus
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GNAS mRNA
CTD
PMID:12419474
NCBI chr 3:183,489,648...183,554,570
Ensembl chr 3:163,071,417...163,127,262 Ensembl chr 3:163,071,417...163,127,262
G
Gnb5
G protein subunit beta 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GNB5 mRNA
CTD
PMID:15336504
NCBI chr 8:84,956,629...84,985,576
Ensembl chr 8:76,073,306...76,105,069
G
Gnpnat1
glucosamine-phosphate N-acetyltransferase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GNPNAT1 mRNA
CTD
PMID:15003993
NCBI chr15:21,076,129...21,088,526
Ensembl chr15:18,596,442...18,608,739
G
Gns
glucosamine (N-acetyl)-6-sulfatase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GNS mRNA
CTD
PMID:15336504
NCBI chr 7:58,774,625...58,808,650
Ensembl chr 7:56,889,232...56,923,151
G
Gosr2
golgi SNAP receptor complex member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GOSR2 mRNA
CTD
PMID:15003993
NCBI chr10:89,085,323...89,105,665
Ensembl chr10:88,586,299...88,605,625
G
Got1
glutamic-oxaloacetic transaminase 1
multiple interactions increases activity increases expression
EXP
baicalin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GOT1 protein]; caffeic acid inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GOT1 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GOT1 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased expression of GOT1 protein]
CTD
PMID:15095147 PMID:15212457 PMID:15645217
NCBI chr 1:252,306,541...252,337,622
Ensembl chr 1:242,357,306...242,380,633
G
Gpat3
glycerol-3-phosphate acyltransferase 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GPAT3 mRNA
CTD
PMID:23410634
NCBI chr14:9,018,762...9,072,552
Ensembl chr14:8,714,373...8,766,490
G
Gpc1
glypican 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GPC1 mRNA
CTD
PMID:15003993
NCBI chr 9:100,843,645...100,871,458
Ensembl chr 9:93,396,234...93,424,047
G
Gper1
G protein-coupled estrogen receptor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GPER1 mRNA
CTD
PMID:15336504
NCBI chr12:20,331,073...20,336,527
Ensembl chr12:15,217,442...15,221,889
G
Gpi
glucose-6-phosphate isomerase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GPI1 mRNA
CTD
PMID:15003993
NCBI chr 1:95,965,389...95,996,932
Ensembl chr 1:86,828,216...86,856,086
G
Gpnmb
glycoprotein nmb
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GPNMB mRNA
CTD
PMID:15336504
NCBI chr 4:79,341,128...79,362,366
Ensembl chr 4:78,010,197...78,049,367
G
Gpr107
G protein-coupled receptor 107
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GPR107 mRNA
CTD
PMID:15336504
NCBI chr 3:34,832,462...34,893,692
Ensembl chr 3:14,434,723...14,495,958
G
Gpr161
G protein-coupled receptor 161
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GPR161 mRNA
CTD
PMID:15336504
NCBI chr13:80,111,271...80,156,517
Ensembl chr13:77,577,739...77,619,613
G
Gpr4
G protein-coupled receptor 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GPR4 mRNA
CTD
PMID:15336504
NCBI chr 1:87,993,398...88,004,568
Ensembl chr 1:78,865,409...78,876,599
G
Gprc5b
G protein-coupled receptor, class C, group 5, member B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GPRC5B mRNA
CTD
PMID:15336504 PMID:29432895
NCBI chr 1:182,748,247...182,772,711
Ensembl chr 1:173,316,907...173,340,932
G
Gpsm2
G-protein signaling modulator 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GPSM2 mRNA
CTD
PMID:15336504
NCBI chr 2:199,015,250...199,063,788
Ensembl chr 2:196,327,149...196,375,154
G
Gpsm3
G-protein signaling modulator 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GPSM3 mRNA
CTD
PMID:15336504
NCBI chr20:4,161,730...4,163,591
Ensembl chr20:4,157,123...4,159,035
G
Gpt
glutamic--pyruvic transaminase
multiple interactions increases activity increases expression
EXP ISO
baicalin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein]; caffeic acid inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased expression of GPT protein] rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GPT protein]
CTD
PMID:15015760 PMID:15095147 PMID:15212457 PMID:15645217 PMID:28025122
NCBI chr 7:110,295,599...110,300,134
Ensembl chr 7:108,416,642...108,419,494
G
Gpx1
glutathione peroxidase 1
increases reduction decreases response to substance increases response to substance increases expression
ISO EXP
GPX1 protein results in increased reduction of tert-Butylhydroperoxide GPX1 protein results in decreased susceptibility to tert-Butylhydroperoxide GPX1 gene mutant form results in increased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of GPX1 mRNA
CTD
PMID:8428933 PMID:9741587 PMID:15182862 PMID:19720132
NCBI chr 8:117,905,462...117,906,588
Ensembl chr 8:109,026,905...109,028,024
G
Gpx2
glutathione peroxidase 2
increases reduction decreases expression increases expression
ISO
GPX2 protein results in increased reduction of tert-Butylhydroperoxide tert-Butylhydroperoxide results in decreased expression of GPX2 mRNA tert-Butylhydroperoxide results in increased expression of GPX2 mRNA
CTD
PMID:8428933 PMID:10806356 PMID:12414654 PMID:12419474
NCBI chr 6:101,226,745...101,230,033
Ensembl chr 6:95,493,589...95,496,877
G
Gpx4
glutathione peroxidase 4
multiple interactions decreases response to substance increases response to substance
ISO
GPX4 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein] GPX4 protein results in decreased susceptibility to tert-Butylhydroperoxide GPX4 gene mutant form results in increased susceptibility to tert-Butylhydroperoxide
CTD
PMID:12566075 PMID:15496407
NCBI chr 7:10,300,833...10,303,629
Ensembl chr 7:9,650,185...9,652,982
G
Grb2
growth factor receptor bound protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GRB2 mRNA
CTD
PMID:15336504
NCBI chr10:101,380,354...101,448,138
Ensembl chr10:100,869,718...100,949,309
G
Grem1
gremlin 1, DAN family BMP antagonist
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GREM1 mRNA
CTD
PMID:15336504
NCBI chr 3:120,966,639...120,978,319
Ensembl chr 3:100,512,313...100,524,082
G
Grhpr
glyoxylate and hydroxypyruvate reductase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GRHPR mRNA
CTD
PMID:15003993
NCBI chr 5:64,029,856...64,039,287
Ensembl chr 5:59,234,192...59,243,603
G
Grin2c
glutamate ionotropic receptor NMDA type subunit 2C
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GRIN2C mRNA
CTD
PMID:12414654
NCBI chr10:100,987,410...101,006,064
Ensembl chr10:100,488,431...100,506,427
G
Grpel1
GrpE-like 1, mitochondrial
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GRPEL1 mRNA
CTD
PMID:15336504
NCBI chr14:78,517,049...78,522,868
Ensembl chr14:74,292,023...74,298,200
G
Gsk3b
glycogen synthase kinase 3 beta
increases expression multiple interactions decreases phosphorylation
ISO
tert-Butylhydroperoxide results in increased expression of GSK3B mRNA 3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased phosphorylation of GSK3B protein]
CTD
PMID:15336504 PMID:29128606
NCBI chr11:76,004,502...76,154,665
Ensembl chr11:62,504,316...62,648,646
G
Gsn
gelsolin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GSN mRNA
CTD
PMID:15003993
NCBI chr 3:38,982,605...39,035,849
Ensembl chr 3:18,585,172...18,638,402
G
Gspt1
G1 to S phase transition 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GSPT1 mRNA
CTD
PMID:15336504
NCBI chr10:4,867,687...4,904,186
Ensembl chr10:4,362,510...4,397,198
G
Gspt2
G1 to S phase transition 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GSPT2 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr X:63,582,649...63,597,467
Ensembl chr X:59,587,276...59,594,162
G
Gsr
glutathione-disulfide reductase
multiple interactions decreases expression increases activity decreases activity decreases methylation increases expression
ISO EXP
Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased activity of GSR protein] tert-Butylhydroperoxide results in decreased expression of GSR mRNA Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of GSR protein] tert-Butylhydroperoxide results in decreased methylation of GSR gene tert-Butylhydroperoxide results in increased expression of GSR mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15212457 PMID:15336504 PMID:15849717 PMID:16126241 PMID:16928893 PMID:17427263 PMID:23410634 PMID:27509014 More...
NCBI chr16:65,185,574...65,228,742
Ensembl chr16:58,482,505...58,525,661
G
Gsta2
glutathione S-transferase alpha 2
increases metabolic processing decreases metabolic processing decreases response to substance increases expression
ISO
GSTA2 protein results in increased metabolism of tert-Butylhydroperoxide GSTA2 protein polymorphism results in decreased metabolism of tert-Butylhydroperoxide GSTA2 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of GSTA2 mRNA
CTD
PMID:3138230 PMID:14729362 PMID:15003993 PMID:15128049
NCBI chr 8:88,064,829...88,077,168
Ensembl chr 8:79,184,322...79,196,798
G
Gsta4
glutathione S-transferase alpha 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GSTA4 mRNA
CTD
PMID:15336504 PMID:31627909
NCBI chr 8:87,947,247...87,964,490
Ensembl chr 8:79,066,934...79,084,182
G
Gstk1
glutathione S-transferase kappa 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GSTK1 mRNA
CTD
PMID:15336504
NCBI chr 4:72,085,532...72,089,934
Ensembl chr 4:71,118,896...71,123,292
G
Gstm2
glutathione S-transferase mu 2
decreases expression increases expression decreases response to substance
ISO EXP
tert-Butylhydroperoxide results in decreased expression of GSTM2 mRNA; tert-Butylhydroperoxide results in decreased expression of GSTM2 protein tert-Butylhydroperoxide results in increased expression of GSTM2 mRNA; tert-Butylhydroperoxide results in increased expression of GSTM5 mRNA GSTM2 protein results in decreased susceptibility to tert-Butylhydroperoxide; GSTM5 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:14729362 PMID:15003993 PMID:15336504 PMID:24394546
NCBI chr 2:198,312,179...198,316,962
Ensembl chr 2:195,544,426...195,628,961
G
Gstm4
glutathione S-transferase mu 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GSTM4 mRNA
CTD
PMID:15336504
NCBI chr 2:198,356,114...198,373,487
Ensembl chr 2:195,680,004...195,685,323
G
Gstp1
glutathione S-transferase pi 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GSTP1 mRNA
CTD
PMID:15336504
NCBI chr 1:210,767,237...210,770,242
Ensembl chr 1:201,321,672...201,340,226
G
Gstt1
glutathione S-transferase theta 1
affects metabolic processing
ISO
GSTT1 protein affects the metabolism of tert-Butylhydroperoxide
CTD
PMID:9854036
NCBI chr20:12,856,068...12,873,020
Ensembl chr20:12,856,669...12,873,585
G
Gstz1
glutathione S-transferase zeta 1
affects metabolic processing
ISO
GSTZ1 protein affects the metabolism of tert-Butylhydroperoxide
CTD
PMID:9396740
NCBI chr 6:112,525,576...112,536,228
Ensembl chr 6:106,794,074...106,805,284
G
Gtf2f1
general transcription factor IIF subunit 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GTF2F1 mRNA
CTD
PMID:15336504
NCBI chr 9:1,931,033...1,940,197
Ensembl chr 9:1,843,901...1,853,423
G
Gtf2i
general transcription factor II I
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GTF2I mRNA
CTD
PMID:15336504
NCBI chr12:28,037,344...28,112,677
Ensembl chr12:22,401,431...22,476,243
G
Gtf2ird1
GTF2I repeat domain containing 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GTF2IRD1 mRNA
CTD
PMID:15336504
NCBI chr12:27,890,594...27,997,506
Ensembl chr12:22,254,221...22,361,040
G
Gtf3a
general transcription factor III A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GTF3A mRNA
CTD
PMID:15336504
NCBI chr12:13,250,643...13,258,587
Ensembl chr12:8,136,747...8,144,690
G
Gulp1
GULP PTB domain containing engulfment adaptor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GULP1 mRNA
CTD
PMID:15336504
NCBI chr 9:54,114,823...54,391,058
Ensembl chr 9:46,622,669...46,899,005
G
Gusb
glucuronidase, beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of GUSB mRNA
CTD
PMID:15336504
NCBI chr12:32,337,281...32,350,838
Ensembl chr12:26,697,951...26,726,905
G
Gys1
glycogen synthase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of GYS1 mRNA
CTD
PMID:15003993
NCBI chr 1:105,051,916...105,071,763
Ensembl chr 1:95,915,443...95,935,292
G
H1f10
H1.10 linker histone
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of H1-10 mRNA
CTD
PMID:15336504
NCBI chr 4:121,997,834...121,998,897
Ensembl chr 4:120,440,870...120,441,448
G
H2ax
H2A.X variant histone
decreases expression increases phosphorylation
ISO
tert-Butylhydroperoxide results in decreased expression of H2AX mRNA tert-Butylhydroperoxide results in increased phosphorylation of H2AX protein
CTD
PMID:15336504 PMID:33207735
NCBI chr 8:53,568,718...53,570,072
Ensembl chr 8:44,671,786...44,673,239 Ensembl chr 4:44,671,786...44,673,239
G
H2az2
H2A.Z variant histone 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of H2AZ2 mRNA
CTD
PMID:15336504
NCBI chr14:85,507,228...85,526,166
Ensembl chr14:81,293,299...81,312,144 Ensembl chr 4:81,293,299...81,312,144 Ensembl chr16:81,293,299...81,312,144
G
H2bc12
H2B clustered histone 12
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of H2BC12 mRNA
CTD
PMID:15336504
NCBI chr17:47,181,477...47,181,940
G
H3f4
H3.4 histone, cluster member
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of H3-4 mRNA tert-Butylhydroperoxide results in increased methylation of H3-4 gene
CTD
PMID:27509014
NCBI chr10:44,240,282...44,240,842
G
H6pd
hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase)
increases activity increases expression
ISO
tert-Butylhydroperoxide results in increased activity of H6PD protein tert-Butylhydroperoxide results in increased expression of H6PD mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 5:165,717,456...165,753,158
Ensembl chr 5:160,438,697...160,470,171
G
Hadh
hydroxyacyl-CoA dehydrogenase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HADH mRNA
CTD
PMID:15336504
NCBI chr 2:222,462,049...222,504,446
Ensembl chr 2:219,787,927...219,830,353
G
Hamp
hepcidin antimicrobial peptide
affects expression
ISO
tert-Butylhydroperoxide affects the expression of HAMP mRNA
CTD
PMID:23410634
NCBI chr 1:95,298,332...95,300,271
Ensembl chr 1:86,170,901...86,172,891
G
Has2
hyaluronan synthase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HAS2 mRNA
CTD
PMID:15336504
NCBI chr 7:90,002,929...90,028,933
Ensembl chr 7:88,113,326...88,128,933
G
Haus7
HAUS augmin-like complex, subunit 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HAUS7 mRNA
CTD
PMID:15336504
NCBI chr X:156,306,320...156,331,940
Ensembl chr X:151,154,979...151,180,577
G
Hbegf
heparin-binding EGF-like growth factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HBEGF mRNA
CTD
PMID:12419474
NCBI chr18:28,380,337...28,390,220
Ensembl chr18:28,105,760...28,116,441
G
Hbp1
HMG-box transcription factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HBP1 mRNA
CTD
PMID:15336504
NCBI chr 6:54,257,118...54,283,373
Ensembl chr 6:48,529,372...48,555,787
G
Hdac1
histone deacetylase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HDAC1 mRNA
CTD
PMID:12419474
NCBI chr 5:147,138,328...147,165,387
Ensembl chr 5:141,853,989...141,881,111
G
Hdac11
histone deacetylase 11
affects expression
ISO
tert-Butylhydroperoxide affects the expression of HDAC11 mRNA
CTD
PMID:23410634
NCBI chr 4:125,203,044...125,224,584
Ensembl chr 4:123,650,157...123,667,405
G
Hdac7
histone deacetylase 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HDAC7 mRNA
CTD
PMID:15003993
NCBI chr 7:130,803,013...130,841,181
Ensembl chr 7:128,923,920...128,962,072
G
Heatr1
HEAT repeat containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HEATR1 mRNA
CTD
PMID:15336504
NCBI chr17:62,745,008...62,785,609
Ensembl chr17:58,051,700...58,093,948
G
Heg1
heart development protein with EGF-like domains 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HEG1 mRNA
CTD
PMID:15336504
NCBI chr11:80,512,096...80,600,150
Ensembl chr11:66,957,190...67,095,051
G
Heph
hephaestin
decreases response to substance decreases expression increases expression
ISO
HEPH protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in decreased expression of HEPH mRNA tert-Butylhydroperoxide results in increased expression of HEPH mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr X:65,160,628...65,412,457
Ensembl chr X:61,296,345...61,402,980
G
Hes1
hes family bHLH transcription factor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HES1 mRNA
CTD
PMID:15336504
NCBI chr11:84,210,632...84,213,045
Ensembl chr11:70,705,764...70,708,192
G
Hes6
hes family bHLH transcription factor 6
affects expression
ISO
tert-Butylhydroperoxide affects the expression of HES6 mRNA
CTD
PMID:23410634
NCBI chr 9:99,449,375...99,451,343
Ensembl chr 9:92,001,841...92,003,559
G
Hgfac
HGF activator
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HGFAC mRNA
CTD
PMID:12419474
NCBI chr14:79,932,219...79,938,773
Ensembl chr14:75,707,591...75,714,278
G
Hif1a
hypoxia inducible factor 1 subunit alpha
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HIF1A mRNA; [HIF1A protein results in increased expression of MCL1 protein] which results in decreased susceptibility to tert-Butylhydroperoxide; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HIF1A mRNA]
CTD
PMID:15611089 PMID:35690295
NCBI chr 6:98,357,788...98,405,068
Ensembl chr 6:92,624,390...92,669,261
G
Hikeshi
heat shock protein nuclear import factor hikeshi
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HIKESHI mRNA
CTD
PMID:15003993
NCBI chr 1:153,237,948...153,261,856
Ensembl chr 1:143,825,923...143,849,363
G
Hilpda
hypoxia inducible lipid droplet-associated
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HILPDA mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HILPDA mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HILPDA mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HILPDA mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HILPDA mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HILPDA mRNA]
CTD
PMID:20847119
NCBI chr 4:58,836,463...58,839,423
Ensembl chr 4:57,871,110...57,874,557
G
Hist1h2bd
histone cluster 1 H2B family member D
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of H2BC5 mRNA
CTD
PMID:15336504
NCBI chr17:47,488,627...47,489,008
G
Hivep1
HIVEP zinc finger 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HIVEP1 mRNA
CTD
PMID:15003993
NCBI chr17:22,790,855...22,920,359
Ensembl chr17:22,585,016...22,711,956
G
Hk1
hexokinase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HK1 mRNA
CTD
PMID:15336504
NCBI chr20:30,773,222...30,874,814
Ensembl chr20:30,230,486...30,332,131
G
Hmga1
high mobility group AT-hook 1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HMGA1 mRNA tert-Butylhydroperoxide results in increased expression of HMGA1 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr20:5,612,902...5,620,596
Ensembl chr20:5,611,694...5,618,752
G
Hmga2
high mobility group AT-hook 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HMGA2 mRNA
CTD
PMID:14729362
NCBI chr 7:57,762,710...57,884,555
Ensembl chr 7:55,880,112...55,994,784
G
Hmgb1
high mobility group box 1
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of HMGB1 protein 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]]; tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]; tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]
CTD
PMID:28063877 PMID:29111459
NCBI chr12:11,009,236...11,015,941
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
G
Hmgcr
3-hydroxy-3-methylglutaryl-CoA reductase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HMGCR mRNA
CTD
PMID:12414654
NCBI chr 2:29,732,163...29,754,276
Ensembl chr 2:27,997,525...28,019,703
G
Hmgn5
high mobility group nucleosome binding domain 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HMGN5 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr X:78,161,439...78,170,613
Ensembl chr X:74,085,875...74,094,441 Ensembl chr 1:74,085,875...74,094,441
G
Hmox1
heme oxygenase 1
decreases response to substance multiple interactions increases expression affects expression decreases expression
ISO EXP
HMOX1 protein results in decreased susceptibility to tert-Butylhydroperoxide [Apigenin results in increased expression of HMOX1 mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [chrysin results in increased expression of HMOX1 mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [Luteolin results in increased expression of HMOX1 mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; [zinc protoporphyrin results in decreased activity of HMOX1 protein] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]]; resveratrol inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA] tert-Butylhydroperoxide affects the expression of HMOX1 mRNA [Biological Products results in increased expression of HMOX1 protein] inhibits the reaction [tert-Butylhydroperoxide results in increased abundance of Reactive Oxygen Species]; [Biological Products results in increased expression of HMOX1 protein] which results in decreased susceptibility to tert-Butylhydroperoxide; MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 protein]; rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 protein]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 protein]; sodium boranocarbonate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 mRNA] tert-Butylhydroperoxide results in decreased expression of HMOX1 mRNA; tert-Butylhydroperoxide results in decreased expression of HMOX1 protein tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA; tert-Butylhydroperoxide results in increased expression of HMOX1 protein 6,7-dihydroxyflavone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HMOX1 protein]
CTD
PMID:12414654 PMID:15336504 PMID:15589375 PMID:16636651 PMID:17295091 PMID:18812229 PMID:22864849 PMID:22954530 PMID:23266269 PMID:27050144 PMID:27509014 PMID:28025122 PMID:30273691 PMID:30547568 PMID:35077135 PMID:38053484 PMID:38272317 More...
NCBI chr19:13,452,365...13,479,823
Ensembl chr19:13,467,244...13,474,079
G
Hmox2
heme oxygenase 2
decreases response to substance decreases expression increases methylation
ISO
HMOX2 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in decreased expression of HMOX2 mRNA tert-Butylhydroperoxide results in increased methylation of HMOX2 gene
CTD
PMID:15589375 PMID:27509014
NCBI chr10:11,303,512...11,337,640
Ensembl chr10:10,797,055...10,831,148
G
Hnrnpa3
heterogeneous nuclear ribonucleoprotein A3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HNRNPA3 mRNA
CTD
PMID:15336504
NCBI chr 3:80,984,470...80,999,413
Ensembl chr 3:60,578,673...60,588,306
G
Hnrnpdl
heterogeneous nuclear ribonucleoprotein D-like
multiple interactions decreases expression increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HNRNPDL mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HNRNPDL mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of HNRNPDL mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HNRNPDL mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HNRNPDL mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HNRNPDL mRNA] tert-Butylhydroperoxide results in decreased expression of HNRNPDL mRNA
CTD
PMID:15336504 PMID:20847119
NCBI chr14:9,861,716...9,867,945
Ensembl chr14:9,557,425...9,562,506
G
Hook2
hook microtubule-tethering protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HOOK2 mRNA
CTD
PMID:15336504
NCBI chr19:40,056,732...40,075,027
Ensembl chr19:23,151,870...23,164,181
G
Hoxd1
homeo box D1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of HOXD1 mRNA
CTD
PMID:23410634
NCBI chr 3:80,073,041...80,075,180
Ensembl chr 3:59,665,629...59,667,769
G
Hp1bp3
heterochromatin protein 1, binding protein 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HP1BP3 mRNA
CTD
PMID:15336504
NCBI chr 5:155,719,109...155,746,329
Ensembl chr 5:150,433,740...150,463,000
G
Hps1
HPS1, biogenesis of lysosomal organelles complex 3 subunit 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HPS1 mRNA
CTD
PMID:15336504
NCBI chr 1:251,500,427...251,526,529
Ensembl chr 1:241,551,175...241,577,268
G
Hs3st3a1
heparan sulfate-glucosamine 3-sulfotransferase 3A1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HS3ST3A1 mRNA
CTD
PMID:15336504
NCBI chr10:49,593,208...49,679,854
Ensembl chr10:49,094,026...49,180,676
G
Hsbp1
heat shock factor binding protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HSBP1 mRNA
CTD
PMID:15336504
NCBI chr19:64,309,703...64,314,035
Ensembl chr19:47,400,966...47,435,821
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
multiple interactions decreases expression
ISO
Catechin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HSD11B1 mRNA]; Grape Seed Extract inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of HSD11B1 mRNA]
CTD
PMID:29935159
NCBI chr13:107,277,526...107,327,462
Ensembl chr13:104,728,539...104,788,687
G
Hsd11b2
hydroxysteroid 11-beta dehydrogenase 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of HSD11B2 mRNA
CTD
PMID:23410634
NCBI chr19:50,307,569...50,312,812
Ensembl chr19:33,397,656...33,402,899
G
Hsd17b10
hydroxysteroid (17-beta) dehydrogenase 10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSD17B10 mRNA
CTD
PMID:15003993
NCBI chr X:24,568,551...24,571,012
Ensembl chr X:21,089,122...21,109,488
G
Hsd17b11
hydroxysteroid (17-beta) dehydrogenase 11
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HSD17B11 mRNA
CTD
PMID:15336504
NCBI chr14:5,997,893...6,047,816
Ensembl chr14:5,711,964...5,743,161
G
Hsd17b2
hydroxysteroid (17-beta) dehydrogenase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSD17B2 mRNA
CTD
PMID:15003993
NCBI chr19:62,662,320...62,733,944
Ensembl chr19:45,753,574...45,825,202
G
Hsd3b7
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSD3B7 mRNA
CTD
PMID:15003993
NCBI chr 1:191,842,688...191,845,919
Ensembl chr 1:182,412,151...182,415,442
G
Hsp90aa1
heat shock protein 90 alpha family class A member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSP90AA1 mRNA
CTD
PMID:15336504
NCBI chr 6:135,523,604...135,529,687
Ensembl chr 6:129,702,383...129,707,268
G
Hspa13
heat shock protein family A (Hsp70) member 13
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HSPA13 mRNA
CTD
PMID:12419474
NCBI chr11:27,862,717...27,876,898
Ensembl chr11:14,373,275...14,389,895
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSPA1A mRNA
CTD
PMID:12414654
NCBI chr20:3,875,411...3,877,866
Ensembl chr20:3,856,006...3,873,227
G
Hspa1b
heat shock protein family A (Hsp70) member 1B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSPA1B mRNA
CTD
PMID:12414654
NCBI chr20:3,859,756...3,863,800
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
G
Hspa1l
heat shock protein family A (Hsp70) member 1 like
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA1L mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA1L mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA1L mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HSPA1L mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HSPA1L mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of HSPA1L mRNA]
CTD
PMID:20847119
NCBI chr20:3,853,496...3,860,223
Ensembl chr20:3,848,843...3,855,571
G
Hspa2
heat shock protein family A (Hsp70) member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HSPA2 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr 6:100,864,172...100,866,946
Ensembl chr 6:95,128,350...95,131,287
G
Hspa4
heat shock protein family A (Hsp70) member 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSPA4 mRNA
CTD
PMID:15336504
NCBI chr10:37,908,866...37,951,994
Ensembl chr10:37,408,025...37,449,001
G
Hspa5
heat shock protein family A (Hsp70) member 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSPA5 mRNA
CTD
PMID:12766906
NCBI chr 3:38,453,016...38,457,475
Ensembl chr 3:18,055,405...18,059,891
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of HSPA6 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA6 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA6 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA6 mRNA]
CTD
PMID:12414654 PMID:35690295
NCBI chr13:85,805,911...85,807,052
G
Hspb1
heat shock protein family B (small) member 1
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSPB1 protein tert-Butylhydroperoxide results in decreased expression of HSPB1 mRNA
CTD
PMID:11295360 PMID:15336504
NCBI chr12:26,430,640...26,432,301
Ensembl chr12:20,794,028...20,795,743
G
Hspb2
heat shock protein family B (small) member 2
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HSPB2 mRNA tert-Butylhydroperoxide results in increased expression of HSPB2 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 8:59,989,640...59,991,215
Ensembl chr 8:51,081,342...51,094,533
G
Hspb8
heat shock protein family B (small) member 8
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HSPB8 mRNA
CTD
PMID:14729362
NCBI chr12:45,835,899...45,866,449
Ensembl chr12:40,176,532...40,191,185
G
Hspd1
heat shock protein family D (Hsp60) member 1
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of HSPD1 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPD1 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPD1 mRNA]
CTD
PMID:15336504 PMID:35690295
NCBI chr 9:64,073,610...64,084,332
Ensembl chr 9:56,579,201...56,589,662
G
Hsph1
heat shock protein family H (Hsp110) member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HSPH1 mRNA
CTD
PMID:15336504
NCBI chr12:10,427,368...10,446,602
Ensembl chr12:5,390,922...5,410,224
G
Htatip2
HIV-1 Tat interactive protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HTATIP2 mRNA
CTD
PMID:15336504
NCBI chr 1:108,609,424...108,624,810
Ensembl chr 1:99,469,245...99,488,629
G
Htra1
HtrA serine peptidase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HTRA1 mRNA
CTD
PMID:15336504
NCBI chr 1:194,928,069...194,977,619
Ensembl chr 1:185,497,735...185,547,379
G
Icam1
intercellular adhesion molecule 1
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of ICAM1 mRNA 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ICAM1 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of ICAM1 mRNA]
CTD
PMID:15336504 PMID:28063877
NCBI chr 8:27,829,688...27,841,618
Ensembl chr 8:19,553,645...19,565,438
G
Icmt
isoprenylcysteine carboxyl methyltransferase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ICMT mRNA
CTD
PMID:15336504
NCBI chr 5:168,084,487...168,097,519
Ensembl chr 5:162,804,368...162,811,128
G
Id1
inhibitor of DNA binding 1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ID1 mRNA tert-Butylhydroperoxide results in increased expression of ID1 mRNA
CTD
PMID:12419474 PMID:15003993
NCBI chr 3:161,671,525...161,672,691
Ensembl chr 3:141,211,267...141,212,419
G
Id2
inhibitor of DNA binding 2
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ID2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ID2 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ID2 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ID2 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ID2 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ID2 mRNA]
CTD
PMID:14729362 PMID:15003993 PMID:20847119
NCBI chr 6:47,469,162...47,470,995
Ensembl chr 6:41,728,946...41,744,400
G
Id3
inhibitor of DNA binding 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ID3 mRNA
CTD
PMID:15003993
NCBI chr 5:153,656,253...153,657,860
Ensembl chr 5:148,372,762...148,374,349
G
Idh1
isocitrate dehydrogenase (NADP(+)) 1
increases activity
EXP
tert-Butylhydroperoxide results in increased activity of IDH1 protein
CTD
PMID:16928893
NCBI chr 9:74,027,887...74,057,442
Ensembl chr 9:66,534,146...66,563,708
G
Idh2
isocitrate dehydrogenase (NADP(+)) 2
decreases activity multiple interactions
ISO
tert-Butylhydroperoxide results in decreased activity of IDH2 protein Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of IDH2 protein]; SIRT3 mutant form inhibits the reaction [Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of IDH2 protein]]
CTD
PMID:25522270
NCBI chr 1:143,447,925...143,467,248
Ensembl chr 1:134,029,772...134,058,025
G
Ier2
immediate early response 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IER2 mRNA
CTD
PMID:15336504
NCBI chr19:40,399,373...40,400,897
Ensembl chr19:23,494,184...23,499,211
G
Ier3
immediate early response 3
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IER3 mRNA tert-Butylhydroperoxide results in increased expression of IER3 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr20:2,933,173...2,934,377
Ensembl chr20:2,928,378...2,929,583
G
Ifi27
interferon, alpha-inducible protein 27
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of IFI27 mRNA tert-Butylhydroperoxide results in decreased expression of IFI27 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 6:128,355,312...128,361,783
Ensembl chr 6:122,590,472...122,779,294
G
Ifi35
interferon-induced protein 35
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IFI35 mRNA
CTD
PMID:15336504
NCBI chr10:86,881,270...86,889,523
Ensembl chr10:86,381,010...86,389,952
G
Ifih1
interferon induced with helicase C domain 1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IFIH1 mRNA tert-Butylhydroperoxide results in increased expression of IFIH1 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 3:67,635,924...67,683,968
Ensembl chr 3:47,227,364...47,275,456
G
Ifit3
interferon-induced protein with tetratricopeptide repeats 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IFIT3 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:241,527,326...241,532,469
Ensembl chr 1:232,114,166...232,119,307
G
Ifitm1
interferon induced transmembrane protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IFITM1 mRNA
CTD
PMID:15336504
NCBI chr 1:205,496,757...205,498,796
Ensembl chr 1:196,067,963...196,069,169
G
Ifitm2
interferon induced transmembrane protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IFITM2 mRNA
CTD
PMID:15336504
NCBI chr 1:205,481,168...205,482,348
Ensembl chr 1:196,051,537...196,052,741
G
Ifitm3
interferon induced transmembrane protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IFITM3 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:205,540,649...205,541,758
Ensembl chr 1:196,111,043...196,112,203
G
Ift122
intraflagellar transport 122
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IFT122 mRNA
CTD
PMID:15336504
NCBI chr 4:150,577,525...150,648,052
Ensembl chr 4:148,905,046...148,975,458
G
Igf1
insulin-like growth factor 1
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of IGF1 mRNA
CTD
PMID:22659508
NCBI chr 7:24,169,608...24,249,446
Ensembl chr 7:22,282,930...22,359,296
G
Igf1r
insulin-like growth factor 1 receptor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IGF1R mRNA
CTD
PMID:12419474
NCBI chr 1:130,959,787...131,248,664
Ensembl chr 1:121,550,743...121,831,777
G
Igf2bp1
insulin-like growth factor 2 mRNA binding protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IGF2BP1 mRNA
CTD
PMID:14729362
NCBI chr10:81,405,021...81,447,814
Ensembl chr10:80,908,076...80,951,129
G
Igfbp2
insulin-like growth factor binding protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IGFBP2 mRNA
CTD
PMID:15336504
NCBI chr 9:81,864,811...81,892,179
Ensembl chr 9:74,415,546...74,442,937
G
Igfbp3
insulin-like growth factor binding protein 3
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IGFBP3 mRNA tert-Butylhydroperoxide results in increased expression of IGFBP3 mRNA
CTD
PMID:15336504 PMID:15963989
NCBI chr14:86,270,208...86,277,944
Ensembl chr14:82,056,347...82,064,083
G
Igfbp4
insulin-like growth factor binding protein 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IGFBP4 mRNA
CTD
PMID:15336504
NCBI chr10:84,491,471...84,503,487
Ensembl chr10:83,989,591...84,007,225
G
Igfbp5
insulin-like growth factor binding protein 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IGFBP5 mRNA
CTD
PMID:12414654
NCBI chr 9:81,901,605...81,914,187
Ensembl chr 9:74,448,382...74,465,156
G
Igfbp6
insulin-like growth factor binding protein 6
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IGFBP6 mRNA tert-Butylhydroperoxide results in increased expression of IGFBP6 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 7:135,154,919...135,159,550
Ensembl chr 7:133,276,234...133,280,966
G
Igsf8
immunoglobulin superfamily, member 8
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IGSF8 mRNA
CTD
PMID:14729362
NCBI chr13:87,282,015...87,314,018
Ensembl chr13:84,770,279...84,778,576
G
Il11
interleukin 11
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of IL11 mRNA; tert-Butylhydroperoxide results in increased expression of IL11 protein tert-Butylhydroperoxide affects the expression of IL11 mRNA
CTD
PMID:15336504 PMID:17295091 PMID:23410634
NCBI chr 1:78,098,622...78,104,915
Ensembl chr 1:69,068,137...69,076,129
G
Il15
interleukin 15
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IL15 mRNA
CTD
PMID:15336504
NCBI chr19:42,536,160...42,611,349
Ensembl chr19:25,640,251...25,706,820
G
Il1b
interleukin 1 beta
multiple interactions increases expression increases secretion
ISO
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of IL1B mRNA]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of IL1B protein]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of IL1B protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of IL1B mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased secretion of IL1B protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL1B mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL1B protein]; tert-Butylhydroperoxide inhibits the reaction [Acetaminophen inhibits the reaction [Calcimycin promotes the reaction [IL1B protein results in increased activity of PTGS2 protein]]]; tert-Butylhydroperoxide inhibits the reaction [Ibuprofen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]]; tert-Butylhydroperoxide inhibits the reaction [Naproxen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]]; tert-Butylhydroperoxide inhibits the reaction [rofecoxib inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]] tert-Butylhydroperoxide results in increased expression of IL1B mRNA; tert-Butylhydroperoxide results in increased expression of IL1B protein
CTD
PMID:15336504 PMID:15705740 PMID:28063877 PMID:29111459
NCBI chr 3:137,030,200...137,036,581
Ensembl chr 3:116,577,010...116,583,415
G
Il3
interleukin 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IL3 mRNA
CTD
PMID:12419474
NCBI chr10:38,906,460...38,908,810
Ensembl chr10:38,405,716...38,408,066
G
Il4r
interleukin 4 receptor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IL4R mRNA
CTD
PMID:15336504
NCBI chr 1:189,545,739...189,570,639
Ensembl chr 1:180,115,120...180,139,980
G
Il6
interleukin 6
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of IL6 mRNA 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of IL6 mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of IL6 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL6 mRNA]
CTD
PMID:15336504 PMID:28063877 PMID:29111459
NCBI chr 4:5,889,999...5,894,575
Ensembl chr 4:5,213,394...5,219,178
G
Il6st
interleukin 6 cytokine family signal transducer
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IL6ST mRNA
CTD
PMID:12419474
NCBI chr 2:45,798,872...45,839,501
Ensembl chr 2:44,066,130...44,109,936
G
Il9
interleukin 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IL9 mRNA
CTD
PMID:12419474
NCBI chr17:8,117,028...8,120,151
Ensembl chr17:8,111,772...8,114,895
G
Ilf3
interleukin enhancer binding factor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ILF3 mRNA
CTD
PMID:15336504
NCBI chr 8:28,198,454...28,236,634
Ensembl chr 8:19,922,460...19,960,350
G
Ilvbl
ilvB acetolactate synthase like
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ILVBL mRNA
CTD
PMID:15336504
NCBI chr 7:11,690,445...11,700,498
Ensembl chr 7:11,039,871...11,049,924
G
Impa2
inositol monophosphatase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IMPA2 mRNA
CTD
PMID:15336504
NCBI chr18:63,104,113...63,135,232
Ensembl chr18:60,834,246...60,865,641
G
Ing1
inhibitor of growth family, member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ING1 mRNA
CTD
PMID:15336504
NCBI chr16:84,639,378...84,649,498
Ensembl chr16:77,937,279...77,946,264
G
Ing3
inhibitor of growth family, member 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ING3 mRNA
CTD
PMID:15336504
NCBI chr 4:51,439,218...51,469,502
Ensembl chr 4:50,477,962...50,503,715
G
Inhba
inhibin subunit beta A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of INHBA mRNA
CTD
PMID:15336504
NCBI chr17:53,787,159...53,810,942
Ensembl chr17:49,095,920...49,108,982
G
Inhbb
inhibin subunit beta B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of INHBB mRNA
CTD
PMID:12414654
NCBI chr13:33,083,671...33,089,373
Ensembl chr13:30,530,860...30,537,832
G
Inpp5b
inositol polyphosphate-5-phosphatase B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of INPP5B mRNA
CTD
PMID:15336504
NCBI chr 5:142,281,454...142,345,993
Ensembl chr 5:136,996,686...137,061,315
G
Insig1
insulin induced gene 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of INSIG1 mRNA
CTD
PMID:15336504
NCBI chr 4:8,049,339...8,057,812
Ensembl chr 4:7,315,495...7,323,952
G
Ints7
integrator complex subunit 7
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of INTS7 gene
CTD
PMID:29432895
NCBI chr13:105,686,208...105,739,609
Ensembl chr13:103,155,090...103,208,592
G
Ipo4
importin 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IPO4 mRNA
CTD
PMID:15336504
NCBI chr15:33,087,321...33,097,241
Ensembl chr15:29,117,365...29,127,285
G
Ipo9
importin 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of IPO9 mRNA
CTD
PMID:15336504
NCBI chr13:49,362,244...49,414,477
Ensembl chr13:46,813,171...46,862,673
G
Irf1
interferon regulatory factor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IRF1 mRNA
CTD
PMID:15003993
NCBI chr10:38,417,935...38,424,946
Ensembl chr10:37,916,670...37,924,166
G
Irf7
interferon regulatory factor 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IRF7 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:205,796,956...205,800,543
Ensembl chr 1:196,367,361...196,370,832
G
Irf9
interferon regulatory factor 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IRF9 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr15:33,065,422...33,071,881
Ensembl chr15:29,095,789...29,101,236
G
Irgm
immunity-related GTPase M
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of IRGM mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr10:33,734,640...33,742,720
Ensembl chr10:33,233,455...33,241,578
G
Isg15
ISG15 ubiquitin-like modifier
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ISG15 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 5:172,066,369...172,067,656
Ensembl chr 5:166,784,148...166,785,435
G
Isg20
interferon stimulated exonuclease gene 20
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ISG20 mRNA
CTD
PMID:15336504
NCBI chr 1:142,234,729...142,246,403
Ensembl chr 1:132,815,123...132,837,027
G
Itch
itchy E3 ubiquitin protein ligase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ITCH mRNA
CTD
PMID:15336504
NCBI chr 3:164,102,490...164,193,932
Ensembl chr 3:143,645,637...143,733,543
G
Itga2
integrin subunit alpha 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ITGA2 mRNA
CTD
PMID:12766906
NCBI chr 2:48,253,412...48,354,509
Ensembl chr 2:46,523,948...46,621,481
G
Itga3
integrin subunit alpha 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ITGA3 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr10:80,486,998...80,522,548
Ensembl chr10:79,990,161...80,022,118
G
Itga4
integrin subunit alpha 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ITGA4 mRNA
CTD
PMID:15336504
NCBI chr 3:84,569,487...84,646,276
Ensembl chr 3:64,163,085...64,233,715
G
Itga5
integrin subunit alpha 5
decreases expression increases expression
ISO EXP
tert-Butylhydroperoxide results in decreased expression of ITGA5 mRNA tert-Butylhydroperoxide results in increased expression of ITGA5 mRNA
CTD
PMID:12419474 PMID:22659508
NCBI chr 7:136,358,097...136,381,305
Ensembl chr 7:134,478,968...134,502,837
G
Itga6
integrin subunit alpha 6
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITGA6 mRNA tert-Butylhydroperoxide results in increased expression of ITGA6 mRNA
CTD
PMID:12419474 PMID:15003993
NCBI chr 3:77,012,168...77,097,076
Ensembl chr 3:56,617,268...56,689,428
G
Itga7
integrin subunit alpha 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITGA7 mRNA
CTD
PMID:15336504
NCBI chr 7:1,944,447...1,973,347
Ensembl chr 7:1,359,940...1,388,450
G
Itgal
integrin subunit alpha L
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITGAL mRNA
CTD
PMID:12419474
NCBI chr 1:191,348,424...191,386,228
Ensembl chr 1:181,918,183...181,955,732
G
Itgav
integrin subunit alpha V
multiple interactions increases expression
ISO
[rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ITGAV mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ITGAV mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ITGAV mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ITGAV mRNA]
CTD
PMID:20847119
NCBI chr 3:89,245,382...89,333,512
Ensembl chr 3:68,838,189...68,926,639
G
Itgb3
integrin subunit beta 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of ITGB3 mRNA
CTD
PMID:22659508
NCBI chr10:90,009,927...90,067,787
Ensembl chr10:89,509,989...89,564,679
G
Itgb4
integrin subunit beta 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITGB4 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr10:101,705,592...101,741,933
Ensembl chr10:101,206,665...101,243,012
G
Itgb5
integrin subunit beta 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITGB5 mRNA
CTD
PMID:12419474
NCBI chr11:80,333,588...80,449,373
Ensembl chr11:66,829,285...66,944,472
G
Itgb6
integrin subunit beta 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITGB6 mRNA
CTD
PMID:12419474
NCBI chr 3:65,454,964...65,579,179
Ensembl chr 3:45,048,044...45,121,671
G
Itm2b
integral membrane protein 2B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITM2B mRNA
CTD
PMID:15336504
NCBI chr15:54,955,549...54,978,455
Ensembl chr15:48,546,001...48,568,917
G
Itpr3
inositol 1,4,5-trisphosphate receptor, type 3
affects expression
ISO
tert-Butylhydroperoxide affects the expression of ITPR3 mRNA
CTD
PMID:23410634
NCBI chr20:5,138,553...5,204,189
Ensembl chr20:5,136,441...5,202,337
G
Itsn1
intersectin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ITSN1 mRNA
CTD
PMID:12419474
NCBI chr11:44,464,515...44,646,598
Ensembl chr11:30,978,590...31,160,645
G
Jak2
Janus kinase 2
decreases phosphorylation multiple interactions
ISO
tert-Butylhydroperoxide results in decreased phosphorylation of JAK2 protein 3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased phosphorylation of JAK2 protein]
CTD
PMID:29128606
NCBI chr 1:236,408,905...236,468,769
Ensembl chr 1:226,995,334...227,054,189
G
Jam3
junctional adhesion molecule 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of JAM3 mRNA
CTD
PMID:14729362
NCBI chr 8:33,767,606...33,828,451
Ensembl chr 8:25,507,057...25,569,355
G
Jmjd6
jumonji domain containing 6, arginine demethylase and lysine hydroxylase
increases expression decreases methylation
ISO
tert-Butylhydroperoxide results in increased expression of JMJD6 mRNA tert-Butylhydroperoxide results in decreased methylation of JMJD6 gene
CTD
PMID:15336504 PMID:29432895
NCBI chr10:102,539,935...102,545,986
Ensembl chr10:102,041,120...102,047,182
G
Jpt2
Jupiter microtubule associated homolog 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of JPT2 mRNA
CTD
PMID:15336504
NCBI chr10:14,467,652...14,487,769
Ensembl chr10:13,963,137...13,983,170
G
Jun
Jun proto-oncogene, AP-1 transcription factor subunit
multiple interactions increases expression
ISO
CAT protein inhibits the reaction [tert-Butylhydroperoxide results in increased expression of JUN mRNA]; Glutathione inhibits the reaction [tert-Butylhydroperoxide results in increased expression of JUN mRNA]; Thiourea inhibits the reaction [tert-Butylhydroperoxide results in increased expression of JUN mRNA]
CTD
PMID:12414654 PMID:15105052 PMID:15336504 PMID:27509014
NCBI chr 5:115,009,900...115,012,993
Ensembl chr 5:109,893,145...109,897,656
G
Jund
JunD proto-oncogene, AP-1 transcription factor subunit
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of JUND mRNA
CTD
PMID:12419474
NCBI chr16:18,768,093...18,769,771
Ensembl chr16:18,734,122...18,735,799
G
Jup
junction plakoglobin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of JUP mRNA
CTD
PMID:15336504
NCBI chr10:85,800,812...85,827,881
Ensembl chr10:85,300,440...85,327,057
G
Kank1
KN motif and ankyrin repeat domains 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KANK1 mRNA
CTD
PMID:15336504
NCBI chr 1:232,381,720...232,500,834
Ensembl chr 1:222,877,622...223,074,514
G
Kank2
KN motif and ankyrin repeat domains 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KANK2 mRNA
CTD
PMID:15336504
NCBI chr 8:28,587,770...28,617,212
Ensembl chr 8:20,311,676...20,340,900
G
Kat2a
lysine acetyltransferase 2A
affects expression
ISO
tert-Butylhydroperoxide affects the expression of KAT2A mRNA
CTD
PMID:23410634
NCBI chr10:86,132,535...86,140,877
Ensembl chr10:85,632,216...85,640,166
G
Kcnab2
potassium voltage-gated channel subfamily A regulatory beta subunit 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KCNAB2 mRNA
CTD
PMID:15003993
NCBI chr 5:168,182,228...168,270,760
Ensembl chr 5:162,901,896...162,988,243
G
Kcnb2
potassium voltage-gated channel subfamily B member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KCNB2 mRNA
CTD
PMID:15336504
NCBI chr 5:8,340,085...8,811,184
Ensembl chr 5:3,569,685...4,028,599
G
Kcnj1
potassium inwardly-rectifying channel, subfamily J, member 1
decreases response to substance
EXP
KCNJ1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:22811560
NCBI chr 8:39,014,822...39,066,716
Ensembl chr 8:30,753,617...30,813,796
G
Kcnn4
potassium calcium-activated channel subfamily N member 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KCNN4 mRNA
CTD
PMID:15003993
NCBI chr 1:89,084,306...89,102,279
Ensembl chr 1:79,959,322...79,974,340
G
Kctd21
potassium channel tetramerization domain containing 21
affects expression
ISO
tert-Butylhydroperoxide affects the expression of KCTD21 mRNA
CTD
PMID:23410634
NCBI chr 1:151,650,074...151,669,775
Ensembl chr 1:151,650,104...151,667,645
G
Kdelr3
KDEL endoplasmic reticulum protein retention receptor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KDELR3 mRNA
CTD
PMID:15336504
NCBI chr 7:112,959,632...112,969,858
Ensembl chr 7:111,079,218...111,101,600
G
Kdm3a
lysine demethylase 3A
affects expression
ISO
tert-Butylhydroperoxide affects the expression of KDM3A mRNA
CTD
PMID:23410634
NCBI chr 4:105,189,208...105,233,526
Ensembl chr 4:103,630,908...103,675,073
G
Kdsr
3-ketodihydrosphingosine reductase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KDSR mRNA
CTD
PMID:15336504
NCBI chr13:23,374,101...23,408,779
Ensembl chr13:22,862,117...22,894,108
G
Keap1
Kelch-like ECH-associated protein 1
multiple interactions increases expression
ISO
Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased expression of KEAP1 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of KEAP1 protein]
CTD
PMID:27050144
NCBI chr 8:28,044,555...28,054,042
Ensembl chr 8:19,768,375...19,777,862
G
Khnyn
KH and NYN domain containing
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KHNYN mRNA
CTD
PMID:15336504
NCBI chr15:29,365,399...29,379,650
Ensembl chr15:29,365,260...29,376,967
G
Kif15
kinesin family member 15
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of KIF15 mRNA tert-Butylhydroperoxide affects the expression of KIF15 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 8:131,479,340...131,550,209
Ensembl chr 8:122,601,897...122,672,750
G
Kif20a
kinesin family member 20A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KIF20A mRNA
CTD
PMID:15003993
NCBI chr18:26,504,422...26,512,908
Ensembl chr18:26,230,230...26,238,780
G
Kif23
kinesin family member 23
affects expression
ISO
tert-Butylhydroperoxide affects the expression of KIF23 mRNA
CTD
PMID:23410634
NCBI chr 8:71,293,439...71,321,911
Ensembl chr 8:62,397,948...62,425,072
G
Kif2c
kinesin family member 2C
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KIF2C mRNA
CTD
PMID:15003993
NCBI chr 5:135,873,925...135,899,267
Ensembl chr 5:130,637,347...130,662,637
G
Kif4a
kinesin family member 4A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KIF4 mRNA
CTD
PMID:15003993
NCBI chr X:69,761,803...69,864,335
Ensembl chr X:65,721,779...65,824,139
G
Kif5c
kinesin family member 5C
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KIF5C mRNA
CTD
PMID:15336504
NCBI chr 3:54,441,266...54,591,630
Ensembl chr 3:34,032,105...34,182,413
G
Kifbp
kinesin family binding protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KIFBP mRNA
CTD
PMID:15336504
NCBI chr20:31,055,625...31,075,232
Ensembl chr20:30,512,901...30,532,476
G
Kifc1
kinesin family member C1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KIFC1 mRNA
CTD
PMID:15336504
NCBI chr20:5,000,929...5,018,967
Ensembl chr20:4,999,047...5,017,105
G
Kiss1r
KISS1 receptor
affects expression
ISO
tert-Butylhydroperoxide affects the expression of KISS1R mRNA
CTD
PMID:23410634
NCBI chr 7:10,435,766...10,439,424
Ensembl chr 7:9,785,135...9,788,793
G
Klf10
KLF transcription factor 10
affects expression
ISO
tert-Butylhydroperoxide affects the expression of KLF10 mRNA
CTD
PMID:23410634
NCBI chr 7:71,352,612...71,358,680
Ensembl chr 7:69,465,619...69,473,994
G
Klf2
KLF transcription factor 2
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of KLF2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of KLF2 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of KLF2 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of KLF2 mRNA]
CTD
PMID:20847119
NCBI chr16:17,555,136...17,557,768
Ensembl chr16:17,514,552...17,523,944
G
Klf9
KLF transcription factor 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KLF9 mRNA
CTD
PMID:15336504
NCBI chr 1:230,126,646...230,151,641
Ensembl chr 1:220,700,108...220,725,037
G
Klhdc3
kelch domain containing 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KLHDC3 mRNA
CTD
PMID:15336504
NCBI chr 9:21,799,870...21,806,337
Ensembl chr 9:14,302,354...14,308,736
G
Kmt2d
lysine methyltransferase 2D
decreases methylation decreases expression
ISO
tert-Butylhydroperoxide results in decreased methylation of KMT2D gene tert-Butylhydroperoxide results in decreased expression of KMT2D mRNA
CTD
PMID:27509014
NCBI chr 7:131,859,696...131,901,032
Ensembl chr 7:129,962,887...130,020,325
G
Kmt5b
lysine methyltransferase 5B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KMT5B mRNA
CTD
PMID:15336504
NCBI chr 1:210,429,672...210,479,042
Ensembl chr 1:201,000,444...201,049,819
G
Kntc1
kinetochore associated 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of KNTC1 mRNA
CTD
PMID:15336504
NCBI chr12:38,429,925...38,500,564
Ensembl chr12:32,769,020...32,839,561
G
Kpnb1
karyopherin subunit beta 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KPNB1 mRNA
CTD
PMID:15336504
NCBI chr10:82,642,082...82,670,856
Ensembl chr10:82,145,420...82,174,605
G
Ktn1
kinectin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of KTN1 mRNA
CTD
PMID:15336504
NCBI chr15:23,392,570...23,485,061
Ensembl chr15:20,914,642...21,002,578
G
Lair1
leukocyte-associated immunoglobulin-like receptor 1
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of LAIR1 intron
CTD
PMID:29432895
NCBI chr 1:79,140,850...79,261,546
Ensembl chr 1:70,157,681...70,185,807
G
Lama5
laminin subunit alpha 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LAMA5 mRNA
CTD
PMID:15336504
NCBI chr 3:187,647,904...187,695,974
Ensembl chr 3:167,270,296...167,318,451
G
Lamb1
laminin subunit beta 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LAMB1 mRNA
CTD
PMID:15336504
NCBI chr 6:53,562,849...53,630,118
Ensembl chr 6:47,835,525...47,902,585
G
Lamb3
laminin subunit beta 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LAMB3 mRNA
CTD
PMID:15336504
NCBI chr13:107,362,514...107,404,081
Ensembl chr13:104,833,873...104,875,405
G
Lamc2
laminin subunit gamma 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LAMC2 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr13:67,835,199...67,894,694
Ensembl chr13:65,284,664...65,344,200
G
Laptm5
lysosomal protein transmembrane 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LAPTM5 mRNA
CTD
PMID:15336504
NCBI chr 5:148,371,880...148,393,927
Ensembl chr 5:143,087,759...143,109,807
G
Lat
linker for activation of T cells
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of LAT mRNA
CTD
PMID:22659508
NCBI chr 1:190,367,111...190,372,515
Ensembl chr 1:180,936,534...180,941,578
G
Lbr
lamin B receptor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LBR mRNA
CTD
PMID:12414654
NCBI chr13:96,071,058...96,095,709
Ensembl chr13:93,538,920...93,564,017
G
Lcat
lecithin cholesterol acyltransferase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LCAT mRNA
CTD
PMID:12419474
NCBI chr19:50,744,598...50,748,064
Ensembl chr19:33,834,403...33,838,231
G
Lcn2
lipocalin 2
decreases secretion
ISO
tert-Butylhydroperoxide results in decreased secretion of LCN2 protein
CTD
PMID:27888128
NCBI chr 3:36,078,432...36,081,851
Ensembl chr 3:15,680,687...15,684,095
G
Lcp1
lymphocyte cytosolic protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LCP1 mRNA
CTD
PMID:14729362
NCBI chr15:56,846,375...56,954,090
Ensembl chr15:50,488,149...50,544,680
G
Ldlr
low density lipoprotein receptor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LDLR mRNA
CTD
PMID:12414654
NCBI chr 8:28,546,191...28,569,075
Ensembl chr 8:20,270,041...20,294,580
G
Lgals3bp
galectin 3 binding protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LGALS3BP mRNA
CTD
PMID:14729362
NCBI chr10:104,118,510...104,127,848
Ensembl chr10:103,619,908...103,629,256
G
Lgals8
galectin 8
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LGALS8 mRNA
CTD
PMID:15336504
NCBI chr17:62,716,368...62,744,272
Ensembl chr17:58,028,105...58,052,764
G
Lgals9
galectin 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LGALS9 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr10:64,405,044...64,428,249
Ensembl chr10:63,907,018...63,930,045
G
Lgr5
leucine rich repeat containing G protein coupled receptor 5
affects expression
ISO
tert-Butylhydroperoxide affects the expression of LGR5 mRNA
CTD
PMID:23410634
NCBI chr 7:52,973,151...53,107,964
Ensembl chr 7:51,088,239...51,222,446
G
Lhx2
LIM homeobox 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LHX2 mRNA
CTD
PMID:15336504
NCBI chr 3:42,523,345...42,553,646
Ensembl chr 3:22,126,007...22,143,908
G
Lif
LIF, interleukin 6 family cytokine
increases expression increases methylation
ISO
tert-Butylhydroperoxide results in increased expression of LIF mRNA tert-Butylhydroperoxide results in increased methylation of LIF gene
CTD
PMID:12414654 PMID:15336504 PMID:23410634 PMID:27509014
NCBI chr14:83,354,602...83,364,053
Ensembl chr14:79,134,574...79,140,482
G
Lifr
LIF receptor subunit alpha
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LIFR mRNA
CTD
PMID:15336504
NCBI chr 2:57,951,787...58,020,357
Ensembl chr 2:56,250,120...56,286,699
G
Lig1
DNA ligase 1
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of LIG1 mRNA tert-Butylhydroperoxide results in increased methylation of LIG1 gene
CTD
PMID:15336504 PMID:29432895
NCBI chr 1:83,243,043...83,281,707
Ensembl chr 1:74,165,842...74,204,413
G
Lilrb4
leukocyte immunoglobulin like receptor B4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LILRB4B mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:78,847,685...78,853,294
Ensembl chr 1:69,805,250...69,810,660
G
Limch1
LIM and calponin homology domains 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LIMCH1 mRNA
CTD
PMID:15336504
NCBI chr14:41,466,433...41,779,477
Ensembl chr14:41,114,803...41,425,191
G
Limk1
LIM domain kinase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LIMK1 mRNA
CTD
PMID:15003993
NCBI chr12:27,663,177...27,697,085
Ensembl chr12:22,026,672...22,060,606
G
Lims1
LIM zinc finger domain containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LIMS1 mRNA
CTD
PMID:15336504
NCBI chr20:26,851,364...26,961,607
Ensembl chr20:26,309,895...26,418,500
G
Lipa
lipase A, lysosomal acid type
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LIPA mRNA
CTD
PMID:15336504
NCBI chr 1:241,437,524...241,470,936
Ensembl chr 1:232,024,356...232,057,633
G
Litaf
lipopolysaccharide-induced TNF factor
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of LITAF mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of LITAF mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of LITAF mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of LITAF mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of LITAF mRNA]
CTD
PMID:20847119
NCBI chr10:5,163,258...5,199,930
Ensembl chr10:4,625,552...4,692,763
G
Lmbr1
limb development membrane protein 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of LMBR1 mRNA
CTD
PMID:23410634
NCBI chr 4:6,649,824...6,820,525
Ensembl chr 4:5,974,750...6,146,368
G
Lmnb1
lamin B1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LMNB1 mRNA
CTD
PMID:15336504
NCBI chr18:52,373,939...52,413,284
Ensembl chr18:50,175,874...50,214,502
G
Lmnb2
lamin B2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LMNB2 mRNA
CTD
PMID:15336504
NCBI chr 7:9,443,308...9,459,468
Ensembl chr 7:8,789,314...8,808,665
G
Lnx2
ligand of numb-protein X 2
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of LNX2 intron
CTD
PMID:29432895
NCBI chr12:13,119,139...13,184,401
Ensembl chr12:8,005,227...8,070,494
G
Lox
lysyl oxidase
affects expression
ISO
tert-Butylhydroperoxide affects the expression of LOX mRNA
CTD
PMID:23410634
NCBI chr18:48,162,889...48,175,640
Ensembl chr18:45,967,343...46,041,477
G
Loxl2
lysyl oxidase-like 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LOXL2 mRNA
CTD
PMID:15963989
NCBI chr15:51,091,547...51,182,843
Ensembl chr15:44,683,880...44,773,067
G
Lpcat1
lysophosphatidylcholine acyltransferase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LPCAT1 mRNA
CTD
PMID:15336504
NCBI chr 1:31,594,621...31,644,946
Ensembl chr 1:29,766,071...29,816,401
G
Lpcat3
lysophosphatidylcholine acyltransferase 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LPCAT3 mRNA
CTD
PMID:15336504
NCBI chr 4:159,154,690...159,196,176
Ensembl chr 4:157,468,290...157,509,880
G
Lpin1
lipin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LPIN1 mRNA
CTD
PMID:14729362
NCBI chr 6:45,039,110...45,145,845
Ensembl chr 6:39,312,748...39,417,097
G
Lpin2
lipin 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LPIN2 mRNA
CTD
PMID:15336504
NCBI chr 9:118,529,988...118,604,796
Ensembl chr 9:111,083,745...111,158,193
G
Lpl
lipoprotein lipase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LPL mRNA
CTD
PMID:15336504
NCBI chr16:25,596,205...25,621,928
Ensembl chr16:20,829,465...20,855,249
G
Lpp
LIM domain containing preferred translocation partner in lipoma
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LPP mRNA
CTD
PMID:15336504
NCBI chr11:89,292,060...89,933,973
Ensembl chr11:75,797,078...76,422,597
G
Lrba
LPS responsive beige-like anchor protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LRBA mRNA
CTD
PMID:14729362
NCBI chr 2:173,919,330...174,500,536
Ensembl chr 2:171,621,507...172,202,724
G
Lrp1
LDL receptor related protein 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of LRP1 mRNA
CTD
PMID:23410634
NCBI chr 7:65,265,639...65,346,196
Ensembl chr 7:63,380,356...63,460,910
G
Lrp6
LDL receptor related protein 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LRP6 mRNA
CTD
PMID:12414654
NCBI chr 4:168,997,937...169,131,716
Ensembl chr 4:167,270,353...167,400,497
G
Lrrc1
leucine rich repeat containing 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LRRC1 mRNA
CTD
PMID:15336504
NCBI chr 8:87,120,281...87,289,748
Ensembl chr 8:78,239,900...78,406,490
G
Lrrc17
leucine rich repeat containing 17
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LRRC17 mRNA
CTD
PMID:15336504
NCBI chr 4:14,393,632...14,424,048
Ensembl chr 4:13,501,436...13,531,845
G
Lrrc23
leucine rich repeat containing 23
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of LRRC23 intron
CTD
PMID:29432895
NCBI chr 4:159,267,572...159,277,764
Ensembl chr 4:157,581,291...157,591,860
G
Lrrc27
leucine rich repeat containing 27
increases methylation
ISO
tert-Butylhydroperoxide results in increased methylation of LRRC27 promoter
CTD
PMID:29432895
NCBI chr 1:203,433,463...203,464,683
Ensembl chr 1:194,005,182...194,035,084
G
Lsm4
LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LSM4 mRNA
CTD
PMID:15336504
NCBI chr16:18,789,466...18,795,164
Ensembl chr16:18,755,484...18,760,926
G
Lss
lanosterol synthase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LSS mRNA
CTD
PMID:14729362
NCBI chr20:12,090,641...12,118,230
Ensembl chr20:12,092,774...12,118,762
G
Ltbp2
latent transforming growth factor beta binding protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LTBP2 mRNA
CTD
PMID:15336504
NCBI chr 6:110,161,029...110,261,586
Ensembl chr 6:104,429,947...104,526,208
G
Ly6a
lymphocyte antigen 6 family member A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LY6A mRNA
CTD
PMID:15003993
NCBI chr 7:109,064,222...109,067,757
Ensembl chr 7:107,183,469...107,189,981
G
Ly96
lymphocyte antigen 96
multiple interactions
ISO
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of IL1B mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of IL6 mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of NOX4 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of TNF mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased secretion of IL1B protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of BAX protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CASP3 protein modified form]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of CXCL8 protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of ICAM1 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL1B mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL1B protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of IL6 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of PTGS2 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of VCAM1 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK8 protein]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK9 protein]; tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]; tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]; tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein]; tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]
CTD
PMID:28063877 PMID:29111459
NCBI chr 5:7,365,536...7,397,864
Ensembl chr 5:2,582,254...2,612,386
G
Lyn
LYN proto-oncogene, Src family tyrosine kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of LYN mRNA
CTD
PMID:12419474
NCBI chr 5:21,437,127...21,553,097
Ensembl chr 5:16,639,466...16,756,868
G
Lypd1
Ly6/Plaur domain containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of LYPD1 mRNA
CTD
PMID:15336504
NCBI chr13:39,874,937...39,922,385
Ensembl chr13:37,326,464...37,368,493
G
Lypla1
lysophospholipase 1
decreases response to substance
ISO
LYPLA1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15003993
NCBI chr 5:19,477,408...19,506,568
Ensembl chr 5:14,679,606...14,708,746
G
Mab21l1
mab-21 like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAB21L1 mRNA
CTD
PMID:15336504
NCBI chr 2:139,943,496...139,945,885
Ensembl chr 2:139,943,496...139,945,885
G
Mab21l2
mab-21 like 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAB21L2 mRNA
CTD
PMID:15336504
NCBI chr 2:174,244,538...174,247,620
Ensembl chr 2:171,946,573...171,949,655
G
Macroh2a1
macroH2A.1 histone
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MACROH2A1 mRNA
CTD
PMID:15336504
NCBI chr17:8,484,340...8,547,268
Ensembl chr17:8,479,372...8,542,072
G
Mafb
MAF bZIP transcription factor B
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of MAFB mRNA tert-Butylhydroperoxide results in increased methylation of MAFB gene
CTD
PMID:27509014
NCBI chr 3:169,417,890...169,419,810
Ensembl chr 3:148,998,122...149,000,031
G
Maff
MAF bZIP transcription factor F
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MAFF mRNA
CTD
PMID:15336504
NCBI chr 7:112,792,787...112,804,139
Ensembl chr 7:110,912,499...110,923,851
G
Mafg
MAF bZIP transcription factor G
increases expression increases methylation
ISO
tert-Butylhydroperoxide results in increased expression of MAFG mRNA tert-Butylhydroperoxide results in increased methylation of MAFG gene
CTD
PMID:12414654 PMID:27509014
NCBI chr10:106,401,633...106,410,159
Ensembl chr10:105,903,237...105,912,026
G
Mafk
MAF bZIP transcription factor K
increases methylation increases expression
ISO
tert-Butylhydroperoxide results in increased methylation of MAFK gene tert-Butylhydroperoxide results in increased expression of MAFK mRNA
CTD
PMID:27509014
NCBI chr12:19,948,473...19,970,351
Ensembl chr12:14,833,984...14,837,048 Ensembl chr12:14,833,984...14,837,048
G
Mal
mal, T-cell differentiation protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAL mRNA
CTD
PMID:15336504
NCBI chr 3:135,317,664...135,341,423
Ensembl chr 3:114,864,378...114,888,136
G
Man2a2
mannosidase, alpha, class 2A, member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAN2A2 mRNA
CTD
PMID:15336504
NCBI chr 1:143,712,157...143,736,624
Ensembl chr 1:134,306,236...134,327,315
G
Mansc1
MANSC domain containing 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MANSC1 mRNA
CTD
PMID:15336504
NCBI chr 4:167,438,817...167,459,047
Ensembl chr 4:167,439,071...167,479,606
G
Map1lc3b
microtubule-associated protein 1 light chain 3 beta
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MAP1LC3B mRNA
CTD
PMID:15336504
NCBI chr19:66,571,631...66,582,270
Ensembl chr19:49,665,791...49,677,690 Ensembl chr16:49,665,791...49,677,690
G
Map2k3
mitogen activated protein kinase kinase 3
increases expression increases phosphorylation
ISO
tert-Butylhydroperoxide results in increased expression of MAP2K3 mRNA tert-Butylhydroperoxide results in increased phosphorylation of MAP2K3 protein
CTD
PMID:15336504 PMID:17003459
NCBI chr10:46,107,639...46,128,986
Ensembl chr10:45,607,163...45,629,492
G
Map2k4
mitogen activated protein kinase kinase 4
increases phosphorylation
ISO
tert-Butylhydroperoxide results in increased phosphorylation of MAP2K4 protein
CTD
PMID:17003459
NCBI chr10:50,842,348...50,947,063
Ensembl chr10:50,344,915...50,447,993
G
Map2k5
mitogen activated protein kinase kinase 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAP2K5 mRNA
CTD
PMID:12419474
NCBI chr 8:72,520,616...72,748,395
Ensembl chr 8:63,625,221...63,851,983
G
Map2k6
mitogen-activated protein kinase kinase 6
increases phosphorylation
ISO
tert-Butylhydroperoxide results in increased phosphorylation of MAP2K6 protein
CTD
PMID:17003459
NCBI chr10:95,872,747...95,987,747
Ensembl chr10:95,373,204...95,488,293
G
Map3k5
mitogen-activated protein kinase kinase kinase 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MAP3K5 mRNA
CTD
PMID:15336504
NCBI chr 1:16,505,387...16,723,899
Ensembl chr 1:14,685,492...14,904,800
G
Map3k6
mitogen-activated protein kinase kinase kinase 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAP3K6 mRNA
CTD
PMID:15336504
NCBI chr 5:150,724,029...150,736,113
Ensembl chr 5:145,440,346...145,452,212
G
Map3k7
mitogen activated protein kinase kinase kinase 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAP3K7 mRNA
CTD
PMID:15336504
NCBI chr 5:51,149,524...51,212,012
Ensembl chr 5:46,357,931...46,415,597
G
Map4
microtubule-associated protein 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MAP4 mRNA
CTD
PMID:15336504
NCBI chr 8:118,800,393...118,942,805
Ensembl chr 8:109,925,575...110,064,362
G
Mapk1
mitogen activated protein kinase 1
decreases phosphorylation multiple interactions decreases expression increases phosphorylation
ISO EXP
tert-Butylhydroperoxide results in decreased phosphorylation of MAPK1 protein [tert-Butylhydroperoxide co-treated with U 0126] results in decreased phosphorylation of MAPK1 protein; Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of MAPK1 protein modified form] 7-methyljuglone analog inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK1 protein]; Drugs, Chinese Herbal inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK1 protein]
CTD
PMID:17003459 PMID:20100471 PMID:20922651
NCBI chr11:97,462,025...97,529,193
Ensembl chr11:83,957,813...84,023,616
G
Mapk12
mitogen-activated protein kinase 12
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MAPK12 mRNA
CTD
PMID:14729362
NCBI chr 7:122,085,647...122,096,307
Ensembl chr 7:120,206,271...120,216,664
G
Mapk14
mitogen activated protein kinase 14
decreases expression increases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of MAPK14 mRNA tert-Butylhydroperoxide results in increased expression of MAPK14 mRNA tert-Butylhydroperoxide results in increased methylation of MAPK14 gene
CTD
PMID:15336504 PMID:27509014 PMID:29432895
NCBI chr20:6,751,288...6,812,294
Ensembl chr20:6,749,670...6,810,589
G
Mapk3
mitogen activated protein kinase 3
multiple interactions decreases phosphorylation decreases expression increases phosphorylation
ISO EXP
[tert-Butylhydroperoxide co-treated with U 0126] results in decreased phosphorylation of MAPK3 protein; Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of MAPK3 protein modified form] tert-Butylhydroperoxide results in decreased phosphorylation of MAPK3 protein tert-Butylhydroperoxide results in increased phosphorylation of MAPK3 protein 7-methyljuglone analog inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK3 protein]; Drugs, Chinese Herbal inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK3 protein]
CTD
PMID:17003459 PMID:20100471 PMID:20922651
NCBI chr 1:190,797,189...190,803,411
Ensembl chr 1:181,366,637...181,372,863
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions increases phosphorylation
ISO
[phorone co-treated with tert-Butylhydroperoxide] results in increased phosphorylation of MAPK8 protein tert-Butylhydroperoxide results in increased phosphorylation of MAPK8 protein LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK8 protein]
CTD
PMID:20423716 PMID:28063877
NCBI chr16:8,645,171...8,728,225
Ensembl chr16:8,638,924...8,721,981
G
Mapk9
mitogen-activated protein kinase 9
multiple interactions increases phosphorylation
ISO
[phorone co-treated with tert-Butylhydroperoxide] results in increased phosphorylation of MAPK9 protein LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased phosphorylation of MAPK9 protein]
CTD
PMID:20423716 PMID:28063877
NCBI chr10:34,670,750...34,711,972
Ensembl chr10:34,169,675...34,210,178
G
Mapre3
microtubule-associated protein, RP/EB family, member 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MAPRE3 mRNA
CTD
PMID:15003993
NCBI chr 6:31,233,736...31,278,626
Ensembl chr 6:25,513,800...25,558,881
G
Marchf2
membrane associated ring-CH-type finger 2
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of MARCHF2 mRNA tert-Butylhydroperoxide results in increased methylation of MARCHF2 gene
CTD
PMID:15336504 PMID:29432895
NCBI chr 7:15,183,931...15,209,988
Ensembl chr 7:14,481,761...14,507,794
G
Mark3
microtubule affinity regulating kinase 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MARK3 mRNA
CTD
PMID:12419474
NCBI chr 6:130,626,612...130,716,245
Ensembl chr 6:130,627,482...130,716,647
G
Mas1
MAS1 proto-oncogene, G protein-coupled receptor
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of MAS1 gene
CTD
PMID:29432895
NCBI chr 1:50,428,064...50,459,537
Ensembl chr 1:47,880,309...47,911,709
G
Matn2
matrilin 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MATN2 mRNA
CTD
PMID:15336504
NCBI chr 7:67,380,140...67,529,767
Ensembl chr 7:65,494,834...65,645,113
G
Mb21d2
Mab-21 domain containing 2
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of MB21D2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of MB21D2 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of MB21D2 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of MB21D2 mRNA]
CTD
PMID:20847119
NCBI chr11:85,330,526...85,429,543
Ensembl chr11:71,825,748...71,924,769
G
Mbd3
methyl-CpG binding domain protein 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MBD3 mRNA
CTD
PMID:15336504
NCBI chr 7:9,961,053...9,970,845
Ensembl chr 7:9,313,098...9,320,165
G
Mbnl2
muscleblind-like splicing regulator 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MBNL2 mRNA
CTD
PMID:15336504
NCBI chr15:103,792,134...103,949,827
Ensembl chr15:97,385,244...97,542,937
G
Mbtps1
membrane-bound transcription factor peptidase, site 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MBTPS1 mRNA
CTD
PMID:15336504
NCBI chr19:64,470,245...64,521,438
Ensembl chr19:47,561,598...47,612,791
G
Mcam
melanoma cell adhesion molecule
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCAM mRNA
CTD
PMID:15336504
NCBI chr 8:53,376,225...53,384,407
Ensembl chr 8:44,479,376...44,487,571
G
Mcfd2
multiple coagulation factor deficiency 2, ER cargo receptor complex subunit
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCFD2 mRNA
CTD
PMID:15003993
NCBI chr 6:13,028,036...13,039,388
Ensembl chr 6:7,274,469...7,285,841
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
multiple interactions decreases response to substance
ISO
[HIF1A protein results in increased expression of MCL1 protein] which results in decreased susceptibility to tert-Butylhydroperoxide; MCL1 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein] MCL1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15611089
NCBI chr 2:185,884,840...185,912,532
Ensembl chr 2:183,219,220...183,222,303
G
Mcm2
minichromosome maintenance complex component 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCM2 mRNA
CTD
PMID:15336504
NCBI chr 4:122,903,679...122,918,205
Ensembl chr 4:121,346,434...121,360,847
G
Mcm3
minichromosome maintenance complex component 3
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCM3 mRNA tert-Butylhydroperoxide affects the expression of MCM3 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 9:30,715,602...30,733,746
Ensembl chr 9:23,219,169...23,237,314
G
Mcm4
minichromosome maintenance complex component 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCM4 mRNA
CTD
PMID:12419474
NCBI chr11:98,762,599...98,776,300
Ensembl chr11:85,258,443...85,272,144
G
Mcm5
minichromosome maintenance complex component 5
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCM5 mRNA tert-Butylhydroperoxide affects the expression of MCM5 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr19:13,488,813...13,510,131
Ensembl chr19:13,483,066...13,504,389
G
Mcm6
minichromosome maintenance complex component 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCM6 mRNA
CTD
PMID:15336504
NCBI chr13:42,379,161...42,404,352
Ensembl chr13:39,826,763...39,851,960
G
Mcm7
minichromosome maintenance complex component 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCM7 mRNA
CTD
PMID:15336504
NCBI chr12:22,155,921...22,163,320
Ensembl chr12:17,042,212...17,050,063
G
Mcrs1
microspherule protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MCRS1 mRNA
CTD
PMID:15336504
NCBI chr 7:132,262,719...132,271,533
Ensembl chr 7:130,383,853...130,392,685
G
Mdm2
MDM2 proto-oncogene
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MDM2 mRNA
CTD
PMID:27509014
NCBI chr 7:55,176,558...55,201,757
Ensembl chr 7:53,290,664...53,314,915
G
Me1
malic enzyme 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ME1 mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr 8:96,429,057...96,540,244
Ensembl chr 8:87,549,043...87,660,304
G
Mecp2
methyl CpG binding protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MECP2 mRNA
CTD
PMID:15336504
NCBI chr X:156,932,481...156,995,981
Ensembl chr X:151,789,930...151,844,689
G
Med16
mediator complex subunit 16
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MED16 mRNA
CTD
PMID:15336504
NCBI chr 7:10,449,273...10,461,797
Ensembl chr 7:9,798,668...9,811,172
G
Med21
mediator complex subunit 21
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MED21 mRNA
CTD
PMID:15336504
NCBI chr 4:181,291,191...181,314,504
Ensembl chr 4:179,560,579...179,567,548
G
Megf9
multiple EGF-like-domains 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MEGF9 mRNA
CTD
PMID:15336504
NCBI chr 5:89,008,679...89,120,731
Ensembl chr 5:83,993,565...84,105,622
G
Mest
mesoderm specific transcript
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MEST mRNA
CTD
PMID:15336504
NCBI chr 4:60,321,814...60,332,288
Ensembl chr 4:59,354,447...59,366,145
G
Met
MET proto-oncogene, receptor tyrosine kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MET mRNA
CTD
PMID:15336504
NCBI chr 4:46,756,823...46,864,041
Ensembl chr 4:45,790,791...45,897,876
G
Mfsd6
major facilitator superfamily domain containing 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MFSD6 mRNA
CTD
PMID:15336504
NCBI chr 9:48,773,171...48,858,471
Ensembl chr 9:48,773,414...48,858,465
G
Mgll
monoglyceride lipase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MGLL mRNA
CTD
PMID:15336504
NCBI chr 4:122,749,436...122,851,440
Ensembl chr 4:121,192,195...121,294,179
G
Mgp
matrix Gla protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MGP mRNA
CTD
PMID:12766906 PMID:15336504
NCBI chr 4:171,497,472...171,500,888
Ensembl chr 4:169,766,279...169,769,667
G
Mgst2
microsomal glutathione S-transferase 2
decreases response to substance increases expression
ISO
MGST2 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of MGST2 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 2:137,821,787...137,866,664
Ensembl chr 2:135,693,557...135,715,828
G
Mgst3
microsomal glutathione S-transferase 3
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MGST3 mRNA tert-Butylhydroperoxide results in increased expression of MGST3 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr13:82,059,480...82,080,418
Ensembl chr13:79,526,541...79,547,411
G
Mia
MIA SH3 domain containing
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MIA mRNA
CTD
PMID:14729362
NCBI chr 1:91,601,326...91,603,019
Ensembl chr 1:82,473,678...82,475,370
G
Mia2
MIA SH3 domain ER export factor 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MIA2 mRNA
CTD
PMID:12414654
NCBI chr 6:82,522,398...82,620,136
Ensembl chr 6:76,787,508...76,885,211
G
Mia3
MIA SH3 domain ER export factor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MIA3 mRNA
CTD
PMID:15003993
NCBI chr13:97,502,040...97,547,155
Ensembl chr13:94,970,424...95,011,972
G
Mid1ip1
MID1 interacting protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MID1IP1 mRNA
CTD
PMID:15003993
NCBI chr X:14,733,539...14,735,859
Ensembl chr X:12,060,883...12,065,774
G
Mir155
microRNA 155
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MIR155 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MIR155 mRNA]
CTD
PMID:35690295
NCBI chr11:37,261,114...37,261,178
Ensembl chr11:23,774,654...23,774,718
G
Mir184
microRNA 184
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MIR184 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in decreased expression of BCL2 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of AKT1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of APAF1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of ARNT mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of BAX mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP3 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CASP8 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of CDKN1A mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EGFR mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of EXO1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HIF1A mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPA6 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of HSPD1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MIR155 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MLH1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP3 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP9 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MTOR mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of PIK3R1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of SOD1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TNFSF10 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TP53 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA]
CTD
PMID:35690295
NCBI chr 8:99,222,982...99,223,058
Ensembl chr 8:90,343,134...90,343,210
G
Mitf
melanocyte inducing transcription factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MITF mRNA
CTD
PMID:15336504
NCBI chr 4:131,965,676...132,177,790
Ensembl chr 4:130,409,217...130,621,145
G
Mixl1
Mix paired-like homeobox 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of MIXL1 mRNA
CTD
PMID:23410634
NCBI chr13:94,953,907...94,957,938
Ensembl chr13:92,422,031...92,426,065
G
Mkks
MKKS centrosomal shuttling protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MKKS mRNA
CTD
PMID:15336504
NCBI chr 3:144,654,563...144,672,831
Ensembl chr 3:124,201,877...124,220,162
G
Mknk2
MAPK interacting serine/threonine kinase 2
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MKNK2 mRNA tert-Butylhydroperoxide results in increased expression of MKNK2 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 7:9,690,385...9,701,527
Ensembl chr 7:9,039,728...9,050,827
G
Mkrn1
makorin ring finger protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MKRN1 mRNA
CTD
PMID:15336504
NCBI chr 4:69,142,710...69,170,211
Ensembl chr 4:68,175,909...68,197,165 Ensembl chr 9:68,175,909...68,197,165
G
Mlh1
mutL homolog 1
decreases expression multiple interactions
ISO
tert-Butylhydroperoxide results in decreased expression of MLH1 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MLH1 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MLH1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MLH1 mRNA]
CTD
PMID:12419474 PMID:35690295
NCBI chr 8:120,074,871...120,112,109
Ensembl chr 8:111,196,468...111,233,617
G
Mme
membrane metallo-endopeptidase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MME mRNA
CTD
PMID:15336504
NCBI chr 2:149,806,826...149,957,381
Ensembl chr 2:147,722,086...147,803,792
G
Mmp11
matrix metallopeptidase 11
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MMP11 mRNA
CTD
PMID:12419474
NCBI chr20:12,730,284...12,739,067
Ensembl chr20:12,730,836...12,739,628
G
Mmp3
matrix metallopeptidase 3
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP3 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP3 mRNA]
CTD
PMID:35690295
NCBI chr 8:12,925,267...12,938,828
Ensembl chr 8:4,640,416...4,653,961
G
Mmp9
matrix metallopeptidase 9
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP9 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP9 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MMP9 mRNA]
CTD
PMID:35690295
NCBI chr 3:174,103,474...174,111,434
Ensembl chr 3:153,683,858...153,692,120
G
Mob1a
MOB kinase activator 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MOB1A mRNA
CTD
PMID:15336504
NCBI chr 4:117,389,278...117,406,255
Ensembl chr 4:115,831,551...115,848,561 Ensembl chr 1:115,831,551...115,848,561
G
Mok
MOK protein kinase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MOK mRNA
CTD
PMID:15336504
NCBI chr 6:129,823,794...129,854,669
Ensembl chr 6:129,823,795...129,854,700
G
Mospd1
motile sperm domain containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MOSPD1 mRNA
CTD
PMID:15336504
NCBI chr X:138,019,719...138,047,475
Ensembl chr X:133,100,422...133,127,908 Ensembl chr 1:133,100,422...133,127,908 Ensembl chr14:133,100,422...133,127,908
G
Mov10
Mov10 RNA helicase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MOV10 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 2:194,982,014...195,003,513
Ensembl chr 2:192,293,470...192,315,083
G
Moxd1
monooxygenase, DBH-like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MOXD1 mRNA
CTD
PMID:15336504
NCBI chr 1:22,894,543...22,984,599
Ensembl chr 1:21,075,122...21,161,779
G
Mpg
N-methylpurine-DNA glycosylase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MPG mRNA
CTD
PMID:15336504
NCBI chr10:15,900,697...15,906,981
Ensembl chr10:15,395,782...15,402,520
G
Mphosph8
M-phase phosphoprotein 8
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MPHOSPH8 mRNA
CTD
PMID:15336504
NCBI chr15:34,916,169...34,944,038
Ensembl chr15:30,686,613...30,828,810
G
Mphosph9
M-phase phosphoprotein 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MPHOSPH9 mRNA
CTD
PMID:15336504
NCBI chr12:37,936,442...38,007,053
Ensembl chr12:32,275,558...32,342,392
G
Mpp1
MAGUK p55 scaffold protein 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MPP1 mRNA
CTD
PMID:15003993
G
Mppe1
metallophosphoesterase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MPPE1 mRNA
CTD
PMID:15336504
NCBI chr18:63,033,329...63,051,461
Ensembl chr18:60,763,419...60,781,553
G
Mrpl2
mitochondrial ribosomal protein L2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MRPL2 mRNA
CTD
PMID:15336504
NCBI chr 9:21,830,834...21,834,607
Ensembl chr 9:14,333,234...14,337,040
G
Mrpl23
mitochondrial ribosomal protein L23
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MRPL23 mRNA
CTD
PMID:14729362
NCBI chr 1:207,116,930...207,124,702
Ensembl chr 1:197,687,347...197,695,222
G
Mrpl34
mitochondrial ribosomal protein L34
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MRPL34 mRNA
CTD
PMID:15336504
NCBI chr16:18,186,447...18,187,182
Ensembl chr16:18,151,342...18,153,208
G
Mrpl48
mitochondrial ribosomal protein L48
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of MRPL48 mRNA tert-Butylhydroperoxide results in decreased expression of MRPL48 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 1:154,896,663...154,939,285
Ensembl chr 1:154,896,663...154,939,281
G
Mrps14
mitochondrial ribosomal protein S14
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MRPS14 mRNA
CTD
PMID:15336504
NCBI chr13:74,962,597...74,968,344
Ensembl chr13:72,408,558...72,434,915
G
Msh6
mutS homolog 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MSH6 mRNA
CTD
PMID:15336504
NCBI chr 6:12,316,190...12,333,505
Ensembl chr 6:6,562,632...6,579,956
G
Msln
mesothelin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MSLN mRNA
CTD
PMID:15336504
NCBI chr10:15,276,489...15,285,921
Ensembl chr10:14,771,961...14,777,643
G
Msn
moesin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MSN mRNA
CTD
PMID:15336504
NCBI chr X:65,005,546...65,073,512
Ensembl chr X:60,995,951...61,065,628
G
Msra
methionine sulfoxide reductase A
decreases response to substance decreases expression multiple interactions
ISO
MSRA protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in decreased expression of MSRA protein Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of MSRA protein]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of MSRA protein]
CTD
PMID:15914630 PMID:38272317
NCBI chr15:42,514,818...42,853,278
Ensembl chr15:38,351,445...38,676,585
G
Msrb1
methionine sulfoxide reductase B1
decreases response to substance increases expression
ISO
MSRB1 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of MSRB1 mRNA
CTD
PMID:15003993 PMID:15914630
NCBI chr10:14,269,414...14,275,140
Ensembl chr10:13,764,883...13,770,609
G
Msrb2
methionine sulfoxide reductase B2
decreases response to substance decreases expression multiple interactions
ISO
MSRB2 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in decreased expression of MSRB2 protein Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of MSRB2 protein]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of MSRB2 protein]
CTD
PMID:15914630 PMID:38272317
NCBI chr17:86,882,750...86,908,392
Ensembl chr17:81,974,196...82,000,043
G
Msrb3
methionine sulfoxide reductase B3
decreases response to substance
ISO
MSRB3 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15914630
NCBI chr 7:58,188,827...58,311,459
Ensembl chr 7:56,303,308...56,425,496
G
Mt1
metallothionein 1
affects response to substance decreases response to substance
ISO
MT1 protein affects the susceptibility to tert-Butylhydroperoxide MT1 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:7890668 PMID:16150881
NCBI chr19:10,831,959...10,832,975
Ensembl chr19:10,826,032...10,827,049 Ensembl chr17:10,826,032...10,827,049 Ensembl chr X:10,826,032...10,827,049
G
Mt2
metallothionein 2
multiple interactions decreases response to substance increases expression affects response to substance
ISO
MT2A protein inhibits the reaction [tert-Butylhydroperoxide results in increased abundance of Reactive Oxygen Species]; MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of HMOX1 mRNA]; MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of SOD2 mRNA]; MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of TXNRD1 mRNA] MT2A protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of MT2A mRNA MT2 protein results in decreased susceptibility to tert-Butylhydroperoxide MT2 protein affects the susceptibility to tert-Butylhydroperoxide
CTD
PMID:7890668 PMID:12414654 PMID:16150881 PMID:16402917 PMID:16636651
NCBI chr19:10,837,934...10,838,708
Ensembl chr19:10,832,002...10,832,784
G
Mtarc1
mitochondrial amidoxime reducing component 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of MTARC1 mRNA
CTD
PMID:23410634
NCBI chr13:98,854,235...98,894,208
Ensembl chr13:96,339,757...96,397,796
G
Mtf1
metal-regulatory transcription factor 1
increases response to substance
ISO
MTF1 gene mutant form results in increased susceptibility to tert-Butylhydroperoxide
CTD
PMID:15378601
NCBI chr 5:142,347,024...142,391,810
Ensembl chr 5:137,062,376...137,107,136
G
Mtg1
mitochondrial ribosome-associated GTPase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MTG1 mRNA
CTD
PMID:15336504
NCBI chr 1:204,361,176...204,373,917
Ensembl chr 1:194,931,531...194,944,277
G
Mtor
mechanistic target of rapamycin kinase
multiple interactions
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MTOR mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of MTOR mRNA]
CTD
PMID:35690295
NCBI chr 5:164,167,985...164,277,438
Ensembl chr 5:158,884,804...158,994,311
G
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MTR mRNA
CTD
PMID:27509014
NCBI chr17:62,911,705...62,996,544
Ensembl chr17:58,220,071...58,304,822
G
Mtx1
Metaxin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MTX1 mRNA
CTD
PMID:14729362
NCBI chr 2:176,913,225...176,919,148
Ensembl chr 2:174,615,461...174,620,982
G
Muc1
mucin 1, cell surface associated
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MUC1 mRNA
CTD
PMID:15336504
NCBI chr 2:176,933,312...176,938,497
Ensembl chr 2:174,635,995...174,640,733
G
Mx1
MX dynamin like GTPase 1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MX1 mRNA tert-Butylhydroperoxide results in increased expression of MX1 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr11:50,269,056...50,294,699
Ensembl chr11:36,799,660...36,823,507
G
Mxd1
max dimerization protein 1
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of MXD1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of MXD1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of MXD1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of MXD1 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of MXD1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of MXD1 mRNA]
CTD
PMID:20847119
NCBI chr 4:120,654,731...120,678,972
Ensembl chr 4:119,097,353...119,117,751
G
Myc
MYC proto-oncogene, bHLH transcription factor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MYC mRNA
CTD
PMID:27509014
NCBI chr 7:95,483,105...95,488,031
Ensembl chr 7:93,593,705...93,598,630
G
Mydgf
myeloid-derived growth factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MYDGF mRNA
CTD
PMID:15336504
NCBI chr 9:1,086,825...1,095,968
Ensembl chr 9:1,000,722...1,008,822
G
Mylk
myosin light chain kinase
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of MYLK mRNA tert-Butylhydroperoxide affects the expression of MYLK mRNA
CTD
PMID:12419474 PMID:23410634
NCBI chr11:79,288,243...79,535,450
Ensembl chr11:65,783,008...66,030,261
G
Myo10
myosin X
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MYO10 mRNA
CTD
PMID:15336504
NCBI chr 2:77,831,532...78,036,137
Ensembl chr 2:76,100,987...76,303,030
G
Myo5a
myosin VA
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MYO5A mRNA
CTD
PMID:15336504
NCBI chr 8:84,692,524...84,860,564
Ensembl chr 8:75,812,412...75,975,918
G
Myo5c
myosin VC
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of MYO5C mRNA
CTD
PMID:15336504
NCBI chr 8:84,870,031...84,946,996
Ensembl chr 8:75,989,528...76,066,483
G
Myo7a
myosin VIIA
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of MYO7A mRNA
CTD
PMID:14729362
NCBI chr 1:161,755,110...161,825,397
Ensembl chr 1:152,344,448...152,414,157
G
N4bp1
Nedd4 binding protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of N4BP1 mRNA
CTD
PMID:15336504
NCBI chr19:36,396,082...36,446,835
Ensembl chr19:20,222,776...20,273,570
G
N4bp2l2
NEDD4 binding protein 2-like 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of N4BP2L2 mRNA
CTD
PMID:15336504
NCBI chr12:4,972,967...5,038,027
Ensembl chr12:103,590...197,784
G
Naa15
N(alpha)-acetyltransferase 15, NatA auxiliary subunit
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NAA15 mRNA
CTD
PMID:15336504
NCBI chr 2:137,608,883...137,671,618
Ensembl chr 2:135,457,948...135,520,756
G
Nap1l1
nucleosome assembly protein 1-like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NAP1L1 mRNA
CTD
PMID:15336504
NCBI chr 7:48,819,464...48,844,108
Ensembl chr 7:46,933,356...46,956,593
G
Napsa
napsin A aspartic peptidase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NAPSA mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:104,200,967...104,213,603
Ensembl chr 1:95,064,900...95,077,094
G
Nav3
neuron navigator 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NAV3 mRNA
CTD
PMID:15336504
NCBI chr 7:46,938,577...47,726,839
Ensembl chr 7:45,054,296...45,840,698
G
Naxd
NAD(P)HX dehydratase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NAXD mRNA
CTD
PMID:15336504
NCBI chr16:77,986,148...78,004,200
Ensembl chr16:77,987,726...78,004,192
G
Ncam1
neural cell adhesion molecule 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NCAM1 mRNA
CTD
PMID:15336504
NCBI chr 8:58,762,088...59,062,131
Ensembl chr 8:49,865,633...50,166,014
G
Ncapd2
non-SMC condensin I complex, subunit D2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NCAPD2 mRNA
CTD
PMID:15336504
NCBI chr 4:159,655,051...159,677,938
Ensembl chr 4:157,968,815...157,992,020
G
Ncapg2
non-SMC condensin II complex, subunit G2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NCAPG2 mRNA
CTD
PMID:15336504
NCBI chr 6:143,484,651...143,561,850
Ensembl chr 6:137,342,943...137,415,159
G
Ncf1
neutrophil cytosolic factor 1
increases expression multiple interactions affects localization
EXP ISO
tert-Butylhydroperoxide results in increased expression of NCF1 mRNA 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide affects the localization of NCF1 protein]
CTD
PMID:22659508 PMID:29111459
NCBI chr12:28,121,816...28,131,080
Ensembl chr12:22,485,451...22,494,646
G
Ncf4
neutrophil cytosolic factor 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NCF4 mRNA
CTD
PMID:14729362
NCBI chr 7:111,705,926...111,723,893
Ensembl chr 7:109,826,020...109,843,389
G
Ncor2
nuclear receptor co-repressor 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NCOR2 mRNA
CTD
PMID:15336504
NCBI chr12:37,127,736...37,289,612
Ensembl chr12:31,466,412...31,628,319
G
Ndc80
NDC80 kinetochore complex component
affects expression
ISO
tert-Butylhydroperoxide affects the expression of NDC80 mRNA
CTD
PMID:23410634
NCBI chr 9:118,853,806...118,887,582
Ensembl chr 9:111,407,191...111,440,924
G
Ndrg1
N-myc downstream regulated 1
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of NDRG1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of NDRG1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of NDRG1 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NDRG1 mRNA]
CTD
PMID:20847119
NCBI chr 7:100,573,526...100,614,902
Ensembl chr 7:98,684,487...98,725,880
G
Ndrg3
NDRG family member 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NDRG3 mRNA
CTD
PMID:15336504
NCBI chr 3:166,007,556...166,070,981
Ensembl chr 3:145,548,041...145,650,873 Ensembl chr 3:145,548,041...145,650,873
G
Ndrg4
NDRG family member 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NDRG4 mRNA
CTD
PMID:15336504
NCBI chr19:9,357,470...9,393,465
Ensembl chr19:9,351,404...9,386,914
G
Ndufa3
NADH:ubiquinone oxidoreductase subunit A3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NDUFA3 mRNA
CTD
PMID:15003993
NCBI chr 1:74,512,928...74,515,558
Ensembl chr 1:65,597,578...65,600,235
G
Ndufa7
NADH:ubiquinone oxidoreductase subunit A7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NDUFA7 mRNA
CTD
PMID:15336504
NCBI chr 7:15,311,446...15,324,226
Ensembl chr 7:14,609,146...14,631,976
G
Ndufb2
NADH:ubiquinone oxidoreductase subunit B2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NDUFB2 mRNA
CTD
PMID:15336504
NCBI chr 4:69,334,307...69,341,394
Ensembl chr15:46,536,062...46,536,851 Ensembl chr 4:46,536,062...46,536,851
G
Ndufb7
NADH:ubiquinone oxidoreductase subunit B7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NDUFB7 mRNA
CTD
PMID:15336504
NCBI chr19:41,472,953...41,477,291
Ensembl chr19:24,568,241...24,572,579
G
Ndufs7
NADH:ubiquinone oxidoreductase core subunit S7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NDUFS7 mRNA
CTD
PMID:15336504
NCBI chr 7:10,103,226...10,110,862
Ensembl chr 7:9,450,392...9,460,195
G
Necap1
NECAP endocytosis associated 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of NECAP1 mRNA
CTD
PMID:23410634
NCBI chr 4:156,103,935...156,119,068
Ensembl chr 4:156,103,988...156,119,068
G
Nedd4l
NEDD4 like E3 ubiquitin protein ligase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NEDD4L mRNA
CTD
PMID:15336504
NCBI chr18:60,663,918...60,996,824
Ensembl chr18:58,393,509...58,723,137
G
Nelfcd
negative elongation factor complex member C/D
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NELFCD mRNA
CTD
PMID:15336504
NCBI chr 3:183,631,968...183,643,088
Ensembl chr 3:163,213,762...163,224,884
G
Nes
nestin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NES mRNA
CTD
PMID:15003993
NCBI chr 2:175,735,715...175,745,631
Ensembl chr 2:173,438,734...173,447,777
G
Nf2
NF2, moesin-ezrin-radixin like (MERLIN) tumor suppressor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NF2 mRNA
CTD
PMID:12419474
NCBI chr14:83,850,894...83,934,263
Ensembl chr14:79,627,399...79,710,667
G
Nfatc1
nuclear factor of activated T-cells 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NFATC1 mRNA
CTD
PMID:12419474
NCBI chr18:76,321,386...76,430,997
Ensembl chr18:74,046,904...74,156,028
G
Nfatc2ip
nuclear factor of activated T-cells 2 interacting protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NFATC2IP mRNA
CTD
PMID:15336504
NCBI chr 1:190,385,416...190,403,309
Ensembl chr 1:180,955,043...180,971,747
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions decreases response to substance decreases expression increases expression affects localization
ISO
NFE2L2 protein affects the reaction [3-methylquercetin results in decreased susceptibility to tert-Butylhydroperoxide]; NFE2L2 protein affects the susceptibility to [tert-Butylhydroperoxide results in increased abundance of Reactive Oxygen Species] NFE2L2 protein results in decreased susceptibility to tert-Butylhydroperoxide Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 mRNA]; Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein]; nectandrin-B inhibits the reaction [tert-Butylhydroperoxide affects the localization of NFE2L2 protein]; NFE2L2 mRNA affects the reaction [plumbagin results in decreased susceptibility to tert-Butylhydroperoxide]; Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 mRNA]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein]; sodium boranocarbonate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NFE2L2 mRNA] tert-Butylhydroperoxide results in decreased expression of NFE2L2 mRNA; tert-Butylhydroperoxide results in decreased expression of NFE2L2 protein tert-Butylhydroperoxide results in increased expression of NFE2L2 mRNA
CTD
PMID:19647727 PMID:20028456 PMID:20100471 PMID:20932822 PMID:24211276 PMID:27050144 PMID:27509014 PMID:27511913 PMID:28025122 PMID:30273691 PMID:38272317 More...
NCBI chr 3:81,001,529...81,031,165
Ensembl chr 3:60,594,242...60,621,737
G
Nfic
nuclear factor I/C
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NFIC mRNA
CTD
PMID:15003993
NCBI chr 7:8,928,423...8,963,455
Ensembl chr 7:8,253,361...8,309,936
G
Nfix
nuclear factor I X
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NFIX mRNA
CTD
PMID:12419474
NCBI chr19:40,259,873...40,356,966
Ensembl chr19:23,355,498...23,448,265
G
Nfkb1
nuclear factor kappa B subunit 1
decreases expression increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in decreased expression of NFKB1 mRNA tert-Butylhydroperoxide results in increased expression of NFKB1 mRNA Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NFKB1 protein]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NFKB1 protein]
CTD
PMID:12419474 PMID:16704919 PMID:24394546
NCBI chr 2:226,689,745...226,805,897
Ensembl chr 2:224,016,214...224,110,404
G
Nfkbia
NFKB inhibitor alpha
increases expression increases phosphorylation multiple interactions affects expression
ISO
tert-Butylhydroperoxide results in increased expression of NFKBIA mRNA tert-Butylhydroperoxide results in increased phosphorylation of NFKBIA protein Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of NFKBIA protein] tert-Butylhydroperoxide affects the expression of NFKBIA mRNA
CTD
PMID:15336504 PMID:15879681 PMID:23410634
NCBI chr 6:78,593,844...78,597,307
Ensembl chr 6:72,858,712...72,861,941
G
Nfkbie
NFKB inhibitor epsilon
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NFKBIE mRNA
CTD
PMID:15336504
NCBI chr 9:22,941,037...22,947,872
Ensembl chr 9:15,436,941...15,450,437
G
Nfyb
nuclear transcription factor Y subunit beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NFYB mRNA
CTD
PMID:15336504
NCBI chr 7:22,852,543...22,868,116
Ensembl chr 7:20,964,993...20,980,565
G
Ngf
nerve growth factor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NGF mRNA
CTD
PMID:15003993
NCBI chr 2:192,589,580...192,642,971
Ensembl chr 2:189,901,058...189,954,452
G
Nip7
nucleolar pre-rRNA processing protein NIP7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NIP7 mRNA
CTD
PMID:15336504
NCBI chr19:51,872,306...51,874,448
Ensembl chr19:34,962,557...34,964,711
G
Nisch
nischarin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NISCH mRNA
CTD
PMID:15336504
NCBI chr16:6,370,809...6,407,104
Ensembl chr16:6,364,374...6,400,668
G
Nit1
nitrilase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NIT1 mRNA
CTD
PMID:14729362
NCBI chr13:86,302,334...86,305,770
Ensembl chr13:83,765,941...83,773,332
G
Nkain1
Sodium/potassium transporting ATPase interacting 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NKAIN1 mRNA
CTD
PMID:15003993
NCBI chr 5:142,747,702...142,792,665
Ensembl chr 5:142,747,505...142,791,863
G
Nkd1
NKD inhibitor of WNT signaling pathway 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of NKD1 mRNA
CTD
PMID:23410634
NCBI chr19:34,649,803...34,722,846
Ensembl chr19:18,476,344...18,549,380
G
Nkiras1
NFKB inhibitor interacting Ras-like 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NKIRAS1 mRNA
CTD
PMID:15003993
NCBI chr15:9,924,316...9,934,538
Ensembl chr15:7,493,531...7,503,854
G
Nktr
natural killer cell triggering receptor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NKTR mRNA
CTD
PMID:15336504
NCBI chr 8:130,255,541...130,298,001
Ensembl chr 8:121,382,436...121,418,314
G
Nkx3-1
NK3 homeobox 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NKX3-1 mRNA
CTD
PMID:15336504
NCBI chr15:50,883,661...50,886,253
Ensembl chr15:44,473,851...44,476,441
G
Nmd3
NMD3 ribosome export adaptor
affects expression
ISO
tert-Butylhydroperoxide affects the expression of NMD3 mRNA
CTD
PMID:23410634
NCBI chr 2:156,285,773...156,348,394
Ensembl chr 2:154,013,020...154,039,259
G
Nme2
NME/NM23 nucleoside diphosphate kinase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NME2 mRNA
CTD
PMID:12419474
NCBI chr10:79,394,999...79,400,418
Ensembl chr10:78,897,770...78,903,538 Ensembl chr20:78,897,770...78,903,538
G
Nmnat3
nicotinamide nucleotide adenylyltransferase 3
decreases response to substance
ISO
NMNAT3 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:18463239
NCBI chr 8:107,771,124...107,888,528
Ensembl chr 8:98,873,398...99,020,645
G
Nmrk1
nicotinamide riboside kinase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NMRK1 mRNA
CTD
PMID:15336504
NCBI chr 1:225,475,975...225,503,414
Ensembl chr 1:216,049,437...216,076,791
G
Nmt1
N-myristoyltransferase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NMT1 mRNA
CTD
PMID:15336504
NCBI chr10:88,488,918...88,525,496
Ensembl chr10:87,988,826...88,022,648
G
Nnt
nicotinamide nucleotide transhydrogenase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NNT mRNA
CTD
PMID:15336504
NCBI chr 2:53,144,157...53,237,857
Ensembl chr 2:51,411,413...51,504,823
G
Noc4l
nucleolar complex associated 4 homolog
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NOC4L mRNA
CTD
PMID:15336504
NCBI chr12:51,675,852...51,680,392
Ensembl chr12:46,016,069...46,020,614
G
Nono
non-POU domain containing, octamer-binding
decreases expression multiple interactions
ISO
tert-Butylhydroperoxide results in decreased expression of NONO mRNA; tert-Butylhydroperoxide results in decreased expression of NONO protein Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NONO mRNA]; Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NONO protein]; NONO protein promotes the reaction [salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 mRNA]]; NONO protein promotes the reaction [salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 protein]]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NONO mRNA]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NONO protein]
CTD
PMID:15336504 PMID:38272317
NCBI chr X:70,594,116...70,611,976
Ensembl chr X:66,554,098...66,571,952
G
Nos2
nitric oxide synthase 2
multiple interactions increases expression
EXP
resveratrol inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NOS2 mRNA]; Silymarin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NOS2 mRNA]; tert-Butylhydroperoxide promotes the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]
CTD
PMID:10231168 PMID:18812229
NCBI chr10:64,313,335...64,349,221
Ensembl chr10:63,815,308...63,851,210
G
Nox4
NADPH oxidase 4
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of NOX4 protein 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of NOX4 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of NOX4 protein]; tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]
CTD
PMID:29111459
NCBI chr 1:150,313,736...150,491,480
Ensembl chr 1:140,901,097...141,077,406
G
Npc1
NPC intracellular cholesterol transporter 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NPC1 mRNA
CTD
PMID:15336504
NCBI chr18:3,654,237...3,699,853
Ensembl chr18:3,379,482...3,425,049
G
Nphp4
nephrocystin 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NPHP4 mRNA
CTD
PMID:15336504
NCBI chr 5:168,270,522...168,356,393
Ensembl chr 5:162,988,370...163,073,706
G
Nppb
natriuretic peptide B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NPPB mRNA
CTD
PMID:15336504
NCBI chr 5:163,699,955...163,701,314
Ensembl chr 5:158,416,866...158,418,168
G
Nqo1
NAD(P)H quinone dehydrogenase 1
increases expression decreases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of NQO1 mRNA tert-Butylhydroperoxide results in decreased expression of NQO1 mRNA; tert-Butylhydroperoxide results in decreased expression of NQO1 protein Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 mRNA]; Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 protein]; NONO protein promotes the reaction [salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 mRNA]]; NONO protein promotes the reaction [salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 protein]]; rutecarpine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 protein]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 mRNA]; salvianolic acid B inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 protein]; sodium boranocarbonate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of NQO1 mRNA]
CTD
PMID:12414654 PMID:28025122 PMID:30273691 PMID:30547568 PMID:35077135 PMID:38272317 More...
NCBI chr19:52,205,374...52,220,267
Ensembl chr19:35,295,573...35,310,557
G
Nqo2
N-ribosyldihydronicotinamide:quinone dehydrogenase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NQO2 mRNA
CTD
PMID:15336504
NCBI chr17:31,114,825...31,144,062
Ensembl chr17:30,909,187...30,938,320
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of NR0B2 mRNA
CTD
PMID:23410634
NCBI chr 5:151,063,160...151,066,475
Ensembl chr 5:145,779,294...145,782,609
G
Nr1h4
nuclear receptor subfamily 1, group H, member 4
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of NR1H4 mRNA tert-Butylhydroperoxide affects the expression of NR1H4 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 7:25,733,471...25,829,440
Ensembl chr 7:23,846,122...23,942,047
G
Nr2f6
nuclear receptor subfamily 2, group F, member 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NR2F6 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr16:18,080,003...18,087,449
Ensembl chr16:18,046,013...18,053,459
G
Nr3c1
nuclear receptor subfamily 3, group C, member 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of NR3C1 mRNA
CTD
PMID:23410634
NCBI chr18:31,522,783...31,644,508
Ensembl chr18:31,271,681...31,393,375
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NR4A1 mRNA
CTD
PMID:12414654
NCBI chr 7:134,247,153...134,268,044
Ensembl chr 7:132,374,840...132,389,297
G
Nrbf2
nuclear receptor binding factor 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NRBF2 mRNA
CTD
PMID:15336504
NCBI chr20:21,307,389...21,325,724
Ensembl chr20:21,308,576...21,326,818
G
Nsd2
nuclear receptor binding SET domain protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NSD2 mRNA
CTD
PMID:15336504
NCBI chr14:81,057,727...81,135,866
Ensembl chr14:76,835,637...76,913,641
G
Nsmaf
neutral sphingomyelinase activation associated factor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NSMAF mRNA
CTD
PMID:15336504
NCBI chr 5:24,315,319...24,378,346
Ensembl chr 5:19,518,348...19,577,627
G
Ntrk2
neurotrophic receptor tyrosine kinase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NTRK2 mRNA
CTD
PMID:15336504
NCBI chr17:5,560,558...5,875,899
Ensembl chr17:5,559,043...5,869,136
G
Nucb1
nucleobindin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NUCB1 mRNA
CTD
PMID:15336504
NCBI chr 1:105,104,793...105,135,730
Ensembl chr 1:95,968,326...96,003,220
G
Nudt11
nudix hydrolase 11
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NUDT11 mRNA
CTD
PMID:15336504
NCBI chr X:18,998,587...19,005,208
Ensembl chr X:16,326,598...16,333,145
G
Nudt21
nudix hydrolase 21
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NUDT21 mRNA tert-Butylhydroperoxide results in increased expression of NUDT21 mRNA
CTD
PMID:15336504
NCBI chr19:10,980,797...10,996,903
Ensembl chr19:10,974,241...10,991,682
G
Nudt6
nudix hydrolase 6
affects expression
ISO
tert-Butylhydroperoxide affects the expression of NUDT6 mRNA
CTD
PMID:23410634
NCBI chr 2:122,218,031...122,234,488
Ensembl chr 2:120,290,847...120,306,230
G
Nup188
nucleoporin 188
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NUP188 mRNA
CTD
PMID:15336504
NCBI chr 3:33,957,778...34,014,122
Ensembl chr 3:13,559,990...13,616,307
G
Nup205
nucleoporin 205
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NUP205 mRNA
CTD
PMID:15336504
NCBI chr 4:64,822,051...64,887,996
Ensembl chr 4:63,854,783...63,920,844
G
Nup37
nucleoporin 37
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of NUP37 mRNA
CTD
PMID:15336504
NCBI chr 7:22,556,544...22,609,622
Ensembl chr 7:22,573,764...22,609,616
G
Nup58
nucleoporin 58
increases methylation increases expression
ISO
tert-Butylhydroperoxide results in increased methylation of NUP58 gene tert-Butylhydroperoxide results in increased expression of NUP58 mRNA
CTD
PMID:27509014
NCBI chr15:38,534,340...38,583,959
Ensembl chr15:34,358,277...34,407,060
G
Nusap1
nucleolar and spindle associated protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of NUSAP1 mRNA
CTD
PMID:15336504
NCBI chr 3:127,057,220...127,092,779
Ensembl chr 3:106,603,289...106,633,624
G
Oas1a
2'-5' oligoadenylate synthetase 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OAS1 mRNA
CTD
PMID:15336504
NCBI chr12:41,330,423...41,341,130
Ensembl chr12:35,669,801...35,680,517
G
Oas3
2'-5'-oligoadenylate synthetase 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OAS3 mRNA
CTD
PMID:15336504
NCBI chr12:41,439,645...41,463,392
Ensembl chr12:35,779,022...35,802,781
G
Oaz1
ornithine decarboxylase antizyme 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OAZ1 mRNA
CTD
PMID:15336504
NCBI chr 7:9,534,530...9,536,990
Ensembl chr 7:8,883,851...8,886,310
G
Obsl1
obscurin like cytoskeletal adaptor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OBSL1 mRNA
CTD
PMID:15336504
NCBI chr 9:84,416,447...84,442,415
Ensembl chr 9:76,974,253...76,993,560
G
Ocel1
occludin/ELL domain containing 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OCEL1 mRNA
CTD
PMID:15336504
NCBI chr16:18,076,428...18,079,068
Ensembl chr16:18,043,309...18,045,078
G
Ocln
occludin
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of OCLN protein
CTD
PMID:34303734
NCBI chr 2:33,391,303...33,442,207
Ensembl chr 2:31,657,220...31,764,150
G
Odc1
ornithine decarboxylase 1
increases activity
ISO
tert-Butylhydroperoxide results in increased activity of ODC1 protein
CTD
PMID:2013121
NCBI chr 6:46,058,439...46,065,148
Ensembl chr 6:40,329,964...40,336,440
G
Ogdh
oxoglutarate dehydrogenase
multiple interactions decreases activity
EXP
[GLRX protein co-treated with Glutathione] inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of OGDH protein]; Dithiothreitol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of OGDH protein]
CTD
PMID:12680778
NCBI chr14:85,363,949...85,431,405
Ensembl chr14:81,150,091...81,217,479
G
Ogfod3
2-oxoglutarate and iron-dependent oxygenase domain containing 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OGFOD3 mRNA
CTD
PMID:15336504
NCBI chr10:106,452,334...106,480,632
Ensembl chr10:106,452,329...106,480,134
G
Ogt
O-linked N-acetylglucosamine (GlcNAc) transferase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OGT mRNA
CTD
PMID:15336504
NCBI chr X:70,811,317...70,856,123
Ensembl chr X:66,771,349...66,816,146
G
Ola1
Obg-like ATPase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of OLA1 mRNA
CTD
PMID:15336504
NCBI chr 3:78,374,440...78,493,401
Ensembl chr 3:57,966,896...58,084,480
G
Opn3
opsin 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OPN3 mRNA
CTD
PMID:15336504
NCBI chr13:90,121,560...90,152,076
Ensembl chr13:87,589,333...87,619,847
G
Os9
OS9, endoplasmic reticulum lectin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OS9 mRNA
CTD
PMID:15336504
NCBI chr 7:64,802,517...64,829,185
Ensembl chr 7:62,915,515...62,943,745
G
Osbpl1a
oxysterol binding protein-like 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OSBPL1A mRNA
CTD
PMID:15336504
NCBI chr18:4,178,734...4,383,511
Ensembl chr18:3,904,006...4,094,585
G
Oser1
oxidative stress responsive serine-rich 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OSER1 mRNA
CTD
PMID:15336504
NCBI chr 3:172,486,417...172,504,607
Ensembl chr 3:152,066,975...152,085,149
G
Osgin1
oxidative stress induced growth inhibitor 1
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of OSGIN1 mRNA tert-Butylhydroperoxide affects the expression of OSGIN1 mRNA
CTD
PMID:12414654 PMID:23410634
NCBI chr19:64,380,336...64,409,165
Ensembl chr19:47,492,171...47,500,516
G
Osr2
odd-skipped related transcription factor 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of OSR2 mRNA
CTD
PMID:15336504
NCBI chr 7:68,372,500...68,380,195
Ensembl chr 7:66,487,839...66,495,224
G
P4ha1
prolyl 4-hydroxylase subunit alpha 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of P4HA1 mRNA
CTD
PMID:15336504
NCBI chr20:27,784,696...27,895,785
Ensembl chr20:27,302,141...27,352,786
G
P4htm
prolyl 4-hydroxylase, transmembrane
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of P4HTM mRNA
CTD
PMID:15336504
NCBI chr 8:118,153,158...118,172,199
Ensembl chr 8:109,274,626...109,292,473
G
Pafah1b1
platelet-activating factor acetylhydrolase 1b, regulatory subunit 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PAFAH1B1 mRNA
CTD
PMID:15336504
NCBI chr10:60,031,441...60,090,259
Ensembl chr10:59,534,117...59,591,808
G
Pafah2
platelet-activating factor acetylhydrolase 2
multiple interactions decreases response to substance affects localization affects response to substance
ISO
PAFAH2 protein inhibits the reaction [tert-Butylhydroperoxide results in increased activity of CASP3 protein] PAFAH2 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide affects the localization of PAFAH2 protein PAFAH2 protein affects the susceptibility to tert-Butylhydroperoxide
CTD
PMID:12406338 PMID:18024956
NCBI chr 5:146,607,050...146,636,203
Ensembl chr 5:146,613,498...146,634,943
G
Palb2
partner and localizer of BRCA2
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of PALB2 intron
CTD
PMID:29432895
NCBI chr 1:186,096,312...186,120,284
Ensembl chr 1:176,665,076...176,688,990
G
Palld
palladin, cytoskeletal associated protein
affects expression
ISO
tert-Butylhydroperoxide affects the expression of PALLD mRNA
CTD
PMID:23410634
NCBI chr16:33,238,943...33,632,236
Ensembl chr16:27,981,354...28,621,337
G
Pam
peptidylglycine alpha-amidating monooxygenase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PAM mRNA
CTD
PMID:15336504
NCBI chr 9:105,445,812...105,719,287
Ensembl chr 9:98,122,916...98,271,965
G
Pan2
poly(A) specific ribonuclease subunit PAN2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PAN2 mRNA
CTD
PMID:15336504
NCBI chr 7:1,313,654...1,332,252
Ensembl chr 7:729,562...747,744
G
Papola
poly (A) polymerase alpha
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PAPOLA mRNA
CTD
PMID:15336504
NCBI chr 6:130,446,236...130,499,371
Ensembl chr 6:124,682,105...124,734,468
G
Papss1
3'-phosphoadenosine 5'-phosphosulfate synthase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PAPSS1 mRNA
CTD
PMID:15336504
NCBI chr 2:222,646,103...222,788,475
Ensembl chr 2:220,040,312...220,114,395
G
Papss2
3'-phosphoadenosine 5'-phosphosulfate synthase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PAPSS2 mRNA
CTD
PMID:15336504
NCBI chr 1:239,867,597...239,952,614
Ensembl chr 1:230,454,426...230,539,331
G
Pard3
par-3 family cell polarity regulator
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PARD3 mRNA
CTD
PMID:15336504
NCBI chr19:71,977,420...72,527,273
Ensembl chr19:55,080,282...55,629,778
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions increases cleavage decreases expression
ISO EXP
6,7-dihydroxyflavone inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein] Curcumin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein] 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; acetovanillone inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; Drugs, Chinese Herbal inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PARP1 protein]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; nectandrin-B inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in increased cleavage of PARP1 protein]
CTD
PMID:15569404 PMID:16753784 PMID:27050144 PMID:27511913 PMID:28733231 PMID:29111459 PMID:38053484 More...
NCBI chr13:94,839,484...94,871,295
Ensembl chr13:92,307,586...92,339,404
G
Pask
PAS domain containing serine/threonine kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PASK mRNA
CTD
PMID:15336504
NCBI chr 9:101,291,673...101,333,288
Ensembl chr 9:93,844,278...93,885,111
G
Pawr
pro-apoptotic WT1 regulator
affects expression
ISO
tert-Butylhydroperoxide affects the expression of PAWR mRNA
CTD
PMID:23410634
NCBI chr 7:45,531,480...45,611,492
Ensembl chr 7:43,645,084...43,725,028
G
Pax6
paired box 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PAX6 mRNA
CTD
PMID:15336504
NCBI chr 3:112,590,034...112,611,771
Ensembl chr 3:92,135,637...92,157,014
G
Paxip1
PAX interacting protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PAXIP1 mRNA
CTD
PMID:15336504
NCBI chr 4:8,258,930...8,310,490
Ensembl chr 4:7,525,004...7,576,548
G
Pbx1
PBX homeobox 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PBX1 mRNA
CTD
PMID:15336504
NCBI chr13:82,811,664...83,121,447
Ensembl chr13:80,278,770...80,588,594
G
Pbx2
PBX homeobox 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PBX2 mRNA
CTD
PMID:15336504
NCBI chr20:4,156,107...4,161,503
Ensembl chr20:4,151,500...4,156,425
G
Pbx3
PBX homeobox 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PBX3 mRNA
CTD
PMID:15336504
NCBI chr 3:37,886,241...38,079,956
Ensembl chr 3:17,488,693...17,682,791
G
Pcdh9
protocadherin 9
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PCDH9 mRNA
CTD
PMID:15336504
NCBI chr15:75,748,472...76,646,644 NCBI chr15:76,078,024...76,127,778
Ensembl chr15:69,340,645...70,237,538
G
Pcid2
PCI domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PCID2 mRNA
CTD
PMID:15336504
NCBI chr16:83,125,386...83,150,851
Ensembl chr16:76,423,245...76,448,712
G
Pcmtd2
protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PCMTD2 mRNA
CTD
PMID:15336504
NCBI chr 3:189,337,758...189,360,525
Ensembl chr 3:168,960,305...168,979,497
G
Pcolce
procollagen C-endopeptidase enhancer
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PCOLCE mRNA
CTD
PMID:15336504
NCBI chr12:24,720,972...24,727,287
Ensembl chr12:19,084,210...19,090,508
G
Pcolce2
procollagen C-endopeptidase enhancer 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PCOLCE2 mRNA
CTD
PMID:15336504
NCBI chr 8:105,073,086...105,130,725
Ensembl chr 8:96,193,461...96,251,114
G
Pcyox1
prenylcysteine oxidase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PCYOX1 mRNA
CTD
PMID:15336504
NCBI chr 4:120,389,545...120,400,382
Ensembl chr 4:118,830,638...118,842,951
G
Pcyox1l
prenylcysteine oxidase 1 like
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PCYOX1L mRNA
CTD
PMID:15336504
NCBI chr18:57,420,971...57,431,632
Ensembl chr18:55,150,650...55,161,327
G
Pdap1
PDGFA associated protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDAP1 mRNA
CTD
PMID:15336504
NCBI chr12:14,584,414...14,594,641
Ensembl chr12:9,470,574...9,535,374
G
Pdcd4
programmed cell death 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDCD4 mRNA
CTD
PMID:15336504
NCBI chr 1:262,912,659...262,949,581
Ensembl chr 1:252,921,392...252,944,275
G
Pdcd5
programmed cell death 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PDCD5 mRNA
CTD
PMID:14729362
NCBI chr 1:97,442,755...97,448,084
Ensembl chr 1:88,305,869...88,311,200
G
Pde4dip
phosphodiesterase 4D interacting protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PDE4DIP mRNA
CTD
PMID:15336504
NCBI chr 2:187,982,002...188,178,937
Ensembl chr 2:185,293,214...185,468,379
G
Pdgfa
platelet derived growth factor subunit A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PDGFA mRNA
CTD
PMID:15336504
NCBI chr12:20,759,366...20,780,337
Ensembl chr12:15,645,541...15,666,497
G
Pdhx
pyruvate dehydrogenase complex, component X
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PDHX mRNA
CTD
PMID:15336504
NCBI chr 3:109,826,579...109,886,869
Ensembl chr 3:89,371,497...89,431,773
G
Pdia4
protein disulfide isomerase family A, member 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDIA4 mRNA
CTD
PMID:15003993
NCBI chr 4:78,134,144...78,153,191
Ensembl chr 4:76,803,198...76,822,107
G
Pdia5
protein disulfide isomerase family A, member 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDIA5 mRNA
CTD
PMID:15003993
NCBI chr11:78,777,436...78,892,370
Ensembl chr11:65,272,155...65,359,084
G
Pdia6
protein disulfide isomerase family A, member 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDIA6 mRNA
CTD
PMID:15003993
NCBI chr 6:45,791,704...45,808,947
Ensembl chr 6:40,062,926...40,080,613
G
Pdlim3
PDZ and LIM domain 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDLIM3 mRNA
CTD
PMID:15336504
NCBI chr16:53,085,020...53,116,495
Ensembl chr16:46,352,467...46,383,657
G
Pdlim4
PDZ and LIM domain 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PDLIM4 mRNA
CTD
PMID:15336504
NCBI chr10:38,699,444...38,713,696
Ensembl chr10:38,198,689...38,212,938
G
Pdlim7
PDZ and LIM domain 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PDLIM7 mRNA
CTD
PMID:15336504
NCBI chr17:9,129,603...9,144,956
Ensembl chr17:9,124,649...9,139,811
G
Pdp1
pyruvate dehydrogenase phosphatase catalytic subunit 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PDP1 mRNA
CTD
PMID:15336504
NCBI chr 5:30,245,699...30,252,494
Ensembl chr 5:25,446,272...25,455,217
G
Pdzd2
PDZ domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PDZD2 mRNA
CTD
PMID:15336504
NCBI chr 2:63,111,650...63,497,520
Ensembl chr 2:61,386,381...61,770,524
G
Peg10
paternally expressed 10
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PEG10 mRNA
CTD
PMID:15336504
NCBI chr 4:33,809,026...33,822,224
Ensembl chr 4:32,848,493...32,852,621
G
Perp
p53 apoptosis effector related to PMP22
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PERP mRNA
CTD
PMID:21382384
NCBI chr 1:15,361,784...15,374,230
Ensembl chr 1:13,542,067...13,554,511
G
Pfdn6
prefoldin subunit 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PFDN6 mRNA
CTD
PMID:15336504
NCBI chr20:4,947,844...4,949,318
Ensembl chr20:4,945,959...4,947,433
G
Pfkl
phosphofructokinase, liver type
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PFKL mRNA
CTD
PMID:15003993
NCBI chr20:10,663,907...10,685,967
Ensembl chr20:10,664,272...10,686,315
G
Pfkp
phosphofructokinase, platelet
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PFKP mRNA
CTD
PMID:15003993
NCBI chr17:68,639,749...68,704,055
Ensembl chr17:63,729,780...63,794,018
G
Pfn2
profilin 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PFN2 mRNA
CTD
PMID:14729362
NCBI chr 2:144,217,100...144,222,936
Ensembl chr 2:142,067,104...142,072,938
G
Pggt1b
protein geranylgeranyltransferase type I subunit beta
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PGGT1B mRNA
CTD
PMID:12414654
NCBI chr18:41,138,536...41,182,145
Ensembl chr18:38,952,914...38,995,503
G
Pgls
6-phosphogluconolactonase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PGLS mRNA
CTD
PMID:15336504
NCBI chr16:18,334,299...18,339,785
Ensembl chr16:18,300,317...18,305,803
G
Pgm2
phosphoglucomutase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PGM2 mRNA
CTD
PMID:15003993
NCBI chr14:44,519,906...44,553,420
Ensembl chr14:44,164,425...44,199,967
G
Phf2
PHD finger protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PHF2 mRNA
CTD
PMID:15336504
NCBI chr17:15,989,594...16,057,583
Ensembl chr17:15,781,864...15,851,208
G
Phka2
phosphorylase kinase regulatory subunit alpha 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PHKA2 mRNA
CTD
PMID:15003993
NCBI chr X:37,979,629...38,102,656
Ensembl chr X:34,171,323...34,293,466
G
Phkb
phosphorylase kinase regulatory subunit beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PHKB mRNA
CTD
PMID:15336504
NCBI chr19:37,179,937...37,383,979
Ensembl chr19:21,025,733...21,210,633
G
Phlda1
pleckstrin homology-like domain, family A, member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PHLDA1 mRNA
CTD
PMID:15336504
NCBI chr 7:48,853,690...48,855,894
Ensembl chr 7:46,967,409...46,969,861
G
Phlda2
pleckstrin homology-like domain, family A, member 2
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of PHLDA2 mRNA tert-Butylhydroperoxide affects the expression of PHLDA2 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 1:208,126,302...208,127,241
Ensembl chr 1:198,696,897...198,697,836
G
Pi4ka
phosphatidylinositol 4-kinase alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PI4KA mRNA
CTD
PMID:15336504
NCBI chr11:97,113,390...97,234,374
Ensembl chr11:83,609,069...83,724,080
G
Pias1
protein inhibitor of activated STAT, 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PIAS1 mRNA
CTD
PMID:15336504
NCBI chr 8:72,233,566...72,347,085
Ensembl chr 8:63,338,150...63,438,905
G
Pid1
phosphotyrosine interaction domain containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PID1 mRNA
CTD
PMID:15336504
NCBI chr 9:92,732,471...92,951,168
Ensembl chr 9:85,284,335...85,503,044
G
Pidd1
p53-induced death domain protein 1
increases expression increases methylation
ISO
tert-Butylhydroperoxide results in increased expression of PIDD1 mRNA tert-Butylhydroperoxide results in increased methylation of PIDD1 gene
CTD
PMID:27509014
NCBI chr 1:205,966,392...205,972,359
Ensembl chr 1:196,536,834...196,542,699
G
Pign
phosphatidylinositol glycan anchor biosynthesis, class N
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PIGN mRNA
CTD
PMID:15336504
NCBI chr13:22,173,670...22,321,344
Ensembl chr13:21,662,455...21,806,790
G
Pik3r1
phosphoinositide-3-kinase regulatory subunit 1
decreases expression multiple interactions
ISO
tert-Butylhydroperoxide results in decreased expression of PIK3R1 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of PIK3R1 mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of PIK3R1 mRNA]
CTD
PMID:15336504 PMID:35690295
NCBI chr 2:34,612,946...34,697,660
Ensembl chr 2:32,882,032...32,963,631
G
Pik3r2
phosphoinositide-3-kinase regulatory subunit 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PIK3R2 mRNA
CTD
PMID:12419474
NCBI chr16:18,699,389...18,708,045
Ensembl chr16:18,665,457...18,674,065
G
Pik3r3
phosphoinositide-3-kinase regulatory subunit 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PIK3R3 mRNA
CTD
PMID:15336504
NCBI chr 5:134,936,790...135,009,303
Ensembl chr 5:129,701,229...129,772,583
G
Pilrb1
paired immunoglobin-like type 2 receptor beta 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PILRB mRNA
CTD
PMID:15336504
NCBI chr12:18,516,161...18,525,375
Ensembl chr12:18,516,156...18,525,346
G
Pkp4
plakophilin 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PKP4 mRNA
CTD
PMID:15336504
NCBI chr 3:64,040,995...64,244,586
Ensembl chr 3:43,631,880...43,835,474
G
Pla2g4a
phospholipase A2 group 4A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLA2G4A mRNA
CTD
PMID:15336504
NCBI chr13:64,427,921...64,572,352
Ensembl chr13:61,877,813...62,022,266
G
Pla2g5
phospholipase A2, group V
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLA2G5 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 5:156,324,628...156,393,065
Ensembl chr 5:151,041,340...151,062,658
G
Pla2g7
phospholipase A2 group VII
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLA2G7 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 9:24,859,491...24,901,747
Ensembl chr 9:17,362,225...17,404,476
G
Pla2r1
phospholipase A2 receptor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLA2R1 mRNA
CTD
PMID:12414654
NCBI chr 3:65,292,629...65,422,462
Ensembl chr 3:44,883,943...45,013,660
G
Plaa
phospholipase A2, activating protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PLAA mRNA
CTD
PMID:15336504
NCBI chr 5:114,544,327...114,576,023
Ensembl chr 5:109,428,265...109,460,282
G
Plagl1
PLAG1 like zinc finger 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLAGL1 mRNA
CTD
PMID:15336504
NCBI chr 1:9,297,066...9,337,394
Ensembl chr 1:7,477,177...7,517,228
G
Plaur
plasminogen activator, urokinase receptor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLAUR mRNA
CTD
PMID:15336504
NCBI chr 1:89,181,363...89,196,308
Ensembl chr 1:80,050,324...80,068,595
G
Plbd1
phospholipase B domain containing 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PLBD1 mRNA
CTD
PMID:15336504
NCBI chr 4:171,204,198...171,260,488
Ensembl chr 4:169,472,983...169,529,277
G
Plcd1
phospholipase C, delta 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLCD1 mRNA
CTD
PMID:15003993
NCBI chr 8:127,672,955...127,695,939
Ensembl chr 8:118,795,201...118,818,186
G
Plce1
phospholipase C, epsilon 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PLCE1 mRNA
CTD
PMID:15336504
NCBI chr 1:245,655,855...245,964,966
Ensembl chr 1:236,244,683...236,551,438
G
Plek2
pleckstrin 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLEK2 mRNA
CTD
PMID:15336504
NCBI chr 6:103,434,156...103,452,457
Ensembl chr 6:97,701,106...97,719,326
G
Plekho1
pleckstrin homology domain containing O1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of PLEKHO1 mRNA
CTD
PMID:23410634
NCBI chr 2:186,233,435...186,242,114
Ensembl chr 2:183,544,499...183,552,785
G
Plin3
perilipin 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PLIN3 mRNA
CTD
PMID:15336504
NCBI chr 9:1,198,336...1,210,212
Ensembl chr 9:1,102,366...1,123,147
G
Plk1
polo-like kinase 1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PLK1 mRNA tert-Butylhydroperoxide results in increased expression of PLK1 mRNA
CTD
PMID:12414654 PMID:15003993
NCBI chr 1:186,147,658...186,157,637
Ensembl chr 1:176,716,420...176,726,400
G
Plk3
polo-like kinase 3
affects expression
ISO
tert-Butylhydroperoxide affects the expression of PLK3 mRNA
CTD
PMID:23410634
NCBI chr 5:135,843,725...135,848,900
Ensembl chr 5:130,607,142...130,612,317
G
Plscr4
phospholipid scramblase 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PLSCR4 mRNA
CTD
PMID:15336504
NCBI chr 8:101,867,057...101,905,827
Ensembl chr 8:92,987,381...93,026,049
G
Plxna2
plexin A2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PLXNA2 mRNA
CTD
PMID:15336504
NCBI chr13:108,683,155...108,888,336
Ensembl chr13:106,163,103...106,358,979
G
Plxnb2
plexin B2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PLXNB2 mRNA
CTD
PMID:15336504
NCBI chr 7:122,111,917...122,138,201
Ensembl chr 7:120,232,331...120,258,330
G
Pmaip1
phorbol-12-myristate-13-acetate-induced protein 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of PMAIP1 mRNA
CTD
PMID:23410634
NCBI chr18:62,255,970...62,262,384
Ensembl chr18:59,986,017...59,992,429
G
Pnp
purine nucleoside phosphorylase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PNP mRNA
CTD
PMID:15336504
NCBI chr15:26,644,147...26,651,808
Ensembl chr15:24,170,602...24,203,986
G
Pnpla6
patatin-like phospholipase domain containing 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PNPLA6 mRNA
CTD
PMID:15336504
NCBI chr12:6,372,284...6,401,632
Ensembl chr12:1,560,363...1,603,734
G
Poglut2
protein O-glucosyltransferase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of POGLUT2 mRNA
CTD
PMID:15336504
NCBI chr 9:53,748,484...53,801,453
Ensembl chr 9:46,256,390...46,268,532
G
Pold1
DNA polymerase delta 1, catalytic subunit
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of POLD1 mRNA
CTD
PMID:12419474
NCBI chr 1:104,161,984...104,178,074
Ensembl chr 1:95,025,499...95,036,465
G
Pold4
DNA polymerase delta 4, accessory subunit
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of POLD4 mRNA tert-Butylhydroperoxide affects the expression of POLD4 mRNA
CTD
PMID:15003993 PMID:23410634
NCBI chr 1:210,956,110...210,957,863
Ensembl chr 1:201,526,665...201,528,401
G
Pole2
DNA polymerase epsilon 2, accessory subunit
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of POLE2 mRNA
CTD
PMID:12414654
NCBI chr 6:93,410,713...93,448,782
Ensembl chr 6:87,674,702...87,699,305
G
Polr2e
RNA polymerase II, I and III subunit E
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of POLR2E mRNA
CTD
PMID:15336504
NCBI chr 7:10,317,332...10,321,280
Ensembl chr 7:9,666,716...9,670,643
G
Polr2j
RNA polymerase II subunit J
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of POLR2J mRNA
CTD
PMID:15336504
NCBI chr12:26,179,649...26,185,201
Ensembl chr12:20,543,038...20,548,594
G
Pon2
paraoxonase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PON2 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 4:34,356,270...34,391,684
Ensembl chr 4:33,389,714...33,425,248
G
Popdc3
popeye domain cAMP effector 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of POPDC3 mRNA
CTD
PMID:15336504
NCBI chr20:50,354,775...50,383,050
Ensembl chr20:48,772,462...48,800,593
G
Pot1
protection of telomeres 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of POT1 mRNA
CTD
PMID:15336504
NCBI chr 4:55,170,821...55,228,588
Ensembl chr 4:54,205,332...54,263,042
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions decreases expression
EXP
acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARA mRNA]; acadesine inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARA protein]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARA mRNA]; Fenofibrate inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARA protein] tert-Butylhydroperoxide results in decreased expression of PPARA mRNA; tert-Butylhydroperoxide results in decreased expression of PPARA protein
CTD
PMID:26989860
NCBI chr 7:118,712,261...118,780,723
Ensembl chr 7:116,832,756...116,895,346
G
Ppard
peroxisome proliferator-activated receptor delta
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PPARD mRNA
CTD
PMID:15336504
NCBI chr20:6,300,527...6,365,707
Ensembl chr20:6,298,785...6,363,968
G
Pparg
peroxisome proliferator-activated receptor gamma
multiple interactions increases activity
ISO
tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]; tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]] tert-Butylhydroperoxide results in increased activity of PPARG protein
CTD
PMID:16417216 PMID:20847119
NCBI chr 4:150,095,743...150,221,104
Ensembl chr 4:148,423,194...148,548,468
G
Ppargc1a
PPARG coactivator 1 alpha
decreases response to substance multiple interactions decreases expression
ISO
PPARGC1A protein results in decreased susceptibility to tert-Butylhydroperoxide AICA ribonucleotide inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARGC1A protein]; dorsomorphin inhibits the reaction [Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARGC1A protein]]; dorsomorphin promotes the reaction [tert-Butylhydroperoxide results in decreased expression of PPARGC1A protein]; Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARGC1A protein]
CTD
PMID:17460188 PMID:25522270
NCBI chr14:63,073,505...63,729,215
Ensembl chr14:58,861,144...59,512,656
G
Ppip5k1
diphosphoinositol pentakisphosphate kinase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PPIP5K1 mRNA
CTD
PMID:15336504
NCBI chr 3:108,284,120...108,327,683
Ensembl chr 3:108,284,120...108,323,428
G
Ppl
periplakin
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of PPL mRNA tert-Butylhydroperoxide results in decreased expression of PPL mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr10:10,957,388...11,003,035
Ensembl chr10:10,450,919...10,496,575
G
Ppm1d
protein phosphatase, Mg2+/Mn2+ dependent, 1D
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PPM1D mRNA
CTD
PMID:12414654
NCBI chr10:70,670,026...70,706,030
Ensembl chr10:70,172,603...70,208,607
G
Ppp1ca
protein phosphatase 1 catalytic subunit alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PPP1CA mRNA
CTD
PMID:12419474
NCBI chr 1:210,914,576...210,918,193
Ensembl chr 1:201,485,085...201,497,327
G
Ppp1cb
protein phosphatase 1 catalytic subunit beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PPP1CB mRNA
CTD
PMID:15336504
NCBI chr 6:29,681,099...29,712,835
Ensembl chr 6:23,960,998...23,992,824
G
Ppp1r15a
protein phosphatase 1, regulatory subunit 15A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PPP1R15A mRNA
CTD
PMID:15336504
NCBI chr 1:105,136,521...105,139,596
Ensembl chr 1:96,000,058...96,003,171
G
Ppp1r3c
protein phosphatase 1, regulatory subunit 3C
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of PPP1R3C mRNA tert-Butylhydroperoxide affects the expression of PPP1R3C mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 1:243,873,524...243,878,527
Ensembl chr 1:234,460,652...234,465,961
G
Ppp1r7
protein phosphatase 1, regulatory subunit 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PPP1R7 mRNA
CTD
PMID:15336504
NCBI chr 9:101,333,472...101,358,589
Ensembl chr 9:93,886,143...93,914,850
G
Ppp1r8
protein phosphatase 1, regulatory subunit 8
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PPP1R8 mRNA
CTD
PMID:12419474
NCBI chr 5:150,315,607...150,332,726
Ensembl chr 5:145,031,498...145,048,752
G
Ppp2cb
protein phosphatase 2 catalytic subunit beta
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PPP2CB mRNA
CTD
PMID:12414654
NCBI chr16:65,261,178...65,282,658
Ensembl chr16:58,558,122...58,579,576
G
Ppp3ca
protein phosphatase 3 catalytic subunit alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PPP3CA mRNA
CTD
PMID:12419474
NCBI chr 2:227,839,058...228,113,560
Ensembl chr 2:225,165,766...225,438,974
G
Ppp3cc
protein phosphatase 3 catalytic subunit gamma
affects expression
ISO
tert-Butylhydroperoxide affects the expression of PPP3CC mRNA
CTD
PMID:23410634
NCBI chr15:51,699,586...51,771,763
Ensembl chr15:45,290,373...45,361,832
G
Pprc1
PPARG related coactivator 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PPRC1 mRNA
CTD
PMID:15336504
NCBI chr 1:254,851,136...254,867,570
Ensembl chr 1:244,902,179...244,918,587
G
Prdx1
peroxiredoxin 1
increases expression increases activity multiple interactions decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of PRDX1 protein tert-Butylhydroperoxide results in increased activity of PRDX1 protein Oleanolic Acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PRDX1 protein]
CTD
PMID:11295360 PMID:16880205 PMID:20100471
NCBI chr 5:135,383,906...135,399,504
Ensembl chr 5:130,147,204...130,162,856
G
Prdx2
peroxiredoxin 2
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PRDX2 mRNA tert-Butylhydroperoxide results in increased expression of PRDX2 protein
CTD
PMID:11295360 PMID:14729362 PMID:15336504
NCBI chr19:40,085,788...40,091,083
Ensembl chr19:23,180,930...23,186,194
G
Prdx3
peroxiredoxin 3
decreases expression
EXP
tert-Butylhydroperoxide results in decreased expression of PRDX3 protein
CTD
PMID:24394546
NCBI chr 1:269,987,691...270,000,111
Ensembl chr 1:260,001,637...260,014,111
G
Prdx5
peroxiredoxin 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PRDX5 mRNA
CTD
PMID:14729362
NCBI chr 1:213,529,042...213,532,787
Ensembl chr 1:204,099,826...204,114,268
G
Prdx6
peroxiredoxin 6
increases expression decreases response to substance increases response to substance affects response to substance
ISO
tert-Butylhydroperoxide results in increased expression of PRDX6 protein PRDX6 protein results in decreased susceptibility to tert-Butylhydroperoxide PRDX6 gene mutant form results in increased susceptibility to tert-Butylhydroperoxide PRDX6 protein affects the susceptibility to tert-Butylhydroperoxide
CTD
PMID:11295360 PMID:12732627 PMID:14741336 PMID:20627125
NCBI chr13:76,062,082...76,072,631
Ensembl chr13:73,528,210...73,539,355
G
Prepl
prolyl endopeptidase-like
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PREPL mRNA
CTD
PMID:15336504
NCBI chr 6:15,333,107...15,362,825
Ensembl chr 6:9,580,217...9,607,772
G
Prkar1a
protein kinase cAMP-dependent type I regulatory subunit alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PRKAR1A mRNA
CTD
PMID:15336504
NCBI chr10:95,120,537...95,139,028
Ensembl chr10:94,620,039...94,639,041
G
Prkca
protein kinase C, alpha
decreases expression affects localization increases activity
ISO EXP
tert-Butylhydroperoxide results in decreased expression of PRKCA mRNA tert-Butylhydroperoxide affects the localization of PRKCA protein tert-Butylhydroperoxide results in increased activity of PRKCA protein
CTD
PMID:15336504 PMID:16716901
NCBI chr10:93,388,991...93,787,617
Ensembl chr10:92,894,012...93,288,012
G
Prkce
protein kinase C, epsilon
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PRKCE mRNA
CTD
PMID:27509014
NCBI chr 6:13,718,050...14,204,931
Ensembl chr 6:7,965,048...8,451,719
G
Prkch
protein kinase C, eta
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PRKCH mRNA
CTD
PMID:15336504
NCBI chr 6:98,027,830...98,226,486
Ensembl chr 6:92,292,000...92,490,654
G
Prkcq
protein kinase C, theta
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of PRKCQ mRNA tert-Butylhydroperoxide results in increased methylation of PRKCQ gene
CTD
PMID:27509014
NCBI chr17:72,156,215...72,288,508
Ensembl chr17:67,246,394...67,378,704
G
Prmt3
protein arginine methyltransferase 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PRMT3 mRNA
CTD
PMID:15336504
NCBI chr 1:108,628,899...108,718,803
Ensembl chr 1:99,492,724...99,579,435
G
Prnp
prion protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PRNP mRNA
CTD
PMID:15336504
NCBI chr 3:139,639,076...139,654,420
Ensembl chr 3:119,177,485...119,203,937
G
Pros1
protein S
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PROS1 mRNA
CTD
PMID:15336504
NCBI chr11:13,676,310...13,757,858
Ensembl chr11:230,696...311,286
G
Prr13
proline rich 13
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PRR13 mRNA
CTD
PMID:15003993
NCBI chr 7:135,471,040...135,474,344
Ensembl chr 7:133,592,490...133,601,005
G
Prrg2
proline rich and Gla domain 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PRRG2 mRNA
CTD
PMID:14729362
NCBI chr 1:95,534,276...95,543,364
Ensembl chr 1:95,534,290...95,543,425
G
Prune1
prune exopolyphosphatase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PRUNE1 mRNA
CTD
PMID:15336504
NCBI chr 2:182,830,575...182,859,972
Ensembl chr 2:182,830,578...182,859,336
G
Prune2
prune homolog 2 with BCH domain
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PRUNE2 mRNA
CTD
PMID:15336504
NCBI chr 1:214,352,586...214,624,848
Ensembl chr 1:214,352,955...214,622,650
G
Psca
prostate stem cell antigen
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PSCA mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 7:108,483,974...108,492,098
Ensembl chr 7:106,595,284...106,609,746
G
Psd3
pleckstrin and Sec7 domain containing 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PSD3 mRNA
CTD
PMID:15336504
NCBI chr16:26,238,595...26,802,535
Ensembl chr16:21,465,639...22,034,547
G
Psip1
PC4 and SRSF1 interacting protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PSIP1 mRNA
CTD
PMID:15336504
NCBI chr 5:102,892,929...102,925,191
Ensembl chr 5:97,847,015...97,879,257
G
Psma6
proteasome 20S subunit alpha 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PSMA6 mRNA
CTD
PMID:15336504
NCBI chr 6:78,500,676...78,531,693
Ensembl chr 6:72,765,473...72,796,554
G
Psmb9
proteasome 20S subunit beta 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PSMB9 mRNA
CTD
PMID:15003993
NCBI chr20:4,668,952...4,674,421
Ensembl chr20:4,666,046...4,672,512
G
Psmd11
proteasome 26S subunit, non-ATPase 11
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PSMD11 mRNA
CTD
PMID:15336504
NCBI chr10:65,923,669...65,977,523
Ensembl chr10:65,433,853...65,479,766
G
Psmd12
proteasome 26S subunit, non-ATPase 12
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PSMD12 mRNA
CTD
PMID:12414654
NCBI chr10:92,937,957...92,956,601
Ensembl chr10:92,438,298...92,457,287
G
Psrc1
proline and serine rich coiled-coil 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PSRC1 mRNA
CTD
PMID:15336504
NCBI chr 2:198,710,427...198,715,001
Ensembl chr 2:196,022,361...196,026,874
G
Ptbp2
polypyrimidine tract binding protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTBP2 mRNA
CTD
PMID:15336504
NCBI chr 2:210,497,610...210,558,497
Ensembl chr 2:207,812,920...207,873,506
G
Pten
phosphatase and tensin homolog
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTEN mRNA
CTD
PMID:15336504
NCBI chr 1:240,043,707...240,110,330
Ensembl chr 1:230,630,338...230,696,838
G
Ptges
prostaglandin E synthase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTGES mRNA
CTD
PMID:15336504
NCBI chr 3:34,575,643...34,586,987
G
Ptgr1
prostaglandin reductase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTGR1 mRNA
CTD
PMID:14729362 PMID:23410634
NCBI chr 5:78,579,060...78,597,671
Ensembl chr 5:73,784,009...73,802,666
G
Ptgs1
prostaglandin-endoperoxide synthase 1
increases activity
EXP
tert-Butylhydroperoxide results in increased activity of PTGS1 protein
CTD
PMID:15604817
NCBI chr 3:39,981,419...40,002,993
Ensembl chr 3:19,584,015...19,605,586
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions increases expression increases activity
ISO EXP
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of PTGS2 mRNA]; 2-chloro-5-nitrobenzanilide inhibits the reaction [tert-Butylhydroperoxide results in increased expression of PTGS2 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of PTGS2 mRNA]; tert-Butylhydroperoxide inhibits the reaction [Acetaminophen inhibits the reaction [Calcimycin promotes the reaction [IL1B protein results in increased activity of PTGS2 protein]]]; tert-Butylhydroperoxide inhibits the reaction [Ibuprofen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]]; tert-Butylhydroperoxide inhibits the reaction [Naproxen inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]]; tert-Butylhydroperoxide inhibits the reaction [rofecoxib inhibits the reaction [IL1B protein results in increased activity of PTGS2 protein]] tert-Butylhydroperoxide results in increased activity of PTGS2 protein
CTD
PMID:14729362 PMID:15604817 PMID:15705740 PMID:16417216 PMID:28063877
NCBI chr13:64,714,063...64,722,320
Ensembl chr13:62,163,932...62,172,188
G
Ptk2
protein tyrosine kinase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PTK2 mRNA
CTD
PMID:15336504
NCBI chr 7:107,015,730...107,220,865
Ensembl chr 7:105,126,728...105,331,783
G
Ptma
prothymosin alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PTMA mRNA
CTD
PMID:12419474
NCBI chr 9:94,624,194...94,628,276
Ensembl chr 9:87,176,230...87,180,333
G
Ptp4a1
protein tyrosine phosphatase 4A1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTP4A1 mRNA
CTD
PMID:15336504
NCBI chr 9:40,710,250...40,718,176
Ensembl chr 9:33,214,208...33,221,964
G
Ptp4a2
protein tyrosine phosphatase 4A2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTP4A2 mRNA
CTD
PMID:15336504
NCBI chr 5:147,449,733...147,476,739
Ensembl chr 5:142,165,700...142,191,899
G
Ptprr
protein tyrosine phosphatase, receptor type, R
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTPRR mRNA
CTD
PMID:15336504
NCBI chr 7:53,548,611...53,815,632
Ensembl chr 7:51,662,595...51,929,603
G
Ptrh2
peptidyl-tRNA hydrolase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTRH2 mRNA
CTD
PMID:15336504
NCBI chr10:72,002,450...72,012,606
Ensembl chr10:71,504,956...71,515,398
G
Pttg1
PTTG1 regulator of sister chromatid separation, securin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PTTG1 mRNA
CTD
PMID:15003993
NCBI chr10:28,394,940...28,406,410
Ensembl chr10:27,893,689...27,904,837
G
Pum2
pumilio RNA-binding family member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PUM2 mRNA
CTD
PMID:15336504
NCBI chr 6:37,182,130...37,262,223
Ensembl chr 6:31,462,872...31,542,976
G
Pvr
PVR cell adhesion molecule
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PVR mRNA
CTD
PMID:15336504
NCBI chr 1:88,689,235...88,704,641
Ensembl chr 1:79,546,879...79,576,715
G
Pxmp2
peroxisomal membrane protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of PXMP2 mRNA
CTD
PMID:15336504
NCBI chr12:52,053,951...52,064,283
Ensembl chr12:46,394,193...46,404,557
G
Pygl
glycogen phosphorylase L
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of PYGL mRNA
CTD
PMID:15336504
NCBI chr 6:94,433,558...94,476,219
Ensembl chr 6:88,697,593...88,740,310
G
Qsox1
quiescin sulfhydryl oxidase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of QSOX1 mRNA
CTD
PMID:12419474
NCBI chr13:70,500,060...70,537,711
Ensembl chr13:67,949,780...67,987,459
G
R3hdm2
R3H domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of R3HDM2 mRNA
CTD
PMID:15336504
NCBI chr 7:65,097,685...65,225,863
Ensembl chr 7:63,232,346...63,340,540
G
Rab22a
RAB22A, member RAS oncogene family
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RAB22A mRNA
CTD
PMID:15336504
NCBI chr 3:182,877,746...182,924,400
Ensembl chr 3:162,459,726...162,506,137
G
Rab27a
RAB27A, member RAS oncogene family
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RAB27A mRNA
CTD
PMID:15336504
NCBI chr 8:82,663,373...82,717,267
Ensembl chr 8:73,782,694...73,847,829
G
Rab29
RAB29, member RAS oncogene family
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RAB29 mRNA
CTD
PMID:15336504
NCBI chr13:45,859,930...45,865,468
Ensembl chr13:43,307,775...43,313,417
G
Rab4a
RAB4A, member RAS oncogene family
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RAB4A mRNA
CTD
PMID:15336504
NCBI chr19:68,692,228...68,720,169
Ensembl chr19:51,795,613...51,822,703
G
Rab5c
RAB5C, member RAS oncogene family
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of RAB5C intron
CTD
PMID:29432895
NCBI chr10:86,142,872...86,166,449
Ensembl chr10:85,642,809...85,666,103
G
Rab7a
RAB7A, member RAS oncogene family
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RAB7 mRNA
CTD
PMID:12419474
NCBI chr 4:122,019,281...122,068,067
Ensembl chr 4:120,461,963...120,506,889
G
Rab8a
RAB8A, member RAS oncogene family
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RAB8A mRNA
CTD
PMID:15336504
NCBI chr16:17,688,049...17,709,412
Ensembl chr16:17,654,034...17,675,678
G
Rabep2
rabaptin, RAB GTPase binding effector protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RABEP2 mRNA
CTD
PMID:15336504
NCBI chr 1:190,433,501...190,457,241
Ensembl chr 1:181,010,305...181,026,648
G
Rabgap1
RAB GTPase activating protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RABGAP1 mRNA
CTD
PMID:15336504
NCBI chr 3:41,617,784...41,735,795
Ensembl chr 3:21,208,055...21,326,013
G
Rabgap1l
RAB GTPase activating protein 1-like
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RABGAP1L mRNA
CTD
PMID:15336504
NCBI chr13:74,997,542...75,593,240
Ensembl chr13:72,468,110...73,059,984
G
Rac2
Rac family small GTPase 2
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of RAC2 mRNA
CTD
PMID:22659508
NCBI chr 7:111,981,825...112,009,201
Ensembl chr 7:110,116,260...110,128,720
G
Rad23a
RAD23 homolog A, nucleotide excision repair protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RAD23A mRNA
CTD
PMID:15336504
NCBI chr19:40,219,235...40,225,543
Ensembl chr19:23,314,797...23,320,695
G
Raet1e
retinoic acid early transcript 1E
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RAET1G mRNA
CTD
PMID:14729362
NCBI chr 1:3,474,487...3,476,431
Ensembl chr 1:1,807,644...1,812,755
G
Rala
RAS like proto-oncogene A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RALA mRNA
CTD
PMID:15336504
NCBI chr17:51,787,682...51,840,738
Ensembl chr17:47,092,207...47,144,063
G
Ranbp2
RAN binding protein 2
multiple interactions increases expression
ISO
pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RANBP2 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RANBP2 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RANBP2 mRNA]
CTD
PMID:20847119
NCBI chr20:26,984,520...27,036,573
Ensembl chr20:26,442,217...26,493,481
G
Ranbp9
RAN binding protein 9
affects expression
ISO
tert-Butylhydroperoxide affects the expression of RANBP9 mRNA
CTD
PMID:23410634
NCBI chr17:21,220,807...21,303,009
Ensembl chr17:21,220,618...21,303,004
G
Rap1gap
Rap1 GTPase-activating protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RAP1GAP mRNA
CTD
PMID:23410634
NCBI chr 5:155,157,511...155,222,622
Ensembl chr 5:149,892,019...149,939,253
G
Rap1gds1
Rap1 GTPase-GDP dissociation stimulator 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RAP1GDS1 mRNA
CTD
PMID:15336504
NCBI chr 2:230,173,713...230,318,555
Ensembl chr 2:227,500,367...227,645,169
G
Rap2a
RAP2A, member of RAS oncogene family
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RAP2A mRNA
CTD
PMID:15336504
NCBI chr15:104,003,744...104,004,234
Ensembl chr15:97,596,020...97,624,138
G
Rapgef2
Rap guanine nucleotide exchange factor 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RAPGEF2 mRNA
CTD
PMID:15336504
NCBI chr 2:166,505,868...166,728,139
Ensembl chr 2:164,207,513...164,244,247
G
Rarb
retinoic acid receptor, beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RARB mRNA
CTD
PMID:12419474
NCBI chr15:10,837,252...11,482,037
Ensembl chr15:8,406,492...9,051,288
G
Rasa4
RAS p21 protein activator 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RASA4 mRNA
CTD
PMID:15003993
NCBI chr12:26,189,416...26,216,801
Ensembl chr12:20,552,806...20,580,147
G
Rasgrf1
RAS protein-specific guanine nucleotide-releasing factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RASGRF1 mRNA
CTD
PMID:15336504
NCBI chr 8:99,324,986...99,454,099
Ensembl chr 8:90,445,154...90,574,269
G
Rasgrp3
RAS guanyl releasing protein 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RASGRP3 mRNA
CTD
PMID:15336504
NCBI chr 6:25,647,386...25,745,952
Ensembl chr 6:19,895,390...19,958,578
G
Rb1
RB transcriptional corepressor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RB1 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr15:54,780,858...54,911,989
Ensembl chr15:48,371,296...48,502,302
G
Rbbp8
RB binding protein 8, endonuclease
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RBBP8 mRNA
CTD
PMID:15336504
NCBI chr18:3,198,188...3,263,643
Ensembl chr18:2,921,286...2,988,846
G
Rbl2
RB transcriptional corepressor like 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RBL2 mRNA
CTD
PMID:12419474
NCBI chr19:32,049,690...32,096,467
Ensembl chr19:15,876,853...15,923,572
G
Rbm12
RNA binding motif protein 12
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RBM12 mRNA
CTD
PMID:15336504
NCBI chr 3:165,069,744...165,089,994
Ensembl chr 3:144,611,623...144,629,915
G
Rcn1
reticulocalbin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RCN1 mRNA
CTD
PMID:14729362
NCBI chr 3:112,295,838...112,310,082
Ensembl chr 3:91,841,052...91,855,295
G
Rcn3
reticulocalbin 3
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RCN3 mRNA tert-Butylhydroperoxide results in increased expression of RCN3 mRNA
CTD
PMID:15336504
NCBI chr 1:104,700,969...104,710,228
Ensembl chr 1:95,564,380...95,573,725
G
Rcor3
REST corepressor 3
affects expression
ISO
tert-Butylhydroperoxide affects the expression of RCOR3 mRNA
CTD
PMID:23410634
NCBI chr13:106,156,166...106,196,542
Ensembl chr13:103,624,971...103,665,565
G
Rdh14
retinol dehydrogenase 14
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RDH14 mRNA
CTD
PMID:15336504
NCBI chr 6:38,875,693...38,880,836
Ensembl chr 6:33,156,569...33,161,712
G
Recql
RecQ like helicase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RECQL mRNA
CTD
PMID:15336504
NCBI chr 4:177,039,351...177,063,968
Ensembl chr 4:175,304,117...175,332,945
G
Reep3
receptor accessory protein 3
multiple interactions increases expression
ISO
pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of REEP3 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of REEP3 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of REEP3 mRNA]
CTD
PMID:20847119
NCBI chr20:21,492,695...21,575,138
Ensembl chr20:21,493,954...21,578,697
G
Reep4
receptor accessory protein 4
affects expression
ISO
tert-Butylhydroperoxide affects the expression of REEP4 mRNA
CTD
PMID:23410634
NCBI chr15:52,030,022...52,033,229
Ensembl chr15:45,619,941...45,623,526
G
Reep5
receptor accessory protein 5
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of REEP5 mRNA tert-Butylhydroperoxide results in increased expression of REEP5 mRNA
CTD
PMID:15336504
NCBI chr18:26,219,528...26,257,505
Ensembl chr18:25,945,381...25,976,509
G
Rel
REL proto-oncogene, NF-kB subunit
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of REL mRNA
CTD
PMID:12419474
NCBI chr14:101,891,238...101,922,324
Ensembl chr14:97,695,161...97,720,892
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions increases expression affects localization
ISO
Catechin inhibits the reaction [tert-Butylhydroperoxide affects the localization of RELA protein] tert-Butylhydroperoxide results in increased expression of RELA mRNA
CTD
PMID:15879681 PMID:16704919
NCBI chr 1:212,354,336...212,364,815
Ensembl chr 1:202,924,945...202,935,484
G
Relb
RELB proto-oncogene, NF-kB subunit
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RELB mRNA
CTD
PMID:15336504
NCBI chr 1:88,385,717...88,413,380
Ensembl chr 1:79,257,725...79,285,507
G
Renbp
renin binding protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RENBP mRNA
CTD
PMID:14729362
NCBI chr X:156,812,785...156,821,860
Ensembl chr X:151,661,458...151,670,516
G
Rer1
retention in endoplasmic reticulum sorting receptor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RER1 mRNA
CTD
PMID:15336504
NCBI chr 5:170,916,643...170,929,073
Ensembl chr 5:165,634,300...165,646,750
G
Retsat
retinol saturase
increases response to substance
ISO
RETSAT protein results in increased susceptibility to tert-Butylhydroperoxide
CTD
PMID:17664141
NCBI chr 4:106,211,459...106,220,222
Ensembl chr 4:104,653,155...104,668,310
G
Rfc3
replication factor C subunit 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RFC3 mRNA
CTD
PMID:15336504
NCBI chr12:5,836,546...5,847,331
Ensembl chr12:1,000,994...1,011,778
G
Rfxank
regulatory factor X-associated ankyrin-containing protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RFXANK mRNA
CTD
PMID:15336504
NCBI chr16:19,314,307...19,322,827
Ensembl chr16:19,281,475...19,460,255
G
Rgn
regucalcin
multiple interactions decreases expression
EXP
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of RGN protein]
CTD
PMID:16677110 PMID:24394546
NCBI chr X:4,172,537...4,190,112
Ensembl chr X:1,619,032...1,634,450
G
Rgs10
regulator of G-protein signaling 10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RGS10 mRNA
CTD
PMID:15003993
NCBI chr 1:192,376,772...192,422,640
Ensembl chr 1:182,946,336...182,987,697
G
Rgs2
regulator of G-protein signaling 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RGS2 mRNA
CTD
PMID:15336504
NCBI chr13:58,350,063...58,352,666
Ensembl chr13:55,798,829...55,802,385
G
Rgs3
regulator of G-protein signaling 3
affects expression
ISO
tert-Butylhydroperoxide affects the expression of RGS3 mRNA
CTD
PMID:23410634
NCBI chr 5:81,037,588...81,177,446
Ensembl chr 5:76,022,001...76,161,894
G
Rhd
Rh blood group, D antigen
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RHD mRNA
CTD
PMID:15003993
NCBI chr 5:152,371,160...152,405,396
Ensembl chr 5:147,087,518...147,121,715
G
Rheb
Ras homolog, mTORC1 binding
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RHEB mRNA
CTD
PMID:15336504
NCBI chr 4:11,012,173...11,053,860
Ensembl chr 4:10,279,370...10,320,160
G
Rhod
ras homolog family member D
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RHOD mRNA
CTD
PMID:15336504
NCBI chr 1:211,138,126...211,153,953
Ensembl chr 1:201,708,699...201,722,632
G
Rhpn2
rhophilin, Rho GTPase binding protein 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RHPN2 mRNA
CTD
PMID:14729362
NCBI chr 1:87,991,143...88,051,895
Ensembl chr 1:87,991,144...88,051,902
G
Rictor
RPTOR independent companion of MTOR, complex 2
multiple interactions increases expression affects expression
ISO
[troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of RICTOR mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RICTOR mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RICTOR mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of RICTOR mRNA] tert-Butylhydroperoxide affects the expression of RICTOR mRNA
CTD
PMID:20847119 PMID:23410634
NCBI chr 2:57,539,279...57,631,291
Ensembl chr 2:55,811,322...55,901,426
G
Riox1
ribosomal oxygenase 1
multiple interactions decreases expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of RIOX1 mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of RIOX1 mRNA; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of RIOX1 mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of RIOX1 mRNA]
CTD
PMID:20847119
NCBI chr 6:109,310,748...109,313,365
Ensembl chr 6:103,579,642...103,582,250
G
Ripk2
receptor-interacting serine-threonine kinase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RIPK2 mRNA
CTD
PMID:15336504
NCBI chr 5:34,428,573...34,459,808
Ensembl chr 5:29,631,570...29,662,657
G
Rmnd5b
required for meiotic nuclear division 5 homolog B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RMND5B mRNA
CTD
PMID:15336504
NCBI chr10:36,382,212...36,394,801
Ensembl chr10:35,881,268...35,892,265
G
Rnaseh2c
ribonuclease H2, subunit C
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RNASEH2C mRNA
CTD
PMID:15003993
NCBI chr 1:212,323,916...212,325,011
Ensembl chr 1:202,894,643...202,897,516
G
Rnd3
Rho family GTPase 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RND3 mRNA
CTD
PMID:15336504
NCBI chr 3:55,981,142...55,998,494
Ensembl chr 3:35,571,143...35,589,327
G
Rnf103
ring finger protein 103
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RNF103 mRNA
CTD
PMID:15003993
NCBI chr 4:105,084,762...105,100,839
Ensembl chr 4:103,526,502...103,555,919
G
Rnf13
ring finger protein 13
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RNF13 mRNA
CTD
PMID:15336504
NCBI chr 2:144,076,526...144,211,520
Ensembl chr 2:141,927,909...142,061,801
G
Rnft2
ring finger protein, transmembrane 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RNFT2 mRNA
CTD
PMID:15336504
NCBI chr12:38,329,217...38,387,303
Ensembl chr12:38,329,269...38,387,290
G
Rnh1
ribonuclease/angiogenin inhibitor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RNH1 mRNA
CTD
PMID:12419474
NCBI chr 1:205,698,882...205,711,348
Ensembl chr 1:196,269,293...196,281,910
G
Rora
RAR-related orphan receptor A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RORA mRNA
CTD
PMID:15336504
NCBI chr 8:78,182,710...78,915,730
Ensembl chr 8:69,301,733...70,025,931
G
Rpa1
replication protein A1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RPA1 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr10:60,647,185...60,698,279
Ensembl chr10:60,148,793...60,199,949
G
Rpgr
retinitis pigmentosa GTPase regulator
affects expression
ISO
tert-Butylhydroperoxide affects the expression of RPGR mRNA
CTD
PMID:23410634
NCBI chr X:15,238,961...15,299,004
Ensembl chr X:12,566,645...12,747,882
G
Rpl13a
ribosomal protein L13A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RPL13A mRNA
CTD
PMID:12419474
NCBI chr 1:104,746,223...104,748,975
Ensembl chr 1:95,609,370...95,620,463
G
Rpl27a
ribosomal protein L27A
affects expression
ISO
tert-Butylhydroperoxide affects the expression of RPL27A mRNA
CTD
PMID:23410634
NCBI chr 1:172,971,957...172,977,591
G
Rpl5
ribosomal protein L5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RPL5 mRNA
CTD
PMID:15336504
NCBI chr14:1,988,792...1,995,236
Ensembl chr14:1,843,770...1,850,290
G
Rps19
ribosomal protein S19
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RPS19 mRNA
CTD
PMID:12419474
NCBI chr 1:89,608,408...89,614,390
Ensembl chr 1:80,480,951...80,486,508 Ensembl chr 7:80,480,951...80,486,508
G
Rps27l
ribosomal protein S27-like
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RPS27L mRNA
CTD
PMID:15336504
NCBI chr 8:76,443,658...76,448,593
Ensembl chr 8:67,562,483...67,567,418 Ensembl chr12:67,562,483...67,567,418 Ensembl chr 2:67,562,483...67,567,418
G
Rps6ka1
ribosomal protein S6 kinase A1
increases phosphorylation multiple interactions
ISO
tert-Butylhydroperoxide results in increased phosphorylation of RPS6KA1 protein U 0126 inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of RPS6KA1 protein]
CTD
PMID:17003459
NCBI chr 5:151,362,819...151,402,064
Ensembl chr 5:146,079,021...146,118,272
G
Rpusd2
RNA pseudouridine synthase domain containing 2
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of RPUSD2 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of RPUSD2 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of RPUSD2 mRNA]
CTD
PMID:20847119
NCBI chr 3:106,017,759...106,023,010
Ensembl chr 3:106,017,864...106,023,251
G
Rrad
RRAD, Ras related glycolysis inhibitor and calcium channel regulator
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RRAD mRNA
CTD
PMID:15336504
NCBI chr19:360,581...363,874
Ensembl chr19:354,198...357,417
G
Rragd
Ras-related GTP binding D
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RRAGD mRNA
CTD
PMID:15336504
NCBI chr 5:52,170,234...52,205,700
Ensembl chr 5:47,373,463...47,409,356
G
Rras2
RAS related 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RRAS2 mRNA
CTD
PMID:23410634
NCBI chr 1:177,668,143...177,737,551
Ensembl chr 1:168,233,693...168,303,111
G
Rrm1
ribonucleotide reductase catalytic subunit M1
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of RRM1 mRNA tert-Butylhydroperoxide affects the expression of RRM1 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 1:166,235,904...166,260,206
Ensembl chr 1:156,823,960...156,848,261
G
Rrn3
RRN3 homolog, RNA polymerase I transcription factor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RRN3 mRNA
CTD
PMID:29432895
NCBI chr10:2,637,016...2,672,338
Ensembl chr10:2,129,978...2,165,663
G
Rsad2
radical S-adenosyl methionine domain containing 2
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of RSAD2 mRNA tert-Butylhydroperoxide results in decreased expression of RSAD2 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 6:48,774,985...48,788,245
Ensembl chr 6:43,047,658...43,059,699
G
Rsl1d1
ribosomal L1 domain containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RSL1D1 mRNA
CTD
PMID:29432895
NCBI chr10:4,931,839...4,943,726
Ensembl chr10:4,397,821...4,439,593
G
RT1-A2
RT1 class Ia, locus A2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of HLA-E mRNA
CTD
PMID:15336504
NCBI chr20:4,872,720...4,876,425
G
RT1-DMb
RT1 class II, locus DMb
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of H2-DMB1 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr20:4,695,009...4,702,560
Ensembl chr20:4,693,103...4,700,340
G
RT1-Ha
RT1 class II, locus Ha
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HLA-DPA1 mRNA
CTD
PMID:15336504
NCBI chr20:4,762,425...4,772,439
Ensembl chr20:4,760,118...4,770,244
G
RT1-Hb-ps1
RT1 class II, locus Hb, pseudogene 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of HLA-DPB1 mRNA
CTD
PMID:15336504
NCBI chr20:4,777,494...4,781,486
Ensembl chr20:4,774,650...4,780,618
G
Rtn3
reticulon 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RTN3 mRNA
CTD
PMID:15336504
NCBI chr 1:214,041,838...214,098,644
Ensembl chr 1:204,612,675...204,669,275
G
Rtn4r
reticulon 4 receptor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of RTN4R mRNA
CTD
PMID:29432895
NCBI chr11:96,348,613...96,373,554
Ensembl chr11:82,844,309...82,869,466
G
Rxra
retinoid X receptor alpha
decreases response to substance
ISO
RXRA protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:14978233
NCBI chr 3:31,387,892...31,474,415
Ensembl chr 3:10,989,832...11,073,712
G
Rxrb
retinoid X receptor beta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of RXRB mRNA
CTD
PMID:12419474
NCBI chr20:4,818,707...4,824,968
Ensembl chr20:4,816,815...4,828,773
G
Rybp
RING1 and YY1 binding protein
increases methylation increases expression
ISO
tert-Butylhydroperoxide results in increased methylation of RYBP gene tert-Butylhydroperoxide results in increased expression of RYBP mRNA
CTD
PMID:27509014
NCBI chr 4:134,432,663...134,484,732
Ensembl chr 4:132,876,361...132,928,316
G
S100a3
S100 calcium binding protein A3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of S100A3 mRNA
CTD
PMID:15336504
NCBI chr 2:178,331,856...178,387,280
Ensembl chr 2:176,049,520...176,089,702
G
S100a4
S100 calcium-binding protein A4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of S100A4 mRNA
CTD
PMID:15336504
NCBI chr 2:178,388,529...178,390,838
Ensembl chr 2:176,091,804...176,093,254
G
S100pbp
S100P binding protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of S100PBP mRNA
CTD
PMID:15336504
NCBI chr 5:141,494,352...141,535,752
Ensembl chr 5:141,494,353...141,535,525
G
Samd4a
sterile alpha motif domain containing 4A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SAMD4A mRNA
CTD
PMID:15336504
NCBI chr15:22,616,200...22,831,872
Ensembl chr15:20,134,377...20,348,380
G
Sap18
Sin3A associated protein 18
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SAP18 mRNA
CTD
PMID:15336504
NCBI chr15:36,058,784...36,063,089
Ensembl chr15:31,943,230...31,950,038 Ensembl chr10:31,943,230...31,950,038
G
Sap30
Sin3A associated protein 30
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SAP30 mRNA
CTD
PMID:15336504
NCBI chr16:37,758,494...37,763,825
Ensembl chr16:32,747,734...32,753,112
G
Sapcd2
suppressor APC domain containing 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SAPCD2 mRNA
CTD
PMID:23410634
NCBI chr 3:28,583,615...28,590,694
Ensembl chr 3:8,187,266...8,192,546
G
Sar1a
secretion associated, Ras related GTPase 1A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SAR1A mRNA
CTD
PMID:15336504
NCBI chr20:30,166,310...30,178,718
Ensembl chr20:29,623,553...29,635,935
G
Sar1b
secretion associated, Ras related GTPase 1B
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SAR1B mRNA
CTD
PMID:15336504
NCBI chr10:36,525,365...36,555,009
Ensembl chr10:36,024,382...36,054,066
G
Saraf
store-operated calcium entry-associated regulatory factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SARAF mRNA
CTD
PMID:15003993
NCBI chr16:64,720,404...64,738,653
Ensembl chr16:58,017,231...58,035,545
G
Sat1
spermidine/spermine N1-acetyl transferase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SAT1 mRNA
CTD
PMID:15336504
NCBI chr X:44,008,089...44,011,376
Ensembl chr X:40,157,046...40,196,813
G
Satb1
SATB homeobox 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SATB1 mRNA
CTD
PMID:15336504
NCBI chr 9:4,916,958...5,010,359
Ensembl chr 9:4,680,920...4,753,251
G
Scarb2
scavenger receptor class B, member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SCARB2 mRNA
CTD
PMID:15336504
NCBI chr14:15,842,583...15,894,123
Ensembl chr14:15,558,236...15,609,813
G
Scd
stearoyl-CoA desaturase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SCD mRNA
CTD
PMID:15336504
NCBI chr 1:253,218,968...253,232,101
Ensembl chr 1:243,269,747...243,282,562
G
Scg5
secretogranin V
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SCG5 mRNA
CTD
PMID:15336504
NCBI chr 3:120,998,420...121,042,881
Ensembl chr 3:100,544,099...100,588,463
G
Scml1
Scm polycomb group protein like 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SCML1 mRNA
CTD
PMID:15336504
NCBI chr X:32,893,100...32,912,686
Ensembl chr X:32,894,327...32,911,366
G
Scp2
sterol carrier protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SCP2 mRNA
CTD
PMID:15336504
NCBI chr 5:128,035,714...128,110,015
Ensembl chr 5:122,776,549...122,881,287
G
Sdc2
syndecan 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SDC2 mRNA
CTD
PMID:15336504
NCBI chr 7:66,012,405...66,125,101
Ensembl chr 7:64,127,110...64,241,081
G
Sec14l1
SEC14-like lipid binding 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SEC14L1 mRNA
CTD
PMID:15336504
NCBI chr10:102,818,693...102,865,841
Ensembl chr10:102,319,920...102,367,068
G
Sec24b
SEC24 homolog B, COPII coat complex component
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SEC24B mRNA
CTD
PMID:23410634
NCBI chr 2:221,236,897...221,306,986
Ensembl chr 2:218,562,676...218,632,699
G
Sectm1b
secreted and transmembrane 1B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SECTM1 mRNA
CTD
PMID:15336504
NCBI chr10:106,822,397...106,832,105
Ensembl chr10:106,325,203...106,333,769
G
Sel1l3
SEL1L family member 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SEL1L3 mRNA
CTD
PMID:15336504
NCBI chr14:61,988,350...62,095,542
Ensembl chr14:57,775,501...57,882,644
G
Selenbp1
selenium binding protein 1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SELENBP1 mRNA tert-Butylhydroperoxide results in increased expression of SELENBP1 mRNA
CTD
PMID:12419474 PMID:15003993
NCBI chr 2:185,183,022...185,193,612
Ensembl chr 2:182,493,978...182,504,594
G
Selenok
selenoprotein K
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SELENOK mRNA
CTD
PMID:15003993
NCBI chr16:5,158,601...5,167,183
Ensembl chr16:5,152,066...5,159,188
G
Selenop
selenoprotein P
multiple interactions decreases response to substance
ISO
dimethyl mercaptosuccinate inhibits the reaction [SELENOP protein results in decreased susceptibility to tert-Butylhydroperoxide]
CTD
PMID:16632112
NCBI chr 2:54,225,736...54,236,022
Ensembl chr 2:52,498,339...52,508,852
G
Sephs1
selenophosphate synthetase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SEPHS1 mRNA
CTD
PMID:15336504
NCBI chr17:78,263,725...78,296,132
Ensembl chr17:73,356,530...73,382,593
G
Septin2
septin 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SEPTIN2 mRNA
CTD
PMID:15336504
NCBI chr 9:101,465,535...101,498,766
Ensembl chr 9:94,018,208...94,051,386
G
Septin9
septin 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SEPTIN9 mRNA
CTD
PMID:15003993
NCBI chr10:102,908,557...103,077,789
Ensembl chr10:102,409,711...102,579,055
G
Serpinb1a
serpin family B member 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SERPINB1 mRNA
CTD
PMID:15336504
NCBI chr17:31,799,446...31,807,853
Ensembl chr17:31,590,677...31,599,102
G
Serpinb2
serpin family B member 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SERPINB2 mRNA
CTD
PMID:15336504
NCBI chr13:24,051,933...24,065,032
Ensembl chr13:23,541,400...23,550,408
G
Serpinb5
serpin family B member 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SERPINB5 mRNA
CTD
PMID:12414654
NCBI chr13:23,500,203...23,520,401
Ensembl chr13:22,985,557...23,005,756
G
Serpinb8
serpin family B member 8
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SERPINB8 mRNA
CTD
PMID:15336504
NCBI chr13:24,141,557...24,164,894
Ensembl chr13:23,626,945...23,650,835
G
Serpine1
serpin family E member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SERPINE1 mRNA
CTD
PMID:15336504
NCBI chr12:25,237,977...25,248,356
Ensembl chr12:19,601,272...19,611,657
G
Serpine2
serpin family E member 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SERPINE2 mRNA
CTD
PMID:15336504
NCBI chr 9:88,573,138...88,637,252
Ensembl chr 9:81,124,804...81,188,826
G
Serpinh1
serpin family H member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SERPINH1 mRNA
CTD
PMID:12766906
NCBI chr 1:163,055,630...163,063,177
Ensembl chr 1:153,643,510...153,650,801
G
Serpini1
serpin family I member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SERPINI1 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 2:162,645,209...162,731,737
Ensembl chr 2:160,346,758...160,433,135
G
Sesn2
sestrin 2
increases expression
ISO EXP
tert-Butylhydroperoxide results in increased expression of SESN2 protein
CTD
PMID:32740777
NCBI chr 5:149,986,304...150,005,255
Ensembl chr 5:144,701,530...144,721,260
G
Setd2
SET domain containing 2, histone lysine methyltransferase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SETD2 mRNA
CTD
PMID:15336504
NCBI chr 8:119,390,207...119,475,863
Ensembl chr 8:110,511,772...110,597,489
G
Setd3
SET domain containing 3, actin N3(tau)-histidine methyltransferase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SETD3 mRNA
CTD
PMID:15336504
NCBI chr 6:132,787,478...132,854,421
Ensembl chr 6:127,023,058...127,090,008
G
Setdb1
SET domain bifurcated histone lysine methyltransferase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SETDB1 mRNA
CTD
PMID:15336504
NCBI chr 2:185,587,722...185,619,084
Ensembl chr 2:182,898,738...182,930,506
G
Sf1
splicing factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SF1 mRNA
CTD
PMID:12419474
NCBI chr 1:213,090,256...213,112,688
Ensembl chr 1:203,670,018...203,684,330
G
Sfpq
splicing factor proline and glutamine rich
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of SFPQ intron
CTD
PMID:29432895
NCBI chr 5:144,621,678...144,637,930
Ensembl chr 5:139,338,075...139,353,472
G
Sgce
sarcoglycan, epsilon
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SGCE mRNA
CTD
PMID:15336504
NCBI chr 4:33,738,066...33,808,907
Ensembl chr 4:32,771,477...32,842,254
G
Sgk2
serum/glucocorticoid regulated kinase 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SGK2 mRNA
CTD
PMID:23410634
NCBI chr 3:172,063,625...172,089,000
Ensembl chr 3:151,644,102...151,669,480
G
Sh2b3
SH2B adaptor protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SH2B3 mRNA
CTD
PMID:15336504
NCBI chr12:40,391,755...40,414,336
Ensembl chr12:34,731,911...34,753,616
G
Sh2d4a
SH2 domain containing 4A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SH2D4A mRNA
CTD
PMID:15336504
NCBI chr16:26,106,721...26,176,069
Ensembl chr16:21,340,015...21,409,260
G
Sh2d5
SH2 domain containing 5
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SH2D5 mRNA
CTD
PMID:23410634
NCBI chr 5:155,753,087...155,763,936
Ensembl chr 5:150,467,728...150,479,955
G
Sh3glb1
SH3 domain -containing GRB2-like endophilin B1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SH3GLB1 mRNA
CTD
PMID:15336504
NCBI chr 2:236,411,194...236,445,225
Ensembl chr 2:233,750,838...233,784,784
G
Shisa5
shisa family member 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SHISA5 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 8:118,569,975...118,584,880
Ensembl chr 8:109,691,522...109,706,408
G
Shmt1
serine hydroxymethyltransferase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SHMT1 mRNA
CTD
PMID:15336504 PMID:27509014
NCBI chr10:45,968,959...45,990,341
Ensembl chr10:45,468,700...45,497,820
G
Siah1
siah E3 ubiquitin protein ligase 1
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of SIAH1A mRNA tert-Butylhydroperoxide affects the expression of SIAH1 mRNA
CTD
PMID:15003993 PMID:23410634
NCBI chr19:36,552,165...36,575,773
Ensembl chr19:20,378,439...20,403,808
G
Sik1
salt-inducible kinase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SIK1 mRNA
CTD
PMID:15336504
NCBI chr20:9,947,104...9,958,729
Ensembl chr20:9,947,396...9,958,991
G
Sin3a
SIN3 transcription regulator family member A
increases localization
EXP
Tert-butyl hydroperoxide increases localization of Sin3a protein at Ar promoter in hepatoma cells
RGD
PMID:18945670
RGD:2306468
NCBI chr 8:66,377,471...66,432,150
Ensembl chr 8:57,481,573...57,536,192
G
Sipa1l1
signal-induced proliferation-associated 1 like 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SIPA1L1 mRNA
CTD
PMID:15336504
NCBI chr 6:107,570,569...107,849,613
Ensembl chr 6:101,839,404...102,116,950
G
Sirt1
sirtuin 1
decreases expression multiple interactions
ISO
tert-Butylhydroperoxide results in decreased expression of SIRT1 protein hyperoside inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of SIRT1 protein]
CTD
PMID:18552516
NCBI chr20:25,305,953...25,328,000
Ensembl chr20:25,306,917...25,329,260
G
Sirt3
sirtuin 3
multiple interactions
ISO
SIRT3 mutant form inhibits the reaction [resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of and results in increased acetylation of SOD2 protein]]; SIRT3 mutant form inhibits the reaction [resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of IDH2 protein]]
CTD
PMID:25522270
NCBI chr 1:205,371,703...205,394,145
Ensembl chr 1:195,942,073...195,964,808
G
Ska3
spindle and kinetochore associated complex subunit 3
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SKA3 mRNA
CTD
PMID:23410634
NCBI chr15:36,067,372...36,086,563
Ensembl chr15:31,951,825...31,971,010
G
Skp2
S-phase kinase associated protein 2
decreases expression decreases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of SKP2 mRNA tert-Butylhydroperoxide results in decreased methylation of SKP2 intron
CTD
PMID:15336504 PMID:29432895
NCBI chr 2:59,888,406...59,916,471
Ensembl chr 2:58,161,229...58,189,338
G
Slamf1
signaling lymphocytic activation molecule family member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLAMF1 mRNA
CTD
PMID:12414654
NCBI chr13:86,802,708...86,837,890
Ensembl chr13:84,270,316...84,305,497
G
Slc11a2
solute carrier family 11 member 2
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC11A2 mRNA tert-Butylhydroperoxide results in decreased expression of SLC11A2 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 7:133,381,878...133,429,921
Ensembl chr 7:131,503,081...131,540,145
G
Slc13a3
solute carrier family 13 member 3
decreases methylation
ISO
tert-Butylhydroperoxide results in decreased methylation of SLC13A3 intron
CTD
PMID:29432895
NCBI chr 3:174,561,174...174,623,893
Ensembl chr 3:154,141,872...154,204,606
G
Slc16a2
solute carrier family 16 member 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC16A2 mRNA
CTD
PMID:15336504
NCBI chr X:72,791,096...72,914,299
Ensembl chr X:68,723,261...68,848,771
G
Slc17a2
solute carrier family 17, member 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SLC17A2 mRNA
CTD
PMID:23410634
NCBI chr17:41,748,195...41,767,601
Ensembl chr17:41,319,701...41,336,325
G
Slc19a2
solute carrier family 19 member 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC19A2 mRNA
CTD
PMID:15336504
NCBI chr13:79,135,118...79,149,316
Ensembl chr13:76,601,900...76,616,172
G
Slc1a1
solute carrier family 1 member 1
decreases expression multiple interactions decreases activity
ISO EXP
tert-Butylhydroperoxide results in decreased expression of SLC1A1 mRNA [Tetradecanoylphorbol Acetate co-treated with Propofol] inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of SLC1A1 protein]
CTD
PMID:15336504 PMID:17382927
NCBI chr 1:235,963,455...236,043,572
Ensembl chr 1:226,549,842...226,630,402
G
Slc1a4
solute carrier family 1 member 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SLC1A4 mRNA
CTD
PMID:15336504
NCBI chr14:98,718,646...98,761,672
Ensembl chr14:94,529,084...94,560,418
G
Slc20a1
solute carrier family 20 member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SLC20A1 mRNA
CTD
PMID:15003993
NCBI chr 3:136,880,360...136,894,255
Ensembl chr 3:116,427,098...116,441,051
G
Slc22a18
solute carrier family 22, member 18
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SLC67A1 mRNA
CTD
PMID:15336504
NCBI chr 1:208,100,032...208,124,382
Ensembl chr 1:198,671,731...198,694,975
G
Slc22a3
solute carrier family 22 member 3
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SLC22A3 mRNA
CTD
PMID:23410634
NCBI chr 1:50,783,218...50,872,358
Ensembl chr 1:48,235,476...48,324,612
G
Slc25a10
solute carrier family 25 member 10
multiple interactions increases expression
EXP ISO
[SLC25A10 protein co-treated with Glutathione] results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of SLC25A10 mRNA
CTD
PMID:12388626 PMID:15003993
NCBI chr10:106,264,396...106,271,895
Ensembl chr10:105,765,372...105,773,556
G
Slc25a16
solute carrier family 25 member 16
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC25A16 mRNA
CTD
PMID:15336504
NCBI chr20:25,659,847...25,717,080
Ensembl chr20:25,662,055...25,716,319
G
Slc27a2
solute carrier family 27 member 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SLC27A2 mRNA
CTD
PMID:23410634
NCBI chr 3:134,258,101...134,295,581
Ensembl chr 3:113,804,728...113,842,208
G
Slc2a3
solute carrier family 2 member 3
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A3 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A3 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of SLC2A3 mRNA; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLC2A3 mRNA]
CTD
PMID:20847119
NCBI chr 4:157,632,887...157,698,034
Ensembl chr 4:155,960,946...156,025,472
G
Slc31a1
solute carrier family 31 member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SLC31A1 mRNA
CTD
PMID:14729362
NCBI chr 5:80,830,574...80,859,810
Ensembl chr 5:75,814,743...75,844,228
G
Slc35f2
solute carrier family 35, member F2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC35F2 mRNA
CTD
PMID:15336504
NCBI chr 8:63,055,503...63,099,791
Ensembl chr 8:54,159,970...54,203,612
G
Slc35g2
solute carrier family 35, member G2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC35G2 mRNA
CTD
PMID:15336504
NCBI chr 8:109,964,589...109,992,347
Ensembl chr 8:101,085,545...101,113,349
G
Slc37a4
solute carrier family 37 member 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SLC37A4 mRNA
CTD
PMID:15336504
NCBI chr 8:53,619,952...53,626,110
Ensembl chr 8:44,723,339...44,729,301
G
Slc39a14
solute carrier family 39 member 14
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC39A14 mRNA
CTD
PMID:15336504
NCBI chr15:51,786,517...51,833,260
Ensembl chr15:45,376,917...45,423,524
G
Slc44a4
solute carrier family 44, member 4
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SLC44A4 mRNA
CTD
PMID:23410634
NCBI chr20:3,907,737...3,923,911
Ensembl chr20:3,903,099...3,919,215
G
Slc46a1
solute carrier family 46 member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SLC46A1 mRNA
CTD
PMID:22956110
NCBI chr10:63,859,551...63,865,987
Ensembl chr10:63,361,486...63,368,848
G
Slc4a1
solute carrier family 4 member 1 (Diego blood group)
increases degradation
ISO
tert-Butylhydroperoxide results in increased degradation of SLC4A1 protein
CTD
PMID:15040847
NCBI chr10:87,807,010...87,823,274
Ensembl chr10:87,306,872...87,323,117
G
Slc4a11
solute carrier family 4 member 11
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC4A11 mRNA
CTD
PMID:29432895
NCBI chr 3:138,353,305...138,365,983
Ensembl chr 3:117,900,223...117,912,674
G
Slc6a14
solute carrier family 6 member 14
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SLC6A14 mRNA
CTD
PMID:23410634
NCBI chr X:117,109,063...117,169,522
Ensembl chr X:112,314,691...112,375,096
G
Slc7a11
solute carrier family 7 member 11
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SLC7A11 mRNA
CTD
PMID:12414654 PMID:23410634
NCBI chr 2:136,532,912...136,668,560
Ensembl chr 2:133,963,107...134,517,536
G
Slc7a5
solute carrier family 7 member 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SLC7A5 mRNA
CTD
PMID:12419474
NCBI chr19:66,843,808...66,872,412
Ensembl chr19:49,935,220...49,963,823
G
Slpi
secretory leukocyte peptidase inhibitor
increases expression decreases response to substance
ISO
tert-Butylhydroperoxide results in increased expression of SLPI mRNA SLPI protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 3:173,501,573...173,503,822
Ensembl chr 3:153,082,369...153,084,453
G
Sltm
SAFB-like, transcription modulator
multiple interactions increases expression
ISO
[Troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of SLTM mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLTM mRNA]; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLTM mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of SLTM mRNA]
CTD
PMID:20847119
NCBI chr 8:71,215,995...71,261,821
Ensembl chr 8:71,216,612...71,261,825
G
Smad1
SMAD family member 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SMAD1 mRNA
CTD
PMID:12419474
NCBI chr19:45,417,430...45,477,962
Ensembl chr19:28,513,131...28,573,651
G
Smad3
SMAD family member 3
increases expression increases methylation
ISO
tert-Butylhydroperoxide results in increased expression of SMAD3 mRNA tert-Butylhydroperoxide results in increased methylation of SMAD3 gene
CTD
PMID:27509014
NCBI chr 8:73,022,204...73,132,324
Ensembl chr 8:64,110,039...64,236,960
G
Smad5
SMAD family member 5
decreases methylation increases expression
ISO
tert-Butylhydroperoxide results in decreased methylation of SMAD5 gene tert-Butylhydroperoxide results in increased expression of SMAD5 mRNA
CTD
PMID:27509014
NCBI chr17:7,867,640...7,896,983
Ensembl chr17:7,864,720...7,891,634
G
Smad7
SMAD family member 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SMAD7 mRNA
CTD
PMID:15336504
NCBI chr18:71,263,508...71,291,849
Ensembl chr18:68,988,429...69,016,765
G
Smad9
SMAD family member 9
decreases expression decreases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of SMAD9 mRNA tert-Butylhydroperoxide results in decreased methylation of SMAD9 gene
CTD
PMID:27509014
NCBI chr 2:141,106,668...141,156,477
Ensembl chr 2:138,986,471...139,006,307
G
Smarca2
SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SMARCA2 mRNA
CTD
PMID:15336504
NCBI chr 1:233,617,277...233,784,908
Ensembl chr 1:224,191,125...224,358,684
G
Smarcc1
SWI/SNF related BAF chromatin remodeling complex subunit C1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SMARCC1 mRNA
CTD
PMID:15336504
NCBI chr 8:118,986,917...119,093,161
Ensembl chr 8:110,111,122...110,214,720
G
Smarcc2
SWI/SNF related BAF chromatin remodeling complex subunit C2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SMARCC2 mRNA
CTD
PMID:15336504
NCBI chr 7:881,844...910,090
Ensembl chr 7:881,421...909,978
G
Smc4
structural maintenance of chromosomes 4
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of SMC4 mRNA tert-Butylhydroperoxide affects the expression of SMC4 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 2:155,550,262...155,578,695
Ensembl chr 2:153,240,283...153,271,571
G
Smim19
small integral membrane protein 19
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SMIM19 mRNA
CTD
PMID:23410634
NCBI chr16:69,551,507...69,564,323
Ensembl chr16:69,553,916...69,567,245
G
Smim7
small integral membrane protein 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SMIM7 mRNA
CTD
PMID:15336504
NCBI chr16:17,308,466...17,312,384
Ensembl chr16:17,273,258...17,278,336
G
Smndc1
survival motor neuron domain containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SMNDC1 mRNA
CTD
PMID:15336504
NCBI chr 1:262,395,034...262,406,104
Ensembl chr 1:252,389,673...252,401,616
G
Smox
spermine oxidase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SMOX mRNA
CTD
PMID:15336504
NCBI chr 3:139,184,793...139,220,174
Ensembl chr 3:118,731,900...118,765,710 Ensembl chr X:118,731,900...118,765,710
G
Smtn
smoothelin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SMTN mRNA
CTD
PMID:15336504
NCBI chr14:82,622,223...82,644,525
Ensembl chr14:78,397,778...78,420,886
G
Snai2
snail family transcriptional repressor 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SNAI2 mRNA
CTD
PMID:15336504
NCBI chr11:99,686,934...99,690,349
Ensembl chr11:86,181,909...86,186,200
G
Snap23
synaptosome associated protein 23
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SNAP23 mRNA
CTD
PMID:15336504
NCBI chr 3:127,966,184...127,999,929
Ensembl chr 3:107,514,131...107,544,320
G
Snn
stannin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SNN mRNA
CTD
PMID:15336504
NCBI chr10:5,079,885...5,088,565
Ensembl chr10:4,572,376...4,584,021 Ensembl chr 1:4,572,376...4,584,021
G
Snx1
sorting nexin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SNX1 mRNA
CTD
PMID:15336504
NCBI chr 8:75,515,780...75,565,487
Ensembl chr 8:66,630,086...66,670,360
G
Snx4
sorting nexin 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SNX4 mRNA
CTD
PMID:15336504
NCBI chr11:80,965,965...81,023,234
Ensembl chr11:67,460,870...67,518,174
G
Soat1
sterol O-acyltransferase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SOAT1 mRNA
CTD
PMID:15336504
NCBI chr13:71,105,178...71,147,776
Ensembl chr13:68,552,317...68,597,494
G
Sobp
sine oculis binding protein homolog
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SOBP mRNA
CTD
PMID:15336504
NCBI chr20:46,482,265...46,661,452
Ensembl chr20:46,482,765...46,663,541
G
Socs1
suppressor of cytokine signaling 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SOCS1 mRNA
CTD
PMID:15003993
NCBI chr10:5,389,574...5,391,265
Ensembl chr10:4,882,560...4,884,383
G
Socs6
suppressor of cytokine signaling 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SOCS6 mRNA
CTD
PMID:15336504
NCBI chr18:84,386,587...84,413,927
Ensembl chr18:82,111,827...82,139,219
G
Sod1
superoxide dismutase 1
decreases response to substance increases activity increases expression multiple interactions
ISO
SOD1 protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased activity of SOD1 protein tert-Butylhydroperoxide results in increased expression of SOD1 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of SOD1 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of SOD1 mRNA]; LGM2605 promotes the reaction [tert-Butylhydroperoxide results in increased expression of SOD1 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of SOD1 mRNA]
CTD
PMID:14729362 PMID:15003993 PMID:15336504 PMID:15849717 PMID:31627909 PMID:35690295 More...
NCBI chr11:42,942,742...42,948,399
Ensembl chr11:29,456,558...29,462,249
G
Sod2
superoxide dismutase 2
increases response to substance increases activity increases expression affects response to substance multiple interactions decreases expression
ISO
SOD2 gene mutant form results in increased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased activity of SOD2 protein tert-Butylhydroperoxide results in increased expression of SOD2 mRNA SOD2 protein affects the susceptibility to tert-Butylhydroperoxide 3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of SOD2 protein]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of SOD2 mRNA; LGM2605 promotes the reaction [tert-Butylhydroperoxide results in increased expression of SOD2 mRNA]; MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of SOD2 mRNA]; Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of SOD2 protein]; Quercetin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of SOD2 protein]; Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of and results in increased acetylation of SOD2 protein]; SIRT3 mutant form inhibits the reaction [Resveratrol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of and results in increased acetylation of SOD2 protein]]; tert-Butylhydroperoxide results in decreased activity of and results in increased acetylation of SOD2 protein
CTD
PMID:15182862 PMID:15336504 PMID:16636651 PMID:16704919 PMID:17003459 PMID:20107204 PMID:25522270 PMID:27050144 PMID:27509014 PMID:29128606 PMID:31627909 PMID:35690295 More...
NCBI chr 1:50,043,323...50,050,168
Ensembl chr 1:47,636,528...47,645,189
G
Sord
sorbitol dehydrogenase
increases expression increases activity decreases expression
ISO EXP
tert-Butylhydroperoxide results in increased expression of SORD mRNA tert-Butylhydroperoxide results in increased activity of SORD protein tert-Butylhydroperoxide results in decreased expression of SORD protein
CTD
PMID:15336504 PMID:16928893 PMID:24394546
NCBI chr 3:129,638,282...129,669,727
Ensembl chr 3:109,184,676...109,216,133
G
Sox9
SRY-box transcription factor 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SOX9 mRNA
CTD
PMID:15336504
NCBI chr10:98,305,744...98,311,250
Ensembl chr10:97,806,485...97,811,994
G
Sp100
SP100 nuclear antigen
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SP100 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 9:93,758,975...93,825,068
Ensembl chr 9:86,311,032...86,377,034
G
Sp2
Sp2 transcription factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SP2 mRNA
CTD
PMID:12419474
NCBI chr10:82,437,024...82,467,583
Ensembl chr10:81,940,587...81,970,548
G
Spag5
sperm associated antigen 5
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SPAG5 mRNA
CTD
PMID:23410634
NCBI chr10:63,693,300...63,714,813
Ensembl chr10:63,198,768...63,216,745
G
Sparc
secreted protein acidic and cysteine rich
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SPARC mRNA tert-Butylhydroperoxide results in increased expression of SPARC mRNA
CTD
PMID:15336504 PMID:15963989
NCBI chr10:40,017,065...40,038,816
Ensembl chr10:39,516,406...39,538,396
G
Spata20
spermatogenesis associated 20
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SPATA20 mRNA
CTD
PMID:15336504
NCBI chr10:79,924,407...79,932,351
Ensembl chr10:79,427,528...79,434,368
G
Spdl1
spindle apparatus coiled-coil protein 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SPDL1 mRNA
CTD
PMID:23410634
NCBI chr10:19,773,456...19,798,341
Ensembl chr10:19,269,127...19,294,127
G
Sphk1
sphingosine kinase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SPHK1 mRNA
CTD
PMID:15336504
NCBI chr10:102,257,413...102,263,086
Ensembl chr10:101,758,711...101,764,240
G
Spint2
serine peptidase inhibitor, Kunitz type, 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SPINT2 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr 1:93,685,637...93,708,091
Ensembl chr 1:84,558,166...84,580,616
G
Spred2
sprouty-related, EVH1 domain containing 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SPRED2 mRNA
CTD
PMID:15336504
NCBI chr14:98,350,577...98,452,143
Ensembl chr14:94,148,837...94,249,162
G
Sprr1a
small proline-rich protein 1A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SPRR1A mRNA
CTD
PMID:15003993
NCBI chr 2:180,750,709...180,752,625
Ensembl chr 2:178,055,096...178,057,063
G
Spry4
sprouty RTK signaling antagonist 4
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SPRY4 mRNA
CTD
PMID:23410634
NCBI chr18:30,687,633...30,702,546
Ensembl chr18:30,436,443...30,453,004
G
Spta1
spectrin, alpha, erythrocytic 1
multiple interactions
ISO
tert-Butylhydroperoxide results in increased degradation of [SPTA1 protein binds to SPTB protein]
CTD
PMID:15040847
NCBI chr13:88,735,833...88,811,697
Ensembl chr13:86,203,504...86,279,371
G
Sptan1
spectrin, alpha, non-erythrocytic 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SPTAN1 mRNA
CTD
PMID:15336504
NCBI chr 3:33,639,020...33,703,890
Ensembl chr 3:13,241,217...13,306,046
G
Sptb
spectrin, beta, erythrocytic
multiple interactions
ISO
tert-Butylhydroperoxide results in increased degradation of [SPTA1 protein binds to SPTB protein]
CTD
PMID:15040847
NCBI chr 6:101,043,512...101,170,389
Ensembl chr 6:95,310,326...95,437,118
G
Sptbn1
spectrin, beta, non-erythrocytic 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SPTBN1 mRNA
CTD
PMID:15336504
NCBI chr14:108,042,629...108,217,884
Ensembl chr14:103,842,684...104,008,507
G
Sptlc1
serine palmitoyltransferase, long chain base subunit 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SPTLC1 mRNA
CTD
PMID:15336504
NCBI chr17:12,029,189...12,068,234
Ensembl chr17:11,877,249...11,916,295
G
Sptlc2
serine palmitoyltransferase, long chain base subunit 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SPTLC2 mRNA
CTD
PMID:15336504
NCBI chr 6:112,679,623...112,762,470
Ensembl chr 6:106,950,949...107,031,542
G
Sptssa
serine palmitoyltransferase, small subunit A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SPTSSA mRNA
CTD
PMID:15336504
NCBI chr 6:77,879,931...77,891,344
Ensembl chr 6:72,144,714...72,156,214
G
Sqle
squalene epoxidase
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SQLE mRNA tert-Butylhydroperoxide results in increased expression of SQLE mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr 7:92,758,175...92,773,049
Ensembl chr 7:90,868,011...90,883,618
G
Sqor
sulfide quinone oxidoreductase
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of SQOR mRNA tert-Butylhydroperoxide affects the expression of SQOR mRNA
CTD
PMID:14729362 PMID:15336504 PMID:23410634
NCBI chr 3:130,294,783...130,341,655
Ensembl chr 3:109,841,250...109,960,778
G
Sqstm1
sequestosome 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SQSTM1 mRNA
CTD
PMID:23410634
NCBI chr10:35,026,598...35,037,750
Ensembl chr10:34,525,519...34,536,673
G
Srf
serum response factor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SRF mRNA
CTD
PMID:12419474
NCBI chr 9:21,924,050...21,933,338
Ensembl chr 9:14,426,472...14,435,733
G
Srgn
serglycin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SRGN mRNA
CTD
PMID:15336504
NCBI chr20:30,985,508...31,022,296
Ensembl chr20:30,442,813...30,457,406
G
Srpk2
SRSF protein kinase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SRPK2 mRNA
CTD
PMID:15336504
NCBI chr 4:12,356,983...12,548,345
Ensembl chr 4:11,464,674...11,655,990
G
Srpra
SRP receptor subunit alpha
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SRPRA mRNA
CTD
PMID:15336504
NCBI chr 8:41,818,199...41,824,292
Ensembl chr 8:33,560,348...33,566,470
G
Srpx
sushi-repeat-containing protein, X-linked
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SRPX mRNA
CTD
PMID:15336504
NCBI chr X:15,349,498...15,420,389
Ensembl chr X:12,566,645...12,747,882
G
Srrd
SRR1 domain containing
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SRRD mRNA
CTD
PMID:15336504
NCBI chr12:49,955,081...49,960,693
Ensembl chr12:44,294,271...44,300,287
G
Srrt
serrate, RNA effector molecule
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SRRT mRNA
CTD
PMID:15336504
NCBI chr12:25,027,883...25,042,847
Ensembl chr12:19,392,625...19,406,095
G
Srsf3
serine and arginine rich splicing factor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SRSF3 mRNA
CTD
PMID:15336504
NCBI chr20:7,093,529...7,103,517
Ensembl chr20:7,091,910...7,101,078
G
Srxn1
sulfiredoxin 1
increases expression decreases methylation
ISO
tert-Butylhydroperoxide results in increased expression of SRXN1 mRNA tert-Butylhydroperoxide results in decreased methylation of SRXN1 gene
CTD
PMID:22003191 PMID:23410634 PMID:27509014
NCBI chr 3:161,064,812...161,070,372
Ensembl chr 3:140,599,608...140,628,448
G
Ss18l1
SS18L1 subunit of BAF chromatin remodeling complex
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SS18L1 mRNA
CTD
PMID:15336504
NCBI chr 3:187,521,616...187,542,873
Ensembl chr 3:167,143,994...167,165,253
G
Sst
somatostatin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SST mRNA
CTD
PMID:12414654
NCBI chr11:90,461,546...90,462,823
Ensembl chr11:76,956,896...76,958,173
G
Ssx2ip
SSX family member 2 interacting protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SSX2IP mRNA
CTD
PMID:15336504
NCBI chr 2:237,958,286...237,991,026
Ensembl chr 2:235,298,088...235,330,745
G
St3gal1
ST3 beta-galactoside alpha-2,3-sialyltransferase 1
multiple interactions increases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ST3GAL1 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ST3GAL1 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ST3GAL1 mRNA; pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ST3GAL1 mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ST3GAL1 mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ST3GAL1 mRNA]
CTD
PMID:20847119
NCBI chr 7:100,734,300...100,802,443
Ensembl chr 7:98,845,270...98,913,236
G
St6galnac4
ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ST6GALNAC4 mRNA
CTD
PMID:15003993
NCBI chr 3:36,269,834...36,282,971
Ensembl chr 3:15,872,532...15,885,243
G
St7
suppression of tumorigenicity 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ST7 mRNA
CTD
PMID:15336504
NCBI chr 4:46,041,655...46,289,745
Ensembl chr 4:46,042,236...46,289,740
G
Stag1
STAG1 cohesin complex component
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of STAG1 mRNA
CTD
PMID:15336504
NCBI chr 8:110,057,981...110,443,666
Ensembl chr 8:101,179,039...101,564,677
G
Stat1
signal transducer and activator of transcription 1
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of STAT1 mRNA tert-Butylhydroperoxide results in increased expression of STAT1 mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 9:56,911,522...56,951,926
Ensembl chr 9:49,419,340...49,588,540
G
Stat3
signal transducer and activator of transcription 3
multiple interactions decreases phosphorylation
ISO
3,4-dihydroxyphenyllactic acid inhibits the reaction [tert-Butylhydroperoxide results in decreased phosphorylation of STAT3 protein]
CTD
PMID:29128606
NCBI chr10:86,311,528...86,363,513
Ensembl chr10:85,811,218...85,863,057
G
Stat5a
signal transducer and activator of transcription 5A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of STAT5A mRNA
CTD
PMID:12766906
NCBI chr10:86,285,859...86,310,187
Ensembl chr10:85,785,537...85,809,866
G
Stat6
signal transducer and activator of transcription 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of STAT6 mRNA
CTD
PMID:12419474
NCBI chr 7:65,365,505...65,382,825
Ensembl chr 7:63,479,642...63,498,495
G
Stc1
stanniocalcin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of STC1 mRNA
CTD
PMID:15336504
NCBI chr15:50,709,439...50,720,093
Ensembl chr15:44,299,621...44,310,264
G
Stc2
stanniocalcin 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of STC2 mRNA
CTD
PMID:15336504
NCBI chr10:16,755,508...16,765,275
Ensembl chr10:16,250,853...16,262,973
G
Stk10
serine/threonine kinase 10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of STK10 mRNA
CTD
PMID:15336504
NCBI chr10:17,622,149...17,716,337
Ensembl chr10:17,117,878...17,212,061
G
Stk24
serine/threonine kinase 24
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of STK24 mRNA
CTD
PMID:15336504
NCBI chr15:104,770,556...104,866,524
Ensembl chr15:98,365,791...98,460,553
G
Stmn1
stathmin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of STMN1 mRNA
CTD
PMID:15336504
NCBI chr 5:151,964,308...151,970,843
Ensembl chr 5:146,681,436...146,687,154
G
Stx7
syntaxin 7
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of STX7 mRNA
CTD
PMID:15336504
NCBI chr 1:23,016,330...23,056,579
Ensembl chr 1:21,197,075...21,237,279
G
Sugp2
SURP and G patch domain containing 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SUGP2 mRNA
CTD
PMID:15336504
NCBI chr16:19,193,910...19,225,364
Ensembl chr16:19,164,767...19,191,340
G
Sumo3
small ubiquitin-like modifier 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SUMO3 mRNA
CTD
PMID:29432895
NCBI chr20:11,009,730...11,020,502
Ensembl chr20:11,007,148...11,020,877 Ensembl chr20:11,007,148...11,020,877
G
Suox
sulfite oxidase
affects expression
ISO
tert-Butylhydroperoxide affects the expression of SUOX mRNA
CTD
PMID:23410634
NCBI chr 7:1,687,666...1,691,759
Ensembl chr 7:1,103,151...1,107,038
G
Susd6
sushi domain containing 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SUSD6 mRNA
CTD
PMID:15336504
NCBI chr 6:100,437,834...100,531,621
Ensembl chr 6:100,437,642...100,531,606
G
Synj2
synaptojanin 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of SYNJ2 mRNA
CTD
PMID:15336504
NCBI chr 1:48,923,742...49,027,153
Ensembl chr 1:46,518,709...46,633,687
G
Syt1
synaptotagmin 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of SYT1 mRNA
CTD
PMID:15336504
NCBI chr 7:45,699,649...46,244,460
Ensembl chr 7:43,815,785...44,357,803
G
Tada3
transcriptional adaptor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TADA3 mRNA
CTD
PMID:12419474
NCBI chr 4:148,065,859...148,077,347
Ensembl chr 4:146,510,246...146,521,590
G
Tap1
transporter 1, ATP binding cassette subfamily B member
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TAP1 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr20:4,658,171...4,668,543
Ensembl chr20:4,656,263...4,666,901
G
Tapbpl
TAP binding protein-like
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TAPBPL mRNA
CTD
PMID:15336504
NCBI chr 4:159,707,686...159,715,137
G
Tasor
transcription activation suppressor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TASOR mRNA
CTD
PMID:15336504
NCBI chr16:2,612,942...2,669,870
Ensembl chr16:2,603,936...2,667,292
G
Tbc1d22a
TBC1 domain family, member 22a
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TBC1D22A mRNA
CTD
PMID:15336504
NCBI chr 7:119,172,284...119,457,271
Ensembl chr 7:117,292,631...117,577,483
G
Tbl1xr1
TBL1X/Y related 1
affects expression decreases methylation
ISO
tert-Butylhydroperoxide affects the expression of TBL1XR1 mRNA tert-Butylhydroperoxide results in decreased methylation of TBL1XR1 intron
CTD
PMID:23410634 PMID:29432895
NCBI chr 2:106,718,811...106,857,989
Ensembl chr 2:104,801,721...104,929,055
G
Tbrg1
transforming growth factor beta regulator 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TBRG1 mRNA
CTD
PMID:14729362
NCBI chr 8:37,355,274...37,362,933
Ensembl chr 8:37,354,658...37,362,930
G
Tcaf1
TRPM8 channel-associated factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TCAF1 mRNA
CTD
PMID:15336504
NCBI chr 4:72,589,710...72,639,304
Ensembl chr 4:71,591,200...71,613,309
G
Tcea1
transcription elongation factor A1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TCEA1 mRNA
CTD
PMID:12419474
NCBI chr 5:19,414,351...19,466,629
Ensembl chr 5:14,631,454...14,668,745 Ensembl chr15:14,631,454...14,668,745
G
Tcf3
transcription factor 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TCF3 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr 7:9,931,251...9,952,994
Ensembl chr 7:9,280,571...9,302,314
G
Tcf4
transcription factor 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TCF4 mRNA
CTD
PMID:15336504
NCBI chr18:65,216,840...65,563,186
Ensembl chr18:62,943,782...63,284,425
G
Tcfl5
transcription factor like 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TCFL5 mRNA
CTD
PMID:15336504
NCBI chr 3:188,112,037...188,131,883
Ensembl chr 3:167,734,473...167,754,282
G
Tead4
TEA domain transcription factor 4
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of TEAD4 mRNA tert-Butylhydroperoxide affects the expression of TEAD4 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 4:163,180,192...163,258,342
Ensembl chr 4:161,497,851...161,572,323
G
Tenm4
teneurin transmembrane protein 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TENM4 mRNA
CTD
PMID:15336504
NCBI chr 1:157,699,611...160,674,549
Ensembl chr 1:150,780,381...151,259,144
G
Tent2
terminal nucleotidyltransferase 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of TENT2 mRNA
CTD
PMID:23410634
NCBI chr 2:26,115,150...26,167,465
Ensembl chr 2:24,380,225...24,432,099
G
Terf1
telomeric repeat binding factor 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TERF1 mRNA
CTD
PMID:12419474
NCBI chr 5:8,226,345...8,255,614
Ensembl chr 5:3,443,106...3,472,340
G
Tet1
tet methylcytosine dioxygenase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TET1 mRNA
CTD
PMID:27509014
NCBI chr20:25,766,806...25,839,598
Ensembl chr20:25,768,120...25,833,052
G
Tex10
testis expressed 10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TEX10 mRNA
CTD
PMID:15336504
NCBI chr 5:62,762,230...62,808,373
Ensembl chr 5:62,762,230...62,808,373
G
Tfcp2
transcription factor CP2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TFCP2 mRNA
CTD
PMID:15336504
NCBI chr 7:133,495,577...133,537,799
Ensembl chr 7:131,616,785...131,658,939
G
Tfdp1
transcription factor Dp-1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TFDP1 mRNA
CTD
PMID:15336504
NCBI chr16:82,864,220...82,903,166
Ensembl chr16:76,162,043...76,200,817
G
Tfpi2
tissue factor pathway inhibitor 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TFPI2 mRNA
CTD
PMID:15336504
NCBI chr 4:32,936,462...32,941,385
Ensembl chr 4:31,982,178...31,986,600
G
Tfrc
transferrin receptor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TFRC mRNA
CTD
PMID:15336504 PMID:15963989
NCBI chr11:81,668,478...81,690,318
Ensembl chr11:68,163,413...68,185,257
G
Tgfa
transforming growth factor alpha
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TGFA mRNA
CTD
PMID:15336504
NCBI chr 4:120,175,549...120,258,342
Ensembl chr 4:118,618,269...118,700,894
G
Tgfb1
transforming growth factor, beta 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TGFB1 mRNA; tert-Butylhydroperoxide results in increased expression of TGFB1 protein
CTD
PMID:15147944 PMID:15336504 PMID:15963989
NCBI chr 1:90,324,312...90,340,627
Ensembl chr 1:81,196,532...81,212,847
G
Tgfb1i1
transforming growth factor beta 1 induced transcript 1
increases expression affects expression
ISO
tert-Butylhydroperoxide results in increased expression of TGFB1I1 mRNA tert-Butylhydroperoxide affects the expression of TGFB1I1 mRNA
CTD
PMID:15336504 PMID:23410634
NCBI chr 1:192,258,992...192,265,903
Ensembl chr 1:182,828,544...182,837,080
G
Tgm2
transglutaminase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TGM2 mRNA
CTD
PMID:15336504
NCBI chr 3:167,192,612...167,221,845
Ensembl chr 3:146,772,687...146,801,981
G
Tgoln2
trans-golgi network protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TGOLN2 mRNA
CTD
PMID:15336504
NCBI chr 4:106,221,503...106,229,360
Ensembl chr 4:104,663,353...104,671,164
G
Thap1
THAP domain containing 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of THAP1 mRNA
CTD
PMID:23410634
NCBI chr16:72,608,096...72,612,690
Ensembl chr16:65,904,230...65,909,942
G
Thbd
thrombomodulin
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of THBD mRNA
CTD
PMID:15336504
NCBI chr 3:156,316,526...156,320,178
Ensembl chr 3:135,862,835...135,867,193
G
Thbs1
thrombospondin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of THBS1 mRNA
CTD
PMID:29432895
NCBI chr 3:125,510,250...125,525,402
Ensembl chr 3:105,056,292...105,071,440
G
Thbs3
thrombospondin 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of THBS3 mRNA
CTD
PMID:14729362
NCBI chr 2:176,919,549...176,931,357
Ensembl chr 2:174,621,812...174,633,594
G
Them6
thioesterase superfamily member 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of THEM6 mRNA
CTD
PMID:15336504
NCBI chr 7:108,495,554...108,498,731
Ensembl chr 7:106,606,570...106,609,746
G
Thoc6
THO complex subunit 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of THOC6 mRNA
CTD
PMID:15336504
NCBI chr10:13,204,643...13,210,004
Ensembl chr10:12,700,051...12,706,925
G
Tia1
TIA1 cytotoxic granule-associated RNA binding protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TIA1 mRNA
CTD
PMID:15336504
NCBI chr 4:120,410,180...120,440,676
Ensembl chr 4:118,852,837...118,880,586
G
Tial1
Tia1 cytotoxic granule-associated RNA binding protein-like 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TIAL1 mRNA
CTD
PMID:15336504
NCBI chr 1:192,438,794...192,475,520
Ensembl chr 1:183,009,253...183,031,637
G
Tie1
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TIE1 mRNA
CTD
PMID:15336504
NCBI chr 5:137,285,408...137,305,047
Ensembl chr 5:132,000,015...132,019,592
G
Timm22
translocase of inner mitochondrial membrane 22
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TIMM22 mRNA
CTD
PMID:15003993
NCBI chr10:61,751,686...61,759,444
Ensembl chr10:61,253,450...61,261,755
G
Timm9
translocase of inner mitochondrial membrane 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TIMM9 mRNA
CTD
PMID:15336504
NCBI chr 6:95,346,065...95,358,895
Ensembl chr 6:89,610,094...89,622,924
G
Timp3
TIMP metallopeptidase inhibitor 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TIMP3 mRNA
CTD
PMID:15336504
NCBI chr 7:19,408,539...19,459,558
Ensembl chr 7:17,521,919...17,571,839
G
Tinagl1
tubulointerstitial nephritis antigen-like 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TINAGL1 mRNA
CTD
PMID:15003993
NCBI chr 5:147,797,884...147,807,925
Ensembl chr 5:142,513,714...142,523,720
G
Tiparp
TCDD-inducible poly(ADP-ribose) polymerase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TIPARP mRNA
CTD
PMID:15336504
NCBI chr 2:152,063,769...152,090,414
Ensembl chr 2:149,753,682...149,780,327
G
Tjp1
tight junction protein 1
multiple interactions affects localization
EXP
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]; 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]; Bucladesine inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]; Go 6976 inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]; Staurosporine inhibits the reaction [tert-Butylhydroperoxide affects the localization of TJP1 protein]
CTD
PMID:16716901
NCBI chr 1:128,260,330...128,505,018
Ensembl chr 1:118,849,838...119,094,432
G
Tk1
thymidine kinase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TK1 mRNA
CTD
PMID:12414654
NCBI chr10:103,533,449...103,544,818
Ensembl chr10:103,031,521...103,046,920
G
Tkfc
triokinase and FMN cyclase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TKFC mRNA
CTD
PMID:15336504
NCBI chr 1:216,664,446...216,677,815
Ensembl chr 1:207,236,557...207,252,737
G
Tle3
TLE family member 3, transcriptional corepressor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TLE3 mRNA
CTD
PMID:15336504
NCBI chr 8:70,753,182...70,799,080
Ensembl chr 8:61,858,200...61,903,493
G
Tle4
TLE family member 4, transcriptional corepressor
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TLE4 mRNA
CTD
PMID:15336504
NCBI chr 1:221,086,250...221,222,826
Ensembl chr 1:211,661,746...211,797,862
G
Tle5
TLE family member 5, transcriptional modulator
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TLE5 mRNA tert-Butylhydroperoxide results in increased expression of TLE5 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr 7:8,794,123...8,801,056
Ensembl chr 7:8,143,357...8,150,113
G
Tlr4
toll-like receptor 4
multiple interactions
ISO
1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein]]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]]; tert-Butylhydroperoxide promotes the reaction [HMGB1 protein binds to LY96 protein binds to TLR4 protein]; tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein binds to HMGB1 protein]; tert-Butylhydroperoxide promotes the reaction [LY96 protein binds to TLR4 protein]; tert-Butylhydroperoxide promotes the reaction [NOX4 protein binds to LY96 protein binds to TLR4 protein]
CTD
PMID:28063877 PMID:29111459
NCBI chr 5:85,161,247...85,174,882
Ensembl chr 5:80,145,826...80,159,628
G
Tm4sf1
transmembrane 4 L six family member 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TM4SF1 mRNA
CTD
PMID:12766906 PMID:15336504
NCBI chr 2:143,606,980...143,616,176
Ensembl chr 2:141,453,310...141,466,146
G
Tm7sf2
transmembrane 7 superfamily member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TM7SF2 mRNA
CTD
PMID:15336504
NCBI chr 1:212,785,217...212,789,572
Ensembl chr 1:203,355,931...203,360,270
G
Tm9sf2
transmembrane 9 superfamily member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TM9SF2 mRNA
CTD
PMID:15336504
NCBI chr15:105,606,082...105,660,715
Ensembl chr15:99,201,489...99,254,049
G
Tm9sf3
transmembrane 9 superfamily member 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TM9SF3 mRNA
CTD
PMID:15336504
NCBI chr 1:249,981,458...250,034,247
Ensembl chr 1:240,035,003...240,084,776
G
Tmco3
transmembrane and coiled-coil domains 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMCO3 mRNA
CTD
PMID:15336504
NCBI chr16:82,919,324...82,956,485
Ensembl chr16:76,217,201...76,254,107
G
Tmem106c
transmembrane protein 106C
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMEM106C mRNA
CTD
PMID:15336504
NCBI chr 7:129,088,468...129,094,128
Ensembl chr 7:129,088,498...129,094,130
G
Tmem132a
transmembrane protein 132A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TMEM132A mRNA
CTD
PMID:15336504
NCBI chr 1:216,931,962...216,943,644
Ensembl chr 1:207,507,077...207,518,758
G
Tmem158
transmembrane protein 158
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TMEM158 mRNA
CTD
PMID:15336504
NCBI chr 8:131,791,137...131,792,135
Ensembl chr 8:122,913,675...122,914,673
G
Tmem177
transmembrane protein 177
multiple interactions increases expression decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of TMEM177 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of TMEM177 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of TMEM177 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of TMEM177 mRNA] tert-Butylhydroperoxide results in increased expression of TMEM177 mRNA
CTD
PMID:15336504 PMID:20847119
NCBI chr13:31,023,893...31,027,368
Ensembl chr13:31,023,455...31,027,378
G
Tmem205
transmembrane protein 205
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TMEM205 mRNA
CTD
PMID:14729362
NCBI chr 8:28,728,172...28,733,908
Ensembl chr 8:20,452,092...20,457,828
G
Tmem248
transmembrane protein 248
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMEM248 mRNA
CTD
PMID:15336504
NCBI chr12:32,069,113...32,093,380
Ensembl chr12:26,432,953...26,457,105
G
Tmem80
transmembrane protein 80
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMEM80 mRNA
CTD
PMID:15336504
NCBI chr 1:205,865,564...205,873,933
Ensembl chr 1:196,436,003...196,444,367 Ensembl chr 1:196,436,003...196,444,367
G
Tmpo
thymopoietin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMPO mRNA
CTD
PMID:12414654 PMID:15336504
NCBI chr 7:27,529,977...27,554,980
Ensembl chr 7:25,586,725...25,667,727
G
Tmsb10
thymosin, beta 10
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TMSB10 mRNA
CTD
PMID:15003993
NCBI chr 4:106,568,080...106,569,210
Ensembl chr 4:105,009,212...105,011,028
G
Tmsb15b2
thymosin beta 15B2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMSB15A mRNA
CTD
PMID:15336504
NCBI chr X:105,090,980...105,093,094
Ensembl chr X:100,298,514...100,300,886
G
Tmt1a
thiol methyltransferase 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMT1A mRNA
CTD
PMID:15336504
NCBI chr 7:133,330,141...133,377,172
Ensembl chr 7:131,451,641...131,460,154
G
Tmx4
thioredoxin-related transmembrane protein 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TMX4 mRNA
CTD
PMID:15336504
NCBI chr 3:142,309,026...142,352,415
Ensembl chr 3:121,856,261...121,899,641
G
Tnc
tenascin C
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TNC mRNA
CTD
PMID:15336504
NCBI chr 5:82,391,340...82,476,197
Ensembl chr 5:77,375,851...77,460,624
G
Tnf
tumor necrosis factor
multiple interactions increases secretion increases expression
ISO EXP
1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; 8-methoxymethyl-3-isobutyl-1-methylxanthine inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; Verapamil inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; W 7 inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein] tert-Butylhydroperoxide promotes the reaction [Lipopolysaccharides results in increased secretion of TNF protein] tert-Butylhydroperoxide results in increased expression of TNF mRNA 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of TNF mRNA]; 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TNF mRNA; acetovanillone inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]; Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased expression of TNF mRNA]; Grape Seed Extract inhibits the reaction [tert-Butylhydroperoxide results in increased expression of TNF mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased expression of TNF mRNA]; LY96 protein affects the reaction [tert-Butylhydroperoxide results in increased secretion of TNF protein]
CTD
PMID:10231168 PMID:17129690 PMID:17369293 PMID:29111459 PMID:29935159 PMID:35690295 More...
NCBI chr20:3,626,685...3,629,303
Ensembl chr20:3,622,011...3,624,629
G
Tnfaip3
TNF alpha induced protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TNFAIP3 mRNA
CTD
PMID:15336504
NCBI chr 1:15,528,921...15,543,993
Ensembl chr 1:13,709,206...13,725,282
G
Tnfrsf1a
TNF receptor superfamily member 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TNFRSF1A mRNA
CTD
PMID:12419474
NCBI chr 4:159,837,119...159,849,817
Ensembl chr 4:158,150,820...158,163,591
G
Tnfrsf9
TNF receptor superfamily member 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TNFRSF9 mRNA
CTD
PMID:15003993
NCBI chr 5:166,664,494...166,690,834
Ensembl chr 5:161,381,662...161,408,000
G
Tnfsf10
TNF superfamily member 10
decreases expression multiple interactions
ISO
tert-Butylhydroperoxide results in decreased expression of TNFSF10 mRNA [Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TNFSF10 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TNFSF10 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TNFSF10 mRNA]
CTD
PMID:15336504 PMID:35690295
NCBI chr 2:112,136,550...112,155,903
Ensembl chr 2:110,207,916...110,225,135
G
Tnnc1
troponin C1, slow skeletal and cardiac type
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TNNC1 mRNA tert-Butylhydroperoxide results in increased expression of TNNC1 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr16:6,408,607...6,412,070
Ensembl chr16:6,402,171...6,405,634
G
Tnnt1
troponin T1, slow skeletal type
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TNNT1 mRNA
CTD
PMID:15336504
NCBI chr 1:78,349,035...78,359,394
Ensembl chr 1:69,306,362...69,316,721
G
Tnnt2
troponin T2, cardiac type
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TNNT2 mRNA
CTD
PMID:14729362
NCBI chr13:49,819,123...49,837,125
Ensembl chr13:47,267,204...47,285,388
G
Tnpo1
transportin 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TNPO1 mRNA
CTD
PMID:15336504
NCBI chr 2:31,941,731...32,034,366
Ensembl chr 2:30,211,510...30,300,375
G
Tnpo2
transportin 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TNPO2 mRNA
CTD
PMID:15336504
NCBI chr19:40,004,271...40,024,565
Ensembl chr19:23,099,401...23,119,596
G
Tom1
target of myb1 membrane trafficking protein
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TOM1 mRNA
CTD
PMID:12414654
NCBI chr19:13,411,227...13,446,129
Ensembl chr19:13,405,501...13,440,384
G
Top6bl
TOP6B like initiator of meiotic double strand breaks
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TOP6BL mRNA
CTD
PMID:15336504
NCBI chr 1:211,331,973...211,419,015
G
Tp53
tumor protein p53
multiple interactions decreases expression increases expression increases glutathionylation increases phosphorylation
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TP53 mRNA; Antineoplastic Agents, Immunological inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TP53 mRNA]; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of TP53 mRNA]; Niacinamide inhibits the reaction [tert-Butylhydroperoxide results in increased expression of TP53 protein]; S-ethyl glutathione inhibits the reaction [tert-Butylhydroperoxide results in increased expression of TP53 protein modified form] tert-Butylhydroperoxide results in decreased expression of TP53 mRNA tert-Butylhydroperoxide results in increased glutathionylation of TP53 protein Catechin inhibits the reaction [tert-Butylhydroperoxide results in increased phosphorylation of TRP53 protein] tert-Butylhydroperoxide results in increased expression of TRP53 mRNA; tert-Butylhydroperoxide results in increased expression of TRP53 protein
CTD
PMID:12419474 PMID:12782109 PMID:15879681 PMID:17555331 PMID:18619952 PMID:35690295 More...
NCBI chr10:54,798,871...54,810,300
Ensembl chr10:54,300,048...54,311,524
G
Tp53bp1
tumor protein p53 binding protein 1
decreases expression decreases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of TP53BP1 mRNA tert-Butylhydroperoxide results in decreased methylation of TP53BP1 gene
CTD
PMID:27509014
NCBI chr 3:128,620,320...128,724,716
Ensembl chr 3:108,169,980...108,269,822
G
Tp53i3
tumor protein p53 inducible protein 3
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TP53I3 mRNA
CTD
PMID:15336504
NCBI chr 6:33,537,779...33,545,204
G
Tp73
tumor protein p73
decreases expression increases methylation
ISO
tert-Butylhydroperoxide results in decreased expression of TP73 mRNA tert-Butylhydroperoxide results in increased methylation of TP73 gene
CTD
PMID:27509014
NCBI chr 5:169,903,801...169,988,075
Ensembl chr 5:164,621,377...164,681,128
G
Tpd52l1
TPD52 like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TPD52L1 mRNA
CTD
PMID:15336504
NCBI chr 1:27,991,114...28,109,767
Ensembl chr 1:26,172,170...26,291,109
G
Tpgs2
tubulin polyglutamylase complex subunit 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TPGS2 mRNA
CTD
PMID:15336504
NCBI chr18:16,432,628...16,489,604
Ensembl chr18:16,422,238...16,489,570
G
Tpm2
tropomyosin 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TPM2 mRNA
CTD
PMID:15336504
NCBI chr 5:62,566,712...62,576,066
Ensembl chr 5:57,770,864...57,779,992
G
Tpp1
tripeptidyl peptidase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TPP1 mRNA
CTD
PMID:12419474 PMID:15336504
NCBI chr 1:169,509,816...169,515,939
Ensembl chr 1:160,096,833...160,104,129
G
Tpsab1
tryptase alpha/beta 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TPSAB1 mRNA
CTD
PMID:15003993
NCBI chr10:14,864,887...14,867,302
Ensembl chr10:14,360,396...14,362,811
G
Tpst2
tyrosylprotein sulfotransferase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TPST2 mRNA
CTD
PMID:15336504
NCBI chr12:49,982,281...50,024,489
Ensembl chr12:44,321,875...44,362,329
G
Traf1
TNF receptor-associated factor 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRAF1 mRNA
CTD
PMID:15003993
NCBI chr 3:38,607,707...38,639,641
Ensembl chr 3:18,222,054...18,241,807
G
Traf2
Tnf receptor-associated factor 2
multiple interactions
ISO
Acetylcysteine inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]; ETFA mutant form inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]]; tert-Butylhydroperoxide promotes the reaction [ERN1 protein binds to TRAF2 protein]
CTD
PMID:24394546
NCBI chr 3:28,740,098...28,764,752
Ensembl chr 3:8,341,951...8,366,538
G
Traf4
Tnf receptor associated factor 4
increases expression increases methylation
ISO
tert-Butylhydroperoxide results in increased expression of TRAF4 mRNA tert-Butylhydroperoxide results in increased methylation of TRAF4 gene
CTD
PMID:27509014
NCBI chr10:63,552,251...63,558,356
Ensembl chr10:63,054,181...63,060,284
G
Trak1
trafficking kinesin protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TRAK1 mRNA
CTD
PMID:15336504
NCBI chr 8:129,861,967...130,016,870
Ensembl chr 8:120,984,431...121,139,367
G
Tram1
translocation associated membrane protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TRAM1 mRNA
CTD
PMID:15336504
NCBI chr 5:10,425,710...10,450,669
Ensembl chr 5:5,642,546...5,686,971
G
Trappc1
trafficking protein particle complex subunit 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRAPPC1 mRNA
CTD
PMID:15003993
NCBI chr10:54,544,406...54,545,992
Ensembl chr10:54,045,537...54,047,331
G
Triap1
TP53 regulated inhibitor of apoptosis 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRIAP1 mRNA
CTD
PMID:15336504
NCBI chr12:46,928,273...46,930,766
Ensembl chr12:41,267,549...41,270,042
G
Trib1
tribbles pseudokinase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRIB1 mRNA
CTD
PMID:15336504
NCBI chr 7:93,096,001...93,102,547
Ensembl chr 7:91,206,579...91,214,731
G
Trib2
tribbles pseudokinase 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TRIB2 mRNA
CTD
PMID:15336504
NCBI chr 6:44,274,762...44,299,139
Ensembl chr 6:38,545,975...38,569,370
G
Trim21
tripartite motif-containing 21
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRIM21 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:166,376,829...166,399,441
Ensembl chr 1:156,964,913...156,987,440
G
Trim25
tripartite motif-containing 25
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRIM25 mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr10:74,310,024...74,328,473
Ensembl chr10:73,812,818...73,831,257
G
Trio
trio Rho guanine nucleotide exchange factor
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRIO mRNA
CTD
PMID:15336504
NCBI chr 2:80,235,485...80,531,824
Ensembl chr 2:78,505,070...78,803,135
G
Triobp
TRIO and F-actin binding protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TRIOBP mRNA
CTD
PMID:15336504
NCBI chr 7:112,386,371...112,452,130
Ensembl chr 7:110,506,248...110,562,474
G
Trip6
thyroid hormone receptor interactor 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TRIP6 mRNA
CTD
PMID:15336504
NCBI chr12:25,022,959...25,027,366
Ensembl chr12:19,386,014...19,390,618
G
Trpv2
transient receptor potential cation channel, subfamily V, member 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TRPV2 mRNA
CTD
PMID:15336504
NCBI chr10:47,772,223...47,797,956
Ensembl chr10:47,272,931...47,294,260
G
Trrap
transformation/transcription domain-associated protein
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TRRAP mRNA
CTD
PMID:15336504
NCBI chr12:14,851,758...14,941,444
Ensembl chr12:9,738,006...9,827,674
G
Tsc22d2
TSC22 domain family, member 2
affects expression
ISO
tert-Butylhydroperoxide affects the expression of TSC22D2 mRNA
CTD
PMID:23410634
NCBI chr 2:144,796,760...144,847,930
Ensembl chr 2:142,644,744...142,693,606
G
Tsg101
tumor susceptibility 101
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TSG101 mRNA
CTD
PMID:12419474
NCBI chr 1:106,549,035...106,578,859
Ensembl chr 1:97,410,848...97,442,554
G
Tshb
thyroid stimulating hormone subunit beta
decreases activity increases oxidation
ISO
tert-Butylhydroperoxide results in decreased activity of TSHB protein tert-Butylhydroperoxide results in increased oxidation of TSHB protein
CTD
PMID:14751029
NCBI chr 2:192,913,171...192,918,054
Ensembl chr 2:190,224,676...190,229,559
G
Tspan14
tetraspanin 14
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TSPAN14 mRNA
CTD
PMID:15336504
NCBI chr16:16,818,344...16,875,462
Ensembl chr16:16,783,234...16,841,400
G
Tspan3
tetraspanin 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TSPAN3 mRNA
CTD
PMID:15336504
NCBI chr 8:56,546,067...56,569,815
Ensembl chr 8:56,546,069...56,569,880
G
Tspan31
tetraspanin 31
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TSPAN31 mRNA
CTD
PMID:12419474
NCBI chr 7:64,774,881...64,783,534
Ensembl chr 7:62,889,552...62,898,388
G
Tspan5
tetraspanin 5
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TSPAN5 mRNA
CTD
PMID:15336504
NCBI chr 2:229,967,521...230,139,012
Ensembl chr 2:227,294,217...227,465,664
G
Tspan9
tetraspanin 9
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TSPAN9 mRNA
CTD
PMID:15003993
NCBI chr 4:162,500,029...162,681,699
Ensembl chr 4:160,813,879...160,995,501
G
Ttc3
tetratricopeptide repeat domain 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TTC3 mRNA
CTD
PMID:15336504
NCBI chr11:47,158,766...47,258,612
Ensembl chr11:33,688,952...33,788,975
G
Tuba1a
tubulin, alpha 1A
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TUBA1A mRNA
CTD
PMID:12414654
NCBI chr 7:131,992,151...131,996,850
Ensembl chr 7:130,081,032...130,196,186
G
Tuba1b
tubulin, alpha 1B
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TUBA1B mRNA; tert-Butylhydroperoxide results in decreased expression of TUBA1B protein
CTD
PMID:12419474 PMID:15050405
NCBI chr 7:131,969,606...131,972,587
Ensembl chr 7:130,081,032...130,196,186
G
Tubb2a
tubulin, beta 2A class IIa
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TUBB2A mRNA
CTD
PMID:14729362
NCBI chr17:31,002,186...31,006,057
Ensembl chr17:30,747,503...30,800,714
G
Tubb2b
tubulin, beta 2B class IIb
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TUBB2B mRNA
CTD
PMID:15336504
NCBI chr17:30,953,086...30,956,133
Ensembl chr17:30,747,734...30,750,638
G
Tubgcp3
tubulin gamma complex component 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TUBGCP3 mRNA
CTD
PMID:15336504
NCBI chr16:83,553,950...83,614,626
Ensembl chr16:76,851,810...76,912,499
G
Tulp3
TUB like protein 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TULP3 mRNA
CTD
PMID:15336504
NCBI chr 4:163,276,583...163,318,297
Ensembl chr 4:161,590,479...161,632,149
G
Tusc3
tumor suppressor candidate 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TUSC3 mRNA
CTD
PMID:15336504
NCBI chr16:59,899,642...60,048,813
Ensembl chr16:53,196,195...53,344,781
G
Txn1
thioredoxin 1
decreases response to substance
ISO
TXN protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:10754530
NCBI chr 5:77,507,455...77,519,685
Ensembl chr 5:72,711,933...72,724,629
G
Txn2
thioredoxin 2
increases oxidation decreases response to substance
ISO
tert-Butylhydroperoxide results in increased oxidation of TXN2 protein TXN2 protein results in decreased susceptibility to tert-Butylhydroperoxide
CTD
PMID:16797630 PMID:18550601
NCBI chr 7:111,377,338...111,390,940
Ensembl chr 7:109,496,761...109,510,359
G
Txnip
thioredoxin interacting protein
decreases expression decreases response to substance increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of TXNIP mRNA TXNIP protein results in decreased susceptibility to tert-Butylhydroperoxide tert-Butylhydroperoxide results in increased expression of TXNIP mRNA
CTD
PMID:14729362 PMID:15003993 PMID:15336504
NCBI chr 2:186,781,933...186,785,736
Ensembl chr 2:184,092,991...184,096,886
G
Txnl1
thioredoxin-like 1
multiple interactions increases expression
ISO
LGM2605 promotes the reaction [tert-Butylhydroperoxide results in increased expression of TXNL1 mRNA]
CTD
PMID:31627909
NCBI chr18:59,397,275...59,428,072
Ensembl chr18:57,125,369...57,165,266
G
Txnrd1
thioredoxin reductase 1
multiple interactions increases expression
ISO
MT2A protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of TXNRD1 mRNA]
CTD
PMID:12414654 PMID:16636651
NCBI chr 7:22,717,620...22,802,553
Ensembl chr 7:20,830,045...20,907,863
G
Txnrd2
thioredoxin reductase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TXNRD2 mRNA
CTD
PMID:14729362 PMID:15336504
NCBI chr11:96,024,321...96,072,475
Ensembl chr11:82,519,999...82,568,156
G
Tymp
thymidine phosphorylase
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of TYMP mRNA
CTD
PMID:14729362
NCBI chr 7:122,318,396...122,323,716
Ensembl chr 7:120,438,770...120,443,874 Ensembl chr 7:120,438,770...120,443,874
G
Uba7
ubiquitin-like modifier activating enzyme 7
decreases expression increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in decreased expression of UBA7 mRNA; tert-Butylhydroperoxide results in decreased expression of UBA7 protein tert-Butylhydroperoxide results in increased expression of UBA7 mRNA Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of UBA7 protein]
CTD
PMID:15003993 PMID:15336504 PMID:25649257
NCBI chr 8:117,543,902...117,552,709
Ensembl chr 8:108,665,292...108,674,099
G
Ubap2
ubiquitin-associated protein 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UBAP2 mRNA
CTD
PMID:14729362
NCBI chr 5:61,144,182...61,233,355
Ensembl chr 5:56,348,246...56,437,049
G
Ube2c
ubiquitin-conjugating enzyme E2C
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UBE2C mRNA
CTD
PMID:12414654
NCBI chr 3:173,925,975...173,928,375
Ensembl chr 3:153,506,636...153,513,339
G
Ube2e1
ubiquitin-conjugating enzyme E2E 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of UBE2E1 mRNA
CTD
PMID:15336504
NCBI chr15:9,870,528...9,924,194
Ensembl chr15:7,439,759...7,493,400
G
Ube2k
ubiquitin-conjugating enzyme E2K
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of UBE2K mRNA
CTD
PMID:15336504
NCBI chr14:43,011,681...43,077,825
Ensembl chr14:42,658,016...42,718,630
G
Ube2l6
ubiquitin-conjugating enzyme E2L 6
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of UBE2L6 mRNA
CTD
PMID:15003993
NCBI chr 3:90,279,705...90,294,721
Ensembl chr 3:69,873,424...69,888,048
G
Ube3c
ubiquitin protein ligase E3C
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UBE3C mRNA
CTD
PMID:15336504
NCBI chr 4:6,323,831...6,425,085
Ensembl chr 4:5,648,690...5,750,011
G
Ubl5
ubiquitin-like 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UBL5 mRNA
CTD
PMID:15336504
NCBI chr 8:27,457,738...27,461,458
Ensembl chr 8:19,181,615...19,185,217
G
Ubxn7
UBX domain protein 7
decreases expression increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UBXN7 mRNA tert-Butylhydroperoxide results in increased expression of UBXN7 mRNA
CTD
PMID:15336504
NCBI chr11:68,427,896...68,460,100
G
Uck2
uridine-cytidine kinase 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of UCK2 mRNA
CTD
PMID:15336504
NCBI chr13:81,913,732...81,971,036
Ensembl chr13:79,383,846...79,438,352
G
Umps
uridine monophosphate synthetase
multiple interactions decreases expression
ISO
[pioglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of UMPS mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of UMPS mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in decreased expression of UMPS mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of UMPS mRNA]
CTD
PMID:20847119
NCBI chr11:80,311,269...80,321,678
Ensembl chr11:66,806,045...66,821,903
G
Ung
uracil-DNA glycosylase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UNG mRNA
CTD
PMID:12414654
NCBI chr12:48,145,838...48,154,789
Ensembl chr12:42,485,276...42,494,206
G
Upb1
beta-ureidopropionase 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UPB1 mRNA
CTD
PMID:29432895
NCBI chr20:13,216,693...13,243,016
Ensembl chr20:13,217,258...13,243,590
G
Upf3a
UPF3A, regulator of nonsense mediated mRNA decay
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of UPF3A mRNA
CTD
PMID:15336504
NCBI chr16:82,459,651...82,470,686
Ensembl chr16:75,757,441...75,769,345
G
Upp1
uridine phosphorylase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of UPP1 mRNA
CTD
PMID:15336504
NCBI chr14:88,023,155...88,043,036
Ensembl chr14:83,809,960...83,829,462
G
Uqcrfs1
ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1
multiple interactions
EXP
[tert-Butylhydroperoxide co-treated with Calcium Chloride] results in decreased phosphorylation of UQCRFS1 protein; Cyclosporine inhibits the reaction [[tert-Butylhydroperoxide co-treated with Calcium Chloride] results in decreased phosphorylation of UQCRFS1 protein]
CTD
PMID:16023995
NCBI chr17:34,173,787...34,190,952
Ensembl chr17:33,977,921...33,982,479
G
Usp17la
ubiquitin specific peptidase 17-like A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of USP17LA mRNA
CTD
PMID:14729362 PMID:15003993
NCBI chr 1:159,165,961...159,169,738
G
Usp18
ubiquitin specific peptidase 18
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of USP18 mRNA
CTD
PMID:15003993
NCBI chr 4:156,143,770...156,171,292
Ensembl chr 4:154,471,592...154,499,144
G
Usp21
ubiquitin specific peptidase 21
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of USP21 mRNA
CTD
PMID:15336504
NCBI chr13:86,235,122...86,241,663
Ensembl chr13:83,702,631...83,708,717
G
Usp22
ubiquitin specific peptidase 22
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of USP22 mRNA
CTD
PMID:15003993
NCBI chr10:46,328,092...46,354,939
Ensembl chr10:45,828,622...45,855,497
G
Usp9x
ubiquitin specific peptidase 9, X-linked
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of USP9X mRNA
CTD
PMID:15336504
NCBI chr X:12,261,633...12,399,780
Ensembl chr X:9,588,825...9,696,711
G
Utp14a
UTP14A small subunit processome component
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of UTP14A mRNA
CTD
PMID:15336504
NCBI chr X:132,317,163...132,342,524
Ensembl chr X:127,439,268...127,464,633
G
Utp25
UTP25 small subunit processome component
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of UTP25 mRNA
CTD
PMID:15336504
NCBI chr13:107,159,092...107,180,361
Ensembl chr13:104,630,391...104,651,662
G
Vamp1
vesicle-associated membrane protein 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of VAMP1 mRNA
CTD
PMID:15336504
NCBI chr 4:159,698,894...159,705,582
Ensembl chr 4:158,012,663...158,019,349
G
Vasn
vasorin
multiple interactions increases expression
ISO
[Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VASN mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VASN mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VASN mRNA; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VASN mRNA]; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VASN mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VASN mRNA]
CTD
PMID:20847119
NCBI chr10:11,424,174...11,434,681
Ensembl chr10:10,917,605...10,928,357
G
Vcam1
vascular cell adhesion molecule 1
decreases expression multiple interactions increases expression
ISO
tert-Butylhydroperoxide results in decreased expression of VCAM1 mRNA 1-(3,4-dihydroxyphenyl)-3-(2-methoxyphenyl)prop-2-en-1-one inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VCAM1 mRNA]; LY96 protein promotes the reaction [tert-Butylhydroperoxide results in increased expression of VCAM1 mRNA]
CTD
PMID:12419474 PMID:28063877
NCBI chr 2:206,723,050...206,742,783
Ensembl chr 2:204,038,114...204,057,958
G
Vcan
versican
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of VCAN mRNA
CTD
PMID:15336504
NCBI chr 2:22,497,035...22,595,955
Ensembl chr 2:20,761,718...20,860,637
G
Vdac2
voltage-dependent anion channel 2
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of VDAC2 mRNA
CTD
PMID:15336504
NCBI chr15:2,512,214...2,526,105
Ensembl chr15:2,463,056...2,476,553
G
Vegfa
vascular endothelial growth factor A
multiple interactions increases secretion increases expression
ISO
[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA; [Pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA; [Rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA; [Troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA; MIR184 mRNA inhibits the reaction [[Deferoxamine co-treated with tert-Butylhydroperoxide] results in increased expression of VEGFA mRNA]; Pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VEGFA mRNA]; Rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VEGFA mRNA]; Troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of VEGFA mRNA] tert-Butylhydroperoxide results in increased secretion of VEGFA protein tert-Butylhydroperoxide results in increased expression of VEGFA mRNA; tert-Butylhydroperoxide results in increased expression of VEGFA protein
CTD
PMID:15336504 PMID:17200665 PMID:20847119 PMID:35690295
NCBI chr 9:22,452,854...22,468,194
Ensembl chr 9:14,955,300...14,970,641
G
Vegfc
vascular endothelial growth factor C
increases secretion increases expression
ISO
tert-Butylhydroperoxide results in increased secretion of VEGFC protein tert-Butylhydroperoxide results in increased expression of VEGFC mRNA; tert-Butylhydroperoxide results in increased expression of VEGFC protein
CTD
PMID:15336504 PMID:17200665
NCBI chr16:44,445,293...44,560,887
Ensembl chr16:37,712,262...37,827,848
G
Vgll4
vestigial-like family member 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of VGLL4 mRNA
CTD
PMID:15336504
NCBI chr 4:149,598,151...149,711,186
Ensembl chr 4:147,927,034...148,038,471
G
Vim
vimentin
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of VIM protein
CTD
PMID:15050405
NCBI chr17:81,577,261...81,585,746
Ensembl chr17:76,668,647...76,677,187
G
Vsnl1
visinin-like 1
affects expression
ISO
tert-Butylhydroperoxide affects the expression of VSNL1 mRNA
CTD
PMID:23410634
NCBI chr 6:39,757,721...39,878,556
Ensembl chr 6:34,038,642...34,159,479
G
Wbp11
WW domain binding protein 11
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of WBP11 mRNA
CTD
PMID:15336504
NCBI chr 4:171,412,187...171,425,634
Ensembl chr 4:169,680,983...169,694,443
G
Wdr1
WD repeat domain 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of WDR1 mRNA
CTD
PMID:15336504
NCBI chr14:76,470,238...76,504,086
Ensembl chr14:72,257,956...72,291,766
G
Wdr26
WD repeat domain 26
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of WDR26 mRNA
CTD
PMID:15336504
NCBI chr13:95,462,017...95,503,826
Ensembl chr13:92,930,285...92,977,295
G
Wdr43
WD repeat domain 43
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of WDR43 mRNA
CTD
PMID:15336504
NCBI chr 6:29,565,610...29,604,954
Ensembl chr 6:23,845,499...23,884,846
G
Wdr77
WD repeat domain 77
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of WDR77 mRNA
CTD
PMID:15336504
NCBI chr 2:196,123,882...196,133,853
Ensembl chr 2:193,435,468...193,445,520
G
Wee1
WEE1 G2 checkpoint kinase
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of WEE1 mRNA
CTD
PMID:15336504
NCBI chr 1:173,605,609...173,632,450
Ensembl chr 1:164,174,779...164,197,688
G
Wipi1
WD repeat domain, phosphoinositide interacting 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of WIPI1 mRNA
CTD
PMID:15336504
NCBI chr10:95,042,451...95,079,679
Ensembl chr10:94,542,946...94,579,846
G
Wnt4
Wnt family member 4
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of WNT4 mRNA
CTD
PMID:15003993
NCBI chr 5:154,797,245...154,818,565
Ensembl chr 5:149,514,018...149,532,859
G
Xcr1
X-C motif chemokine receptor 1
increases methylation
ISO
tert-Butylhydroperoxide results in increased methylation of XCR1 exon
CTD
PMID:29432895
NCBI chr 8:132,357,020...132,393,596
Ensembl chr 8:123,479,590...123,487,226
G
Xist
X inactive specific transcript
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of XIST mRNA
CTD
PMID:15336504
NCBI chr X:72,540,753...72,558,266
G
Xpnpep1
X-prolyl aminopeptidase 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of XPNPEP1 mRNA
CTD
PMID:15336504
NCBI chr 1:262,006,761...262,057,479
Ensembl chr 1:252,001,367...252,051,479
G
Xpnpep3
X-prolyl aminopeptidase 3
increases expression decreases methylation
ISO
tert-Butylhydroperoxide results in increased expression of XPNPEP3 mRNA tert-Butylhydroperoxide results in decreased methylation of XPNPEP3 gene
CTD
PMID:29432895
NCBI chr 7:114,806,398...114,858,934
Ensembl chr 7:112,926,248...112,974,878
G
Ybx3
Y box binding protein 3
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of YBX3 mRNA
CTD
PMID:12419474
NCBI chr 4:166,861,180...166,884,532
Ensembl chr 4:165,129,758...165,153,161
G
Yipf2
Yip1 domain family, member 2
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of YIPF2 mRNA
CTD
PMID:15336504
NCBI chr 8:28,417,254...28,421,455
Ensembl chr 8:20,141,155...20,145,339
G
Ypel1
yippee-like 1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of YPEL1 mRNA
CTD
PMID:15336504
NCBI chr11:97,426,012...97,440,646
G
Ythdf1
YTH N6-methyladenosine RNA binding protein F1
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of YTHDF1 mRNA
CTD
PMID:15003993
NCBI chr 3:188,402,228...188,417,740
Ensembl chr 3:168,024,663...168,040,172
G
Ywhah
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of YWHAH mRNA
CTD
PMID:12419474
NCBI chr14:81,920,819...81,930,202
Ensembl chr14:77,696,333...77,705,741
G
Zap70
zeta chain of T cell receptor associated protein kinase 70
increases expression
EXP
tert-Butylhydroperoxide results in increased expression of ZAP70 mRNA
CTD
PMID:22659508
NCBI chr 9:46,485,605...46,507,552
Ensembl chr 9:38,989,750...39,011,700
G
Zbtb5
zinc finger and BTB domain containing 5
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ZBTB5 mRNA
CTD
PMID:15336504
NCBI chr 5:64,039,805...64,062,451
Ensembl chr 5:59,243,307...59,265,426
G
Zc3h11a
zinc finger CCCH-type containing 11A
multiple interactions increases expression
ISO
pioglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZC3H11A mRNA]; rosiglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZC3H11A mRNA]; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZC3H11A mRNA]
CTD
PMID:20847119
NCBI chr13:47,625,444...47,665,971
Ensembl chr13:45,071,718...45,114,009
G
Zc3h12a
zinc finger CCCH type containing 12A
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ZC3H12A mRNA
CTD
PMID:15336504
NCBI chr 5:142,661,193...142,670,051
Ensembl chr 5:137,376,564...137,385,351
G
Zdhhc4
zinc finger DHHC-type palmitoyltransferase 4
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ZDHHC4 mRNA
CTD
PMID:15336504
NCBI chr12:16,344,447...16,358,493
Ensembl chr12:11,230,902...11,244,898
G
Zdhhc6
zinc finger DHHC-type palmitoyltransferase 6
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ZDHHC6 mRNA
CTD
PMID:15003993
NCBI chr 1:264,340,883...264,361,435
Ensembl chr 1:254,335,113...254,356,108
G
Zfp217
zinc finger protein 217
affects expression
ISO
tert-Butylhydroperoxide affects the expression of ZNF217 mRNA
CTD
PMID:23410634
NCBI chr 3:179,309,178...179,349,853
Ensembl chr 3:158,892,265...158,913,040
G
Zfp36
zinc finger protein 36
increases expression multiple interactions
ISO
tert-Butylhydroperoxide results in increased expression of ZFP36 mRNA [pioglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ZFP36 mRNA; [rosiglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ZFP36 mRNA; [troglitazone co-treated with tert-Butylhydroperoxide] results in increased expression of ZFP36 mRNA; troglitazone inhibits the reaction [tert-Butylhydroperoxide results in increased expression of ZFP36 mRNA]
CTD
PMID:20847119
NCBI chr 1:92,796,628...92,799,108
Ensembl chr 1:83,669,084...83,671,564
G
Zfp395
zinc finger protein 395
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ZNF395 mRNA
CTD
PMID:15336504
NCBI chr15:43,757,350...43,797,513
Ensembl chr15:39,608,080...39,619,950
G
Zfp593
zinc finger protein 593
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ZNF593 mRNA
CTD
PMID:15336504
NCBI chr 5:146,462,670...146,464,998
Ensembl chr 5:146,462,670...146,465,198
G
Zfyve16
zinc finger FYVE-type containing 16
decreases expression
ISO
tert-Butylhydroperoxide results in decreased expression of ZFYVE16 mRNA
CTD
PMID:15336504
NCBI chr 2:25,448,264...25,495,180
Ensembl chr 2:23,713,766...23,756,990
G
Zmiz1
zinc finger, MIZ-type containing 1
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ZMIZ1 mRNA
CTD
PMID:15336504
NCBI chr16:1,033,983...1,239,425
Ensembl chr16:1,027,325...1,232,597
G
Zmynd19
zinc finger, MYND-type containing 19
increases methylation
ISO
tert-Butylhydroperoxide results in increased methylation of ZMYND19 gene
CTD
PMID:29432895
NCBI chr 3:28,156,314...28,167,903
Ensembl chr 3:7,758,133...7,767,514
G
Znhit1
zinc finger, HIT-type containing 1
increases expression decreases expression
ISO
tert-Butylhydroperoxide results in increased expression of ZNHIT1 mRNA tert-Butylhydroperoxide results in decreased expression of ZNHIT1 mRNA
CTD
PMID:15003993 PMID:15336504
NCBI chr12:25,323,292...25,329,566
Ensembl chr12:19,686,148...19,692,880
G
Zpr1
ZPR1 zinc finger
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ZPR1 mRNA
CTD
PMID:15336504
NCBI chr 8:55,461,839...55,471,413
Ensembl chr 8:46,565,146...46,574,719
G
Zswim7
zinc finger, SWIM-type containing 7
increases expression
ISO
tert-Butylhydroperoxide results in increased expression of ZSWIM7 mRNA
CTD
PMID:15003993
NCBI chr10:47,456,843...47,469,084
Ensembl chr10:46,957,525...46,969,671
G
Zyx
zyxin
decreases expression affects expression
ISO
tert-Butylhydroperoxide results in decreased expression of ZYX mRNA tert-Butylhydroperoxide affects the expression of ZYX mRNA
CTD
PMID:12419474 PMID:23410634
NCBI chr 4:72,203,991...72,213,181
Ensembl chr 4:71,237,451...71,246,553
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all